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African lungfishes (Protopterus spp) can aestivate without food and water for many 
years. Disuse muscle atrophy is not prominent during aestivation, and lungfish 
aroused from aestivation can struggle out of the cocoon. Hence, there could be a tight 
regulation of genes/proteins involved in muscle formation and muscle degradation, 
and in oxidative defense as disuse muscle atrophy is partially attributable to oxidative 
damages, in the aestivating fish. This study aimed to sequence certain genes known to 
be involved in muscle formation [peroxisome proliferator-activated receptor-γ 
coactivator-1α, myogenic differentiation 1 (myod1), myogenin, mitogen-activated 
protein kinases 1 and 3] or muscle degradation [histone deacetylase 1, forkhead box 
O1 (foxO1), forkhead box O3, myostatin (mstn) and F-box protein 32 (fbxo32)] from 
the skeletal muscle of Protopterus annectens, and to determine the effects of 
aestivation on their mRNA expression levels and protein abundances. Efforts were 
also made to determine effects of aestivation on (1) the mRNA expression levels and 
protein abundances of genes/proteins involved in oxidative defense [copper-zinc 
superoxide dismutase (CuZnsod/CuZnSod), manganese superoxide dismutase 
(Mnsod/MnSod), catalase (cat/Cat), glutathione peroxidases 1 (gpx1/Gpx1) and 4 
(gpx4/Gpx4)], (2) the specific activities of Sod, Cat, Gpx, Glutathione reductase and 
Glutathione-S-transferase, and (3) the levels of several oxidative stress markers in the 
skeletal muscle. During the induction phase of aestivation, probably due to the short 
period of fasting and incompleteness of muscle disuse, the expressions of various 
genes/proteins involved in muscle formation and muscle degradation underwent only 
minor changes, of which only tp53 and Fbxo32 increased and decreased, respectively. 
 ii 
 
These results indicate a possible suppression of muscle degradation, which does not 
support the proposition that tissue reconstruction elsewhere involves the mobilization 
of proteins/amino acids from the muscle. The increases in Cat protein abundance, Gr 
activity, [GSSG] and [GSSG]/[GSH], and lack of changes in the levels of oxidative 
damage products demonstrate the robustness of the antioxidant defense system in the 
muscle of P. annectens. During the maintenance phase of aestivation, despite the 
aestivating lungfish undergoing severe fasting, the expressions of genes/proteins 
involved in muscle formation and degradation were maintained at control levels, 
except for Myod1 which displayed an increase in the protein abundance. Muscle 
mass preservation was probably achieved by maintaining a certain rate of protein 
synthesis and suppressing fasting- and/or disuse-induced increase in muscle 
degradation. An upregulation in the protein abundance of CuZnSod, but not MnSod, 
suggests that CuZnSod could be the main Sod protecting the muscle from oxidative 
damage. Increases in the expression of gpx4/Gpx4 and [GSH] indicate that the 
antioxidant capacity in the skeletal muscle of P. annectens was up-regulated. During 
the arousal phase of aestivation, the expression of genes/proteins involved in muscle 
formation remained unchanged. Muscle degradation was likely suppressed, with 
decreases in protein abundance of FoxO1, Mstn and Fbxo32, indicating that muscle 
protein was not mobilized for tissue reconstruction and regenerating. Increases in 
MnSod activity and protein abundances of CuZnSod, Cat and Gpx1, coupled with 
decreases in the concentrations of oxidative damage products, indicate that arousal 
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Notes on abbreviations 
Two different types of abbreviations were adopted in this study for gene and protein 
symbols. This is because the standard abbreviations of genes/proteins of fishes 
(http://zfin.org/cgi-bin/webdriver?MIval=aa-ZDB_home.apg) are different from those 
of frogs and human/non-human primates (http://www.genenames.org).  
Specifically, for fishes, gene symbols are italicized, all in lower case, and 
protein designations are the same as the gene symbol, but not italicized with the first 
letter in upper case. The advantage and appropriateness of using two types of 
abbreviations is that it would allow immediate interpretation of the affiliation 
between the abbreviation with fish or human/non-human primates. All abbreviations 




1. Literature review 
1.1. Lungfishes 
Lungfishes belong to a unique clade of sarcopterygian fishes and are considered to be 
the most closely related living species to the ancestor of tetrapods (Forey, 1986; 
Meyer and Wilson, 1990; Marshall and Schultze, 1992; Tohyama et al., 2000; Perry 
et al., 2001; Brinkmann et al., 2004; Amemiya et al., 2013). There are three extant 
genera of lungfishes, Protopterus, Lepidosiren and Neoceratodus, which are endemic 
species of Africa, South America and Australia, respectively. These three genera of 
lungfishes have evolved separately since the beginning of the continental drift which 
promoted the splitting of big continents (de Almeida-Val et al., 2015). Protopterids 
share similar morphological characteristics with Lepidosiren. Based on this, 
Protopterus and Lepidosiren consist of one lineage which is apparently unchanged 
from the ancestral Dipterus of the Carboniferous Period, and is thus regarded as the 
mainline of dipnoan evolution (Graham, 1997). However, Neoceratodus is a 
descendant of the fossil form Ceratodus which occurred on all continents from the 
Triassic to Cretaceous Periods (Graham, 1997).  
There are six species of extant lungfishes, namely Lepidosiren paradoxa in 
South America (Fitzinger, 1837), Neoceratodus forsteri in Australia (Krefft, 1870) 
and Protopterus annectens (Owen, 1839), P. amphibius (Peters, 1844), P. aethiopicus 
(Heckel, 1851) and P. dolloi (Boulenger, 1900) in Africa. Commonly found in the 
Amazon River basin of South America, L. paradoxa inhabits stagnant or lentic water 
systems (Lowe-McConnell, 1987; Planquette et al., 1996). In Australia, N. forsteri is 
restricted to the river channels and tributary streams within Southeast Queensland 
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(Kind, 2010). The four African lungfishes have a broad geographical distribution in 
Africa (de Almeida-Val et al., 2015). Protopterus aethiopicus is extensively 
distributed in eastern and central Africa, surrounding Congo, Nile Rivers and Lakes 
Victoria, Tanganyika, Albert, Edward, George, and Kyoga (de Almeida-Val et al., 
2015). Protopterus amphibius is distributed in East Africa, while P. annectens is 
found in western Africa and in the Zambezi and Limpopo Rivers of southern Africa 
(de Almeida-Val et al., 2015). Protopterus dolloi is found mainly in the Congo basin 
(de Almeida-Val et al., 2015). Although sympatric populations of the four African 
lungfishes are rare considering their natural geographical distribution, they may still 
co-occur in some places (Mlewa et al., 2010). 
The lungfishes (subclass Dipnoi) possess lungs and are able to breathe air, and 
are described as bimodal breathers. Dipnoans deviate from other sarcopterygians in 
having a mosaic of bones (Schultze, 2015). However, extant lungfishes show 
reductions and fusions of the skull roof bones, which demonstrate no homology with 
the skull roof bones of tetrapods or actinopterygians (de Almeida-Val et al., 2015). 
The separation of Dipnoi as a discrete group is based mainly on the structure and 
arrangement of the skull bones, the teeth, and the endoskeleton of the paired fins (de 
Almeida-Val et al., 2015).  
There are two orders of Dipnoi, which are distinguishable based mainly on the 
number of lungs possessed: Ceratodontiformes which comprises Neoceratodus, and 
Lepidosireniformes which includes both Protopterus and Lepidosiren. 
Ceratodontiformes have only one lung, while Lepidosireniformes have two lungs that 
are fused anteriorly. Neoceratodus forsteri has robust flipper-like pectoral and pelvic 
 3 
 
fins, larger scales and a more laterally compressed body (Thomson, 1969; Kemp, 
1986; Nelson, 2006). In addition, N. forsteri is a bimodal air-breather and possesses 
well-developed gills, which support respiration in well-aerated waters, and a dorsal 
lung, which is used when oxygen levels are low or in forced exercise. By contrast, L. 
paradoxa and the Protopterus spp. exhibit elongated bodies, filamentous pectoral and 
pelvic fins, and their dorsal caudal and anal fins are fused into one continuous 
diphycercal tail (Bemis et al., 1987). As their gills do not allow them to breathe 
exclusively in water, L. paradoxa and the Protopterus spp. are obligate air-breathers, 
and they have to gulp atmospheric air to supply their oxygen requirements. The larval 
stage of L. paradoxa and the Protopterus spp., but not N. forsteri, possesses external 
gills (de Almeida-Val et al., 2015). Although L. paradoxa and the Protopterus spp. 
share morphological similarities, Protopterus spp. has an additional gill arch (5 
versus 4) and lacks the hyper-vascularised pelvic fins that L. paradoxa males develop 
during the spawning season (Mlewa et al., 2010). 
Within Protopterus, the body of P. amphibius is uniformly blue or slaty-green 
with small or inconspicuous black spots, whereas the body of P. annectens is olive or 
brown at the dorsal side and lighter at the ventral side, with black and brown spots on 
the body and fins except on the belly (Trewavas, 1954). Both P. annectens and P. 
amphibius have broad membranes on its pectoral fins, and retain three external gills 
on each side near the operculum for life, with P. annectens possessing smaller 
external gills than P. amphibius (Mlewa et al., 2010). The body of P. dolloi is brown 
and relatively slender, whereas the body of P. aethiopicus is more cylindrical with a 
pinkish toned ground colour or yellowish gray colour with dark slate-gray splotches 
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(Bailey, 1994). This creates a marbling effect over the body and fins of P. aethiopicus 
(Bailey, 1994). The colour pattern of the body of P. aethiopicus varies, with a darker 
dorsal side and a lighter ventral side (Bailey, 1994). External gills is absent in 
juveniles and adult of P. dolloi and P. aethiopicus (Greenwood, 1986). The 
Protopterus spp. can also be distinguished by the number of ribs present; P. 
amphibius has 27-30 ribs, P. annectens has 32-37 ribs, P. aethiopicus has 38-39 ribs, 
and P. dolloi has 47-55 ribs (Poll, 1961).  
1.2. Aestivation 
Aestivation is a state of torpor that is usually associated with high environmental 
temperature with absolutely no food and water intake for an extended period of time 
(Ip and Chew, 2010). From the behavioural point of view, aestivation could be 
defined as inactivity at high environmental temperature to survive arid conditions 
(except for aquatic aestivators like sponges and sea cucumbers) in terrestrial animals, 
especially during summer (Gregory, 1982; Peterson and Stone, 2000). Ultsch (1989) 
advanced the all-behaviour position and described aestivation as ‘a non-mobile 
fossorialism’. From the physiological point of view, aestivation is often associated 
with metabolic depression (Storey, 2002), because conservation of metabolic fuels 
has been regarded as an essential adaptation during long periods of aestivation 
without food intake. While this association is obviously present in endothermic 
mammals during aestivation, it remains debatable as to whether it can be universally 
applied to aestivating ectothermic animals. For instance, in aestivating turtle (Hailey 
and Loveridge, 1997), metabolic depression has been proposed to decrease both urea 
production and respiratory water loss, along with conserving metabolic fuels (Storey 
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and Storey, 1990, Guppy and Withers, 1999). Yet, whether metabolic depression in 
aestivating turtles is an adaptation to aestivation or simply a response to fasting is still 
debatable (Belkin, 1965; Sievert et al., 1988). In fact, the decrease in oxygen 
consumption in laboratory-aestivating yellow mud turtle Kinosternon flavescens is 
identical to that of fully hydrated turtles which are fasted for an equivalent period of 
time (Seidel, 1978; Hailey and Loveridge, 1997).  
While N. forsteri does not aestivate (Kemp, 1986), L. paradoxa and the 
Protopterus spp. greatly increase their chances of survival during periods of dry 
seasons by burrowing into the ground and aestivating (Johansen and Lenfant, 1967; 
Johansen et al., 1976). As lungfishes do not have limbs to facilitate locomotion on 
land, they would have to passively tolerate desiccation, and aestivation could be the 
only means for survival under dehydration at high temperature. In their natural 
environment, L. paradoxa and the Protopterus spp. inhabit swampy areas which dry 
out annually and the intensity of dryness varies according to the weather cycle of 
each year. When most of the water has dried up and only mud remains, L. paradoxa 
burrows in the mud up to 50 cm to avoid drying out (Berra, 2001), leaving two or 
three holes for breathing purposes. Lepidosiren paradoxa excavates the burrows by 
biting the soil and expelling mud through the gill openings. After finishing the 
burrow excavation, L. paradoxa turns around and remains with its head facing the 
burrow opening, so that it can obtain oxygen. However, unlike the Protopterus spp., 
L. paradoxa does not form a mucous cocoon. 
Aestivation in the Protopterus spp. covers the time between two wet seasons, 
which is normally only a fraction of a year (Johnels and Svensson, 1954). However, 
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the duration of the dry season, and hence the length of aestivation, can vary 
significantly each year. In certain areas, like Lake Edward (Poll and Damas, 1939) 
and Lake Victoria (Smith, 1931), Protopterus spp. may live for years without being 
forced into aestivation by drought (Johnels and Svensson 1954). Among the four 
African lungfishes, P. annectens is more reliant on aestivation (Smith, 1931). During 
desiccation, P. annectens excavates a short burrow in mud and secretes mucus that 
gradually hardens to form a cocoon over itself (Johnels and Svensson, 1954). Yet, 
cocoon formation rarely occurs in the natural environment for the other three 
Protopterus species (Brien et al., 1959; Greenwood, 1986). It was reported that in 
Stanley Pool (Congo River), the burrows of P. dolloi remained wet in their lower part 
without cocoon formation (Brien et al., 1959). Moreover, the burrows of P. 
aethiopicus described by Wasawo (1959) resemble the combined dry-season burrow 
and breeding nest of P. dolloi (Greenwood, 1986). Nevertheless, when the lakes dry 
out, P. aethiopicus secretes mucus that gradually hardens to form a cocoon, which 
may reduce water loss. Hence, there are variations in aestivation behaviour and in 
burrow conditions (notably with or without a cocoon) among African lungfishes, 
which is probably dependant on the characteristics of the intensity of the drought and 
the freshwater environment (Otero, 2011). It is critical to note that, under laboratory 
conditions, P. aethiopicus, P. amphibius and P. dolloi can be induced to enter 
aestivation (Smith, 1931; Brien et al., 1959; Janssens, 1964; Greenwood, 1986; Chew 
et al., 2004; Ip et al., 2005a; Loong et al., 2005; Perry et al., 2008) and they are able 
to produce cocoons similar to those described for P. annectens. Despite the fact that 
there are altogether six species of extant lungfishes in the world distributed over three 
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continents (Africa, Australia, and South America), only African lungfishes can 
aestivate without food and water intake in subterranean mud cocoon for up to 5 years 
(Smith, 1931), which could be the longest aestivation period known for vertebrates.  
Other than aerial respiration, there are a number of physiological adaptations 
that are required for aestivation to occur successfully. These adaptations include 
decreased metabolic rate, renal shutdown and mechanisms to limit the negative 
effects of fat and protein metabolism during fasting without access to water (Fishman 
et al., 1992). Many of these physiological adaptations respond specifically to the lack 
of water during aestivation, and thus would not be expected to be observed in 
lungfishes in water-filled burrows (Mlewa et al., 2010). Nevertheless, when the 
surrounding water is inadequate for the lungfish to forage, there would still be a 
prolonged period of seasonal fasting that the lungfish experiences. This fasting period 
is similar in length to the period of aestivation in the natural habitat of the lungfish. 
Non-aestivating lungfishes are able to fast for prolonged periods without excessive 
physiological stress, and this ability enhances their survival in strongly seasonal 
environments (Mlewa et al., 2010). It has been reported that a specimen of P. 
aethiopicus has survived without food for 3.5 years in an aquarium and appears to be 
in good condition (El Hakeem, 1979). Fasting in lungfishes, similar to aestivation, is 
accompanied by a decrease in metabolism and oxygen consumption (Fishman et al., 
1992). However, the decrease is less rapid as metabolic wastes can be excreted or 
diffused to the surrounding water. 
Aestivation comprises three phases: induction, maintenance, and arousal. To 
understand aestivation, it is important to distinguish the mechanisms and processes 
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involved in the three different phases: induction, maintenance and arousal. Although 
many features of the maintenance phase of aestivation in African lungfishes have 
been well characterized, there is still a dearth of information on the induction 
factors/mechanisms, the maintenance mechanisms and the process/mechanism of 
arousal from aestivation. 
1.2.1. The induction phase 
1.2.1.1. Processing of external stimuli and internal cues for aestivation 
Several induction factors have been proposed for aestivation in African lungfishes in 
the past (Fishman et al., 1986). These factors include (1) starvation, resulting in 
metabolic, circulatory and respiratory changes, (2) dehydration, which leads to 
metabolic acidosis and oliguria/anuria, (3) air-breathing on land, bringing about 
respiratory acidosis and CO2 retention, and (4) stress, affecting thyroid function 
and/or inducing the release of neurohumoral mediators. It is highly probable that 
multiple factors are involved in initiating aestivation, and there are synergistic effects 
between factors.  
Ionic composition of the ambient water and salinity changes could be critical 
signals in initiating aestivation. It was reported that P. dolloi exposed to water at 
salinity 3 for 6 days exhibited consistently lower daily urea excretion rate as 
compared with the freshwater control (Ip et al., 2005b). Besides, there were decreases 
in urea contents in various tissues and organs. Ip et al. (2005b) therefore concluded 
that P. dolloi could respond to salinity changes in the external medium as it dried up, 
suppressing ammonia production in preparation of aestivation. The osmolality of the 
external medium (90 mosmol kg-1) at salinity 3 was lower than the blood osmolality 
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(260–280 mosmol kg-1). Moreover, the blood osmolality of experimental fish exposed 
to salinity 3 was comparable to that of the freshwater control. Thus, the decreases in 
endogenous ammonia production were unrelated to dehydration. Since the control 
and experimental fish were fasted for the same period of 6 days, the decreases in 
endogenous ammonia production were unrelated to fasting. Furthermore, both groups 
of fish had free access to air, and had comparable blood pH, PO2 and PCO2 at the end 
of the 6-day period, and hence the results obtained by Ip et al. (2005b) could not be a 
result of metabolic/respiratory acidosis or CO2 retention. Therefore, they concluded 
that salinity and ionic composition changes in the external medium could act as 
important signals to initiate aestivation in P. dolloi during the induction phase as the 
external medium dried up (Ip et al., 2005b).  
At present, there is a dearth of information on the internal cues involved in the 
initiation of aestivation in African lungfishes. As fasting is known to be one of the 
inducing factors of aestivation, urea accumulation could be an essential part of the 
induction mechanism. Ip et al. (2005c) thus undertook a series of experiments to 
determine whether ammonia (as NH4Cl) injected intra-peritoneally into P. dolloi, 
would be excreted directly instead of being detoxified to urea, and to examine 
whether injected urea would be retained in this lungfish, leading to decreases in liver 
arginine and brain tryptophan levels which were observed during aestivation on land. 
Despite being ureogenic, P. dolloi rapidly excreted the excess ammonia within the 
subsequent 12 hours after intra-peritoneal injection of NH4Cl. By contrast, only a 
small percentage (34%) of urea was excreted during the subsequent 24 hours when 
urea was injected intra-peritoneally into P. dolloi. At hour 24, significant quantities of 
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urea were retained in various tissues of P. dolloi. Intra-peritoneal injection of urea led 
to decreases in endogenous ammonia production, hepatic arginine and brain 
tryptophan contents in P. dolloi, all of which had been observed in aestivating P. 
dolloi (Chew et al., 2004). Hence, it was concluded that urea synthesis and 
accumulation could be one of the essential internal cues for initiating and 
perpetuating aestivation in P. dolloi, and urea might have a physiological role other 
than being an accumulating nitrogenous end-product (Ip et al., 2005c).  
1.2.1.2. Hyperventilation, metabolic rate and oxidative defense 
There can be an increase in metabolic rate in African lungfishes during the induction 
phase of aestivation. Hyperventilation occurs and the ventilation rate is enhanced 
two- to five-fold during the first 30 days of aestivation, before returning to the control 
range (2-10 per hour) within 45 days (DeLaney et al., 1974). During the first 10 days 
of aestivation, there is an increase in the arterial PO2 from the control range of 25-40 
to 50-58 mmHg, which then returns to the control range (DeLaney et al. 1974). The 
increase in metabolic rate can be a result of the structural and functional 
modifications of cells and tissues in preparation for the maintenance phase.  
With hyperventilation and a possible increase in metabolism, it is highly 
possible for the African lungfish to be confronted with oxidative stress during the 
induction phase of aestivation. However, there is little information on the importance 
of antioxidant molecules and enzymatic oxidative defense in African lungfishes 
during this period. Ascorbate is renowned for its anti-oxidative and anti-stress 
properties. Although the majority of tetrapods can synthesize ascorbate from glucose 
in their kidney and/or liver, only certain fish species can synthesize ascorbate in the 
 11 
 
kidney. The activity of ʟ-gulono-γ-lactone oxidase, an enzyme involved in ascorbate 
synthesis, has been detected in the kidney of P. aethiopicus (Touhata et al., 1995) and 
P. annectens (Ching et al., 2014), indicating the capacity for ascorbate synthesis in 
African lungfishes. Ching et al. (2014) also reported that the expressions of ʟ-gulono-
γ-lactone oxidase/ʟ-Gulono-γ-lactone oxidase, as well as its enzyme activity, were 
detectable in not only the kidney but also the brain of P. annectens. The expression of 
ʟ-gulono-γ-lactone oxidase in the brain could be necessary for the aestivating lungfish 
in ensuring a continuous supply of ascorbate to counter oxidative stress when the 
main site of ascorbate production, the kidney, shuts down. Indeed, transient increases 
in ascorbate and total ascorbate + dehydroascorbate concentrations were observed in 
the brain of P. annectens after 6 days of aestivation in air (Ching et al., 2014). These 
increases could be attributed to an increase in oxidative stress resulting from 
hyperventilation and a possible increase in metabolic rate during the induction phase, 
thereby leading to increases in ascorbate as an oxidative defense measure. 
1.2.1.3. Decreased ammonia production, increased urea synthesis and energy 
metabolism 
Although decreased ammonia production was suspected to occur during aestivation 
(Janssens and Cohen, 1968), its importance during both the induction and 
maintenance phases has only been confirmed recently (Chew et al., 2003, 2004, 
Loong et al., 2005, Ip et al., 2005a). Chew et al. (2003) demonstrated that urea 
concentrations increased significantly in muscle (8-fold), liver (10.5-fold), and 
plasma (12.6-fold) of P. dolloi exposed to air for 6 days without entering to 
aestivation. In addition, there was a significant increase in the urea excretion rate in P. 
 12 
 
dolloi exposed to air for 3 days or more (Chew et al., 2003). Taken together, these 
results indicate that P. dolloi increased the rate of urea synthesis to detoxify ammonia 
during this period. Besides, there was an increase in the ornithine-urea cycle capacity 
in the liver, as indicated by the significant increases observed in the activities of 
carbamoyl phosphate synthetase III (3.8-fold), argininosuccinate synthetase + 
argininosuccinate lyase (1.8-fold) and glutamine synthetase (2.2-fold) during aerial 
exposure (Chew et al., 2003). Moreover, the ammonia excretion rate in the 
experimental fish decreased significantly but there were no significant increases in 
ammonia contents in the muscle, liver or plasma, signifying that endogenous 
ammonia production was drastically reduced (Chew et al., 2003). The apparent 
decrease in ammonia production in P. dolloi was associated with significant 
decreases in concentrations of glutamate, glutamine, lysine and total free amino acid 
in the liver (Chew et al., 2003). Thus, Chew et al. (2003) interpreted that a decrease 
in proteolysis and amino acid catabolism could have occurred. However, in retrospect, 
the reduction in ammonia production during the induction phase of aestivation should 
not be viewed as an adaptation responding solely to ammonia toxicity and 
conservation of metabolic fuels (Chew et al., 2003). There could actually be an 
increase in protein synthesis, which would also lead to decreases in ammonia 
production and in the total free amino acid content. Since the mucus usually 
comprises of glycoproteins (Ángeles Esteban, 2012), there could be an increase in the 
synthesis of certain proteins for increased mucus production during the induction 
phase. Furthermore, structural modifications cannot occur without increased protein 
synthesis. Hence, the results obtained by Chew et al. (2003) could be interpreted as 
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the occurrence of increased protein synthesis and turnover instead of decreased 
protein degradation during the induction phase of aestivation.  
In a separate study, Loong et al. (2005) reported that the rates of urea 
synthesis in P. aethiopicus and P. annectens during 6 days of aerial exposure 
increased only 1.2- and 1.5-fold, respectively, which were smaller than that in P. 
dolloi. However, unlike P. dolloi, aerial exposure had no significant effects on the 
hepatic Cps III activities of P. aethiopicus and P. annectens. Instead, aerial exposure 
induced relatively greater degrees of reductions in ammonia production in P. 
aethiopicus (34%) and P. annectens (37%) than in P. dolloi (28%). Thus, it was 
concluded that there were subtle differences in responses by various species of 
African lungfishes to aerial exposure, and it would seem that P. aethiopicus and P. 
annectens depended more on a reduction in ammonia production rather than an 
increase in urea synthesis to ameliorate ammonia toxicity during the induction phase 
of aestivation (Loong et al., 2005). In addition, there were significant increases in the 
mRNA expression levels of carbamoyl phosphate synthetase III (Loong et al., 2012a), 
argininosuccinate synthetase and argininosuccinate lyase (Chng et al., 2014), 
indicating increased urea synthesis in the liver of P. annectens during the induction 
phase of aestivation. Aestivation in hypoxia or in mud had a delayed effect on the 
increase in the mRNA expression of carbamoyl phosphate synthetase III, which 
extended beyond the induction phase of aestivation, highlighting the importance of 
differentiating effects intrinsic to aestivation from those intrinsic to hypoxia (Loong 
et al., 2012a).  
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Aestivation-specific gene clusters have been identified through the 
determination of differential gene expressions in the liver of P. annectens after 6 days 
of aestivation in air (normoxia) using suppression subtractive hybridization PCR 
(Loong et al., 2012b). Loong et al. (2012b) reported that 6 days of aestivation in 
normoxia resulted in the upregulation of mRNA expression levels of several genes 
related to urea synthesis, confirming that urea synthesis, despite being an energy-
intensive process, was an essential adaptive response of aestivation. Furthermore, 
several mRNAs encoding proteins involved in lipoprotein metabolism were 
upregulated, indicating that there could be an increase in fatty acid synthesis from 
carbon chains released from amino acid catabolism during the induction phase. Some 
of the carbon chains from amino acid catabolism could also be channeled into 
glycogen, and indeed, there were downregulation of some genes related to glycolysis. 
1.2.1.4. Structural modifications in preparation for the maintenance phase 
Aestivation in African lungfishes has been associated with structural and functional 
modifications in at least the heart (Icardo et al., 2008), kidney (Ojeda et al., 2008; 
Amelio et al., 2008), intestine (Icardo et al., 2012a) and spleen (Icardo et al., 2012b). 
Icardo et al. (2008) reported that in fresh water, the myocytes in the trabeculae 
associated with the free ventricular wall of P. dolloi showed structural signs of low 
transcriptional and metabolic activity (heterochromatin, mitochondria of the dense 
type). These signs are partially reversed in aestivating P. dolloi (euchromatin, 
mitochondria with a light matrix), and paradoxically, aestivation appears to trigger an 
increase in transcriptional and synthetic myocardial activities, especially at the level 
of the ventricular septum (Icardo et al., 2008). Moreover, Ojeda et al. (2008) 
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demonstrated structural modifications in all the components of the renal corpuscle of 
aestivating P. dolloi. All these structural changes have to occur during the induction 
phase to shut off functions of certain tissues or organs and prepare the aestivating 
lungfish to survive the maintenance phase of aestivation (which can last up to 4 
years). As African lungfishes are deprived of food at the start of aestivation, 
reconstruction and regeneration of cells and tissues would require mobilization of 
proteins from biological structures of specific functions, leading to a rapid protein 
turnover with perhaps little nitrogenous waste production (Chew et al., 2015). 
Although preservation of muscle structure and function is essential for the survival of 
aestivating African lungfishes when they arouse, the resources required for 
reconstructing and regenerating cells and tissues may be derived from the 
mobilization of proteins from the muscle, as the muscle is the largest protein source 
in African lungfishes. To date, there is a dearth of knowledge as to where aestivating 
African lungfishes obtain the resources for the required structural and functional 
modifications to sustain them through aestivation. 
1.2.2. The maintenance phase 
1.2.2.1. Arrested growth and regeneration 
Growth and regeneration is arrested in African lungfishes during aestivation. Conant 
(1973) reported that when P. annectens and P. aethiopicus were induced to aestivate 
after they had regenerated varying amounts of limb and tail tissue, aestivation sharply 
limited but did not halt further growth if the regenerate was in the latent phase. Short-
term aestivation experiments revealed that the bulk of the growth took place during 
the induction phase preceding dry cocoon formation (Conant, 1973). Therefore, 
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Conant (1973) concluded that deep aestivation inhibited tissue regeneration, which 
would imply that the fish must regain the ability of tissue regeneration upon arousal 
from aestivation. In addition, Conant (1976) reported that prolonged aestivation (> 17 
months) in African lungfishes was associated with shrinkage of the body including 
fins and skeletal elements. The tail tip became noticeably blunter as the axis shortens 
and all limbs shortened during prolonged aestivation. It was reported that after 28 
weeks of aestivation, one fish had lost 57 g out of the original 345 g, was 35 mm 
shorter than the original 400 mm snout-tail length, and had both pectoral and pelvic 
limbs shortened (Blanc et al., 1956).  
1.2.2.2. Preservation of biological structures 
Animals generally go into a protein catabolic state during long periods of fasting, 
mobilizing amino acids as metabolic fuels and releasing endogenous ammonia (Chew 
et al., 2015). Nonetheless, unlike lipids and carbohydrates, proteins have to be 
mobilized from biological structures of specific functions as there is no known 
protein store in animals. Cardiac, skeletal and smooth muscles are protein structures 
with contractile properties. However, cardiac muscles must be spared from 
catabolism until extremely critical moments. Though skeletal muscle is the most 
prominent protein source that can be mobilized, preservation of muscle structure and 
strength is required for aestivating African lungfishes in preparation for arousal. This 
must be achieved despite the lack of locomotor activity and long-term skeletal muscle 
disuse (Chew et al., 2015). Skeletal muscle disuse can result in decreased protein 
synthesis and increased proteolysis, leading to muscle atrophy in mammals (Childs, 
2003). Yet, a drastic increase in protein degradation, as in the case of fasting alone, 
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does not occur in aestivating African lungfishes; they can effectively preserve muscle 
structure and strength by suppressing proteolysis and amino acid catabolism (Chew et 
al., 2015). Thus, as suggested by Ip and Chew (2010), suppressing proteolysis during 
the maintenance phase of aestivation should be considered mainly as an adaptive 
strategy to preserve proteinaeous structures and functions (Hudson et al., 2005; 
Symonds et al., 2007), and metabolic fuel conservation can at best be regarded as a 
subsidiary phenomenon.  
1.2.2.3. Torpor and muscle disuse 
During periods of fasting, African lungfishes conserve energy by reducing locomotor 
activity. Conant (1973) reported that normally well-fed lungfishes (P. annectnens and 
P. aethiopicus) demonstrated limited nocturnal movement, with occasional episodes 
of swimming alternating with quiet periods. However, all such movements were 
abolished after 2 months of fasting, and except for respiration, the lungfishes seemed 
to remain motionless for days at a time. In comparison, African lungfishes remain 
motionless inside their cocoons in mud (DeLaney et al., 1974; Fishman et al., 1986; 
Sturla et al., 2002; Loong et al., 2008b) or in air (Chew et al., 2004; Ip et al., 2005a; 
Loong et al., 2008b) during the maintenance phase of aestivation. Locomotor activity 
absolutely ceases, although the aestivating lungfish would continue to respond to 
sensory stimuli with bradycardia and altered breathing. In humans, disuse-induced 
muscle atrophy occurs as a result of limb immobilization (stemming from bone 
fractures) or extended bed rest, or as a result of micro-gravity effects during 
prolonged space travel (Fitts et al., 2000, 2001). Hence, the aestivating African 
lungfish represents a rare case of a fish being able to suppress muscle atrophy despite 
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long periods of fasting and inactivity. It has been reported that disuse muscle atrophy 
in mammals occurs as a result of decreased muscle protein synthesis and increased 
muscle protein degradation (Booth and Seider, 1979; Thomason et al., 1989). 
Although it is unclear whether protein synthesis is suppressed during aestivation, the 
expression of myosin isoforms remains unchanged in the muscle of aestivating P. 
annectens (Chanoine et al., 1994). There could be enhanced protein breakdown, but 
protease (cathepsin) activities in liver and muscle are the same among unfed, fed and 
aestivated Protopterus (Janssens, 1964). In fact, African lungfishes only lose 
approximately 9–18% of their original body mass after 250 days of aestivation (Smith 
et al., 1930). Moreover, disuse muscle atrophy is not overtly noticeable in P. dolloi 
and P. annectens even after 1 year of aestivation in air under laboratory conditions, as 
the lungfishes can struggle out of the mucus cocoon and swim to the water surface to 
breathe air within 1–2 h upon arousal (Y.K. Ip and S. F. Chew, unpublished 
observations). This contrasts greatly with human muscles, which undergo rapid 
atrophy when not in use. Currently, there is little information on how African 
lungfishes suppress disuse muscle atrophy during aestivation.  
1.2.2.4. Nitrogen metabolism 
During the maintenance phase of aestivation, there is a complete cessation of feeding 
in African lungfishes for an extended period. Therefore, they must rely on stored fuel 
for energy production. Babiker and El Hakeem (1979) suggested that P. annectens 
probably utilized carbohydrate during the initial phase of aestivation only, and it 
relied almost entirely on protein during the maintenance phase of aestivation. Amino 
acids can be released from muscles and other tissues through increased protein 
 19 
 
catabolism, of which the degradation of amino acids can result in the release of 
ammonia. However, the aestivating African lungfish would have to preserve its 
muscle structure and strength so that it can struggle out of the cocoon upon 
subsequent arousal (Chew et al., 2015), and hence muscle protein should be sparingly 
catabolized. Anyway, ammonia is toxic (Cooper and Plum, 1987); it acts on the 
central nervous system of vertebrates, including fish, causing hyperventilation, 
hyperexcitability, convulsions, coma and death. Therefore, African lungfishes 
ameliorate ammonia toxicity during emersion or aestivation by increasing urea 
synthesis and suppressing ammonia production (see Chew and Ip, 2014 for a review).  
Despite suppressing ammonia production during the maintenance phase, 
endogenous ammonia must be detoxified because of the complete impediment of 
ammonia excretion. By synthesizing and accumulating the moderately less toxic urea, 
aestivating African lungfishes can carry out protein catabolism for a longer period 
without being intoxicated by ammonia, and this increases their chances of surviving 
aestivation. Chew et al. (2004) reported that the rate of urea synthesis in P. dolloi 
increased by 2.4- and 3.8-fold during 6 days and 40 days of aestivation in air, 
respectively. Although activities of ornithine-urea cycle enzymes in fish aestivated 
for 6 days remained unchanged, the activities of several ornithine-urea cycle enzymes 
increased significantly in fish aestivated for 40 days. Previous works by Janssens and 
Cohen (1968) showed that urea accumulation occurred in P. aethiopicus aestivated 
for 78–129 days in an artificial mud cocoon, but they concluded that urea 
accumulation did not involve an increase in the rate of urea synthesis, even though 
the fish appeared to be in continuous gluconeogenesis throughout aestivation. 
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Subsequently, Ip et al. (2005a) undertook a study to test the hypothesis that the urea 
synthesis rate in P. aethiopicus was up-regulated to detoxify ammonia during the 
initial period of aestivation (day 0 to day 12), and that a profound suppression of 
ammonia production occurred at a later period of aestivation (day 34 to day 46) 
which eliminated the need to sustain the increased rate of urea synthesis. Contrary to 
the report of Janssens and Cohen (1968), Ip et al. (2005a) demonstrated a drastic 
increase in urea synthesis (3-fold) in P. aethiopicus during the initial 12 days of 
aestivation, although the magnitude of the increase in urea synthesis decreased over 
the next 34 days. Between day 34 and day 46 (12 days), the urea synthesis rate 
decreased to 42% of the day 0 control value instead (Ip et al., 2005a). There were 
significant increases in tissue urea contents and activities of some ornithine-urea 
cycle enzymes in the liver (Ip et al., 2005a). Since there was a meagre 20% decrease 
in the rate of ammonia production in P. aethiopicus during the initial 12 days, as 
compared to a 96% decrease during the final 12 days of aestivation (day 34 to day 46), 
Ip et al. (2005a) concluded that P. aethiopicus depended mainly on increased urea 
synthesis to ameliorate ammonia toxicity during the initial period of aestivation, but it 
suppressed ammonia production profoundly during prolonged aestivation, eliminating 
the need to increase urea synthesis which is energy intensive.  
1.2.2.5. Increased oxidative defense 
Page et al. (2010)  reported that most of the major intracellular antioxidant enzymes, 
including copper-zinc superoxide dismutase (CuZnSod), manganese Sod (MnSod), 
catalase (Cat), glutathione peroxidase (Gpx) and glutathione reductase (Gr), were 
upregulated in the brain of P. dolloi after 60 days of aestivation. Activities of several 
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of these enzymes also increased in the heart during aestivation (Page et al., 2010). 
These increases were unrelated to fasting as similar phenomena were not observed in 
a group of fish which were deprived of food but maintained in water for the same 
period of time. Products of oxidative protein damage and lipid peroxidation were 
similar in control and aestivating lungfishes, but protein nitrotyrosine levels were 
elevated in the brain of aestivators. Hence, Page et al. (2010) concluded that 
aestivating P. dolloi experienced little oxidative damage in the brain and heart due to 
increased oxidative stress resistance in these organs resulting from increases in 
intracellular antioxidant capacity.  
It was reported that ascorbate levels decreased 99.9%, and dehydroascorbate 
increased 48.5% in the kidney of P. annectens after 6 months of aestivation in air 
(Ching et al., 2014). These changes were accompanied with significant decreases in 
the mRNA expression level and protein abundance of ʟ-Gulono-γ-lactone oxidase in 
the kidney (Ching et al., 2014). These changes could be related to the shut-down of 
renal function (DeLaney et al., 1974) and change in renal corpuscle structure during 
the maintenance phase of aestivation (Ojeda et al., 2008). As kidney is the major site 
of ascorbate synthesis in lungfishes, the decline of ʟ-Gulono-γ-lactone oxidase 
activity and hence ascorbate production could expose the lungfish to possible 
oxidative stress during aestivation. However, there was only a minor decrease in 
ascorbate levels in the brain of P. annectens after 6 months of aestivation, which 
could be attributed to the expression of ʟ-gulono-γ-lactone oxidase and the presence 
of ʟ-Gulono-γ-lactone oxidase enzyme activity in the brain of P. annectens (Ching et 
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al., 2014). To date, there is no information on oxidative defenses in the muscle of 
aestivating lungfishes.  
1.2.3. The arousal phase 
1.2.3.1. Tissue regeneration and feeding 
During arousal, blood flow and heart beat rate recovers. Ojeda et al. (2008) reported 
that all the modifications which rendered the kidney non-functional during the 
maintenance phase of aestivation were partially reversed during the first few days of 
arousal with the return of water. In addition, Garofalo et al. (2015) reported that the 
protein abundance of nitric oxide synthase (Nos) and v-AKT murine thymoma viral 
oncogene homolog (Akt) were down-regulated in the gills during the maintenance 
phase and up-regulated during the arousal phase, while the opposite trend was 
observed in the lungs of P. annectens. This occurred in parallel with organ 
readjustment in the gills and lungs of P. annectens during aestivation and arousal. 
Since the Nos/NO system is often associated with Akt in amplifying and integrating 
extracellular signals for redox balance, cell survival and osomoregulatory signal 
transduction (Amelio et al., 2013), Garofalo et al. (2015) proposed that Nos and Akt 
could play a role in morpho-functional readjusting processes in the gills and lungs of 
P. annectens. However, the exact mechanism for tissue regeneration in African 
lungfishes during the arousal phase is still not known.  
African lungfishes would start feeding only after 7-10 days of arousal from 
aestivation. This indicates that some restructuring of the intestinal epithelium is a 
prerequisite to feeding. Icardo et al. (2012) reported that cell phenotypes in the 
digestive tract of P. annectens were restored in about 6 days after arousal from 6 
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months of aestivation. However, full structural recovery is not attained during the 
experimental period (15 days post-aestivation; Icardo et al., 2012). Therefore, the 
initial recovery of the intestinal epithelium was independent of food intake. Since 
structural modifications for tissue regeneration would require increased syntheses of 
certain proteins, and since they occurred before re-feeding, it would imply the 
mobilization of amino acids of endogenous origin. However, at present, there is a 
dearth of knowledge on protein degradation and synthesis, especially in the skeletal 
muscle, during the arousal phase of aestivation. Moreover, there is no information on 
postprandial nitrogen metabolism and excretion in African lungfishes upon arousal 
from aestivation.  
1.2.3.2. Excretion of accumulated urea 
Upon arousal in water, African lungfishes can efficiently excrete the excess urea 
accumulated in the body during the maintenance phase of aestivation (Smith, 1930; 
Janssens, 1964). Chew et al. (2003) reported that the urea excretion rate increased by 
22-fold in P. dolloi during re-immersion after 6 days of terrestrial exposure as 
compared to the control fish. This is the greatest increase in urea excretion reported 
for fishes during emersion-immersion transition, and suggests that P. dolloi possesses 
transporters which facilitate the urea excretion upon arousal. Subsequently, Wood et 
al. (2005) reported that after 21-30 days of aestivation in air or exposure to air 
without aestivation, the urea excretion rate increased, reaching 2000-6000 µmol-N h-1 
kg-1 at 10-24 hours, in P. dolloi during re-immersion. During arousal, increased urea 
excretion in P. dolloi occurred in pulses (Wood et al., 2005). Ip and Chew (2010) 
proposed that it can be an adaptation to assure complete rehydration, which is 
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dependent on tissue urea content, and to minimize instantaneous osmotic shock to 
cells, upon arousal. Through the injection of NH4Cl + urea, Ip et al. (2005c) 
concluded that excretion of accumulated urea in P. dolloi was regulated by the level 
of internal ammonia. Hence, it is possible that an increase in ammonia production 
occurred through increased amino acid catabolism upon arousal, and the increased 
production of endogenous ammonia act as a signal to enhance urea excretion. 
However, it is not known whether the increased amino acid catabolism occurs 
through increased mobilization of muscle protein.  
1.2.3.3. Increased metabolic rate, energy metabolism and oxidative stress 
There is no available information on the metabolic rate of African lungfishes after 
arousal from long periods of aestivation. However, it would be logical to deduce that 
arousal leads to an increase in the metabolic rate for structural and functional of cells 
and tissues. Furthermore, increases in oxygen consumption and metabolism could 
lead to increased oxidative stress, although how the African lungfish defends itself 
against oxidative stress remains unclear. Aroused fish would only start to feed after 
7–10 days, and the origins of fuel for ATP production to support locomotor activity 
and tissue reconstruction/regeneration remain unclear. It is possible that there could 
be increased mobilization of muscle protein during the arousal phase of aestivation, 
but this aspect has not been investigated yet. 
1.3. Genes/proteins involved in muscle formation 
1.3.1. Ppargc-1α 
Peroxisome proliferator-activated receptor-γ coactivator-1α (PPARGC-1α) is an 
important transcriptional coactivator involved in the regulation of fibre type 
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composition, metabolic function, mitochondrial biogenesis, and antioxidant gene 
expression (St-Pierre et al., 2006; Scarpulla, 2008). PPARGC-1α binds to and 
coactivates multiple transcription factors including many nuclear receptors (Lindholm 
et al., 2012). As PPARGC-1α plays an important role in cell metabolism, it is tightly 
regulated. Signaling pathways which control PPARGC-1α gene expression includes 
calcium signaling (Wu et al., 2002b), calcineurin A (Handschin et al., 2003) and 
cyclic AMP (Yoon et al., 2001). When these pathways are activated, different 
transcription factors are mobilized to PPARGC-1α gene regulatory regions depending 
on the context and tissue. PPARGC-1α activity can be regulated by various post-
translational modifications, including phosphorylation, acetylation and ubiquitylation. 
PPARGC-1α can undergo phosphorylation by various kinases, including p38 
mitogen-activated protein kinase (MAPK) (Fan et al., 2004), AMP-activated protein 
kinase (AMPK) (Jäger et al., 2007), AKT/protein kinase B (Li et al., 2007), and 
glycogen synthase kinase 3β (Olson et al., 2008), thereby affecting PPARGC-1α 
activity in different ways. PPARGC-1α can also be acetylated by acetyltransferases 
such as the histone acetyltransferase GCN5 (Lerin et al., 2006) and be deacetylated 
by sirtuin 1 (Gerhart-Hines et al., 2007; Cantó et al., 2009). Furthermore, PPARGC-
1α protein stability is regulated by specific E3 ligases (Olson et al., 2008; Wei et al., 
2012; Trausch-Azar et al., 2015).  
PPARGC-1α is strongly expressed in skeletal muscle, and its expression is 
enhanced by multiple signals including exercise (Pilegaard et al., 2003; Terada and 
Tabata, 2004; Akimoto et al., 2005) and β-adrenergic signaling (Miura et al., 2007; 
Chinsomboon et al., 2009). PPARGC-1α has a protective effect on muscle, 
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preventing it from atrophying by reducing proteolysis without affecting protein 
synthesis (Brault et al., 2010; Geng et al., 2011; Bonaldo and Sandri, 2013). 
Transgenic mice expressing PPARGC-1α are protected from denervation-induced 
atrophy (Sandri et al., 2006), muscle dystrophy (Handschin et al., 2007a) and 
sarcopenia (Wenz et al., 2009). In addition, PPARGC-1α has anti-inflammatory 
effects in skeletal muscle. PPARGC-1α is involved in the regulation of several 
antioxidant genes in various tissues, and a lack of PPARGC-1α leads to increased 
ROS levels (St-Pierre et al., 2006). The mRNA levels of pro-inflammatory cytokines 
(tumour necrosis factor α and interleukin 6) and ROS levels increased in the skeletal 
muscle of PPARGC-1α-knockout mice (Handschin et al., 2007b). Life-long 
PPARGC-1α overexpression suppresses pro-inflammatory cytokine expression in 
aged mice (Wenz et al., 2009). A dramatic decrease in PPARGC-1α protein 
expression observed in mouse tibialas anterior muscle after 14 days of 
immobilization and 5 days of remobilization indicated that the down-regulation of 
PPARGC-1α is a key cellular mechanism, which leads to the deterioration of muscle 
phenotypic changes following immobilization-remobilization (Kang and Ji, 2013). 
Overexpression of PPARGC-1α by transfection in the same mice models used by 
Kang and Ji (2013) can protect the tibialas anterior muscle from immobilization-
induced metabolic and antioxidant disturbances (Kang et al., 2015). Furthermore, 
transgenic induction of PPARGC-1α extends the maintenance of skeletal muscle 
function in the CuZnSOD mouse model of amyotrophic lateral sclerosis (Da Cruz et 
al., 2012). PPARGC-1α also protects the skeletal muscle of hibernators from atrophy 
(Eddy and Storey, 2003; Eddy et al., 2005a; Xu et al., 2013), and could thus play a 
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similarly important role in aestivating lungfishes, especially since it is heavily 
regulated.  
1.3.2. Myod1 
Myogenic differentiation 1 (MYOD1) belongs to a family of vertebrate proteins 
which are potent transcription factors for muscle genes (Pownall et al., 2002). As one 
of the four myogenic regulatory factors (Weintraub et al., 1991; Rudnicki and 
Jaenisch, 1995), MYOD1 possesses the conserved basic helix-loop-helix (bHLH) 
domain, which makes it such a potent transcription factor. The bHLH domain 
mediates DNA binding and is necessary for heterodimerization with E proteins which 
facilitate the recognition of genomic E-boxes (Massari and Murre, 2000). These 
genomic E-boxes are found in the promoter region of many muscle-specific genes 
(Massari and Murre, 2000). Furthermore, there is a conserved set of amino acids in 
the basic region of MYOD1 and other myogenic bHLH proteins which alter the 
transcriptional activity of the bound MYOD1 (Brennan et al., 1991; Davis et al., 
1990). This conserved set of amino acids, also known as the myogenic code, is 
thought to function by interacting with cofactors such as myocyte enhancer factor 2 
(Molkentin et al., 1995) to alter the conformation of the bound MYOD1 in a manner 
which allows for cofactor interactions at other regions (Bengal et al., 1994; Ma et al., 
1994). MYOD1 is known to promote specification and proliferation along with 
myogenic factors 5 and 6 (Olson, 1992; Megeney and Rudnicki, 1995; Seale et al., 
2000; Hawke and Garry, 2001; Kitzmann and Fernandez, 2001).  
Although null mutation in MYOD1 results in roughly normal muscle 
development in mice embryos, there is a delay in early limb and branchial arch 
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muscle development (Arnold and Winter, 1998). In mice, null mutations in MYOD1 
and myogenic factor 5 result in a complete absence of skeletal myocytes or myofibres 
(Arnold and Winter, 1998). This implies that either MYOD1 or myogenic factor 5 is 
necessary for the formation and/or survival of myoblasts (Arnold and Winter, 1998). 
MYOD1 is negatively regulated by myostatin (MSTN) (McFarlane et al., 2006) and 
can be degraded by F-box protein32 (FBXO32) (Tintignac et al., 2005).  
1.3.3. Myog 
Myogenin (MYOG), similar to MYOD1, is one of the four myogenic regulatory 
factors (Weintraub et al., 1991; Rudnicki and Jaenisch, 1995). However, unlike 
MYOD1, MYOG promotes and maintains the terminal differentiation of muscle 
along with myogenic factor 6 (Olson, 1992; Megeney and Rudnicki, 1995; Hawke 
and Garry, 2001). MYOG apparently functions downstream of MYOD1 and 
myogenic factor 5 to activate muscle gene expression (Tapscott, 2005). The 
importance of MYOG expression has been highlighted by the failure of MYOG-
knockout mice to form myofibres (Hasty et al., 1993; Venuti et al., 1995) due to 
interference with differentiation of already determined myogenic cells. This is 
consistent with studies in cultured cell systems demonstrating that while MYOG is 
not expressed in myoblasts during proliferation, it is regulated in the terminal 
differentiation process as it is essential in turning on the muscle gene expression 
program (Cusella-De Angelis et al., 1992). The expression of MYOG is induced in 
regenerating adult myofibres after muscle damage (Zhao et al., 2002). However, 
conditional knockout in adult muscle does not negatively affect regeneration, 
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indicating that MYOG seems to be less essential in the differentiation process in 
regenerating muscle (Meadows et al., 2011). 
In MYOG-knockout mice, the expression of several differentiation markers 
including myosin heavy chain and myogenic factor 6 decreased, while MYOD1 
expression is normal (Hasty et al., 1993), suggesting that MYOD1 expression is 
unaffected by MYOG. There is increasing evidence demonstrating that MYOG is 
associated with muscle atrophy induced by disuse, such as denervation (Moresi et al., 
2010; Macpherson et al., 2011) and hindlimb suspension (Modziak et al., 1999; 
Alway et al., 2001). MYOG expression increases in these mammalian disuse models 
and it appears to be positively related to disuse muscle atrophy. This is attributed to 
the decrease in the expression of atrogenes and myogenic regulatory factors in the 
skeletal muscle of MYOG-null mice (Moresi et al., 2010). It would thus be 
interesting to note how the expression of Myog and Myod1 changes in the skeletal 
muscle of P. annectens during three phases of aestivation. 
1.3.4. Mapk1/3 
MAPK1/3 is also known as extracellular signal-regulated kinases 2 and 1, 
respectively. MAPK1/3 belong to a family of protein phosphorylating enzymes 
(Lawan et al., 2013) which includes p38 MAPK, c-Jun NH2-terminal kinases 1, 2 and 
3, and extracellular signal-regulated kinase 5 (Bogoyevitch and Court, 2004; Zarubin 
and Han, 2005; Bogoyevitch, 2006; Whitmarsh, 2006). MAPKs are involved in the 
regulation of multiple cellular responses in immunology, neurobiology, physiology 
and energy metabolism (Wancket et al., 2012). MAPKs regulate cellular activities 
such as proliferation, apoptosis, differentiation and motility (Pearson et al., 2001; 
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Cuevas et al., 2007) through transcriptional activation as well as posttranslational 
modification on downstream targets. Furthermore, MAPKs play an important role in 
energy metabolism through the modulation of lipid metabolism (Wu et al., 2006; 
Roth et al., 2009; Flach et al., 2011) and skeletal muscle growth and fibre type 
(Wancket et al., 2012). The fundamental role of MAPKs in a wide range of biological 
processes indicates that MAPKs are tightly regulated. In fact, MAPK activation 
occurs through a three-tiered phosphorylation relay which transmits signals from the 
surface of the cell into biochemical responses (Dhanasekaran et al., 2007; Turjanski 
et al., 2007). This relay involves the phosphorylation and activation of MAPKs by 
upstream MAPK kinases (MKKs), and the phosphorylation and activation of MKKs 
by upstream MKK kinases (MKKKs) (Dhanasekaran et al., 2007; Turjanski et al., 
2007). The regulation of MAPKs is extremely complex as there are multiple kinases 
within each tier of the phosphorylation relay (Geisler et al., 2013).  
There is increasing evidence for the importance of the MAPK pathway in 
muscle atrophy. MAPK phosphatase 1 is a negative regulator of MAPKs; it 
dephosphorylates and inactivates MAPKs (Lawan et al., 2013). Overexpression of 
MAPK phosphatase 1 induces profound muscle fibre atrophy, probably via the 
ubiquitin-proteasome pathway (Shi et al., 2009). This atrophic effect can be conferred 
through the MAPK1/3 signaling pathway. MAPK1/3 is associated with the increase 
in muscle mass and the decrease in the expression of muscle RING-finger protein-1 
(MuRF1), an E3-ubiquitin ligase implicated in muscle atrophy (Shi et al., 2009). 
Hence, MAPK1/3 is involved in protecting skeletal muscle from atrophy. This 
proposition is further supported by the findings that the MAPK1/3 pathway enhances 
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protein synthesis by controlling ribosomal RNA gene expression, thereby 
counteracting muscle wasting (Stefanovsky et al., 2006). Moreover, the MAPK1/3 
pathway also prevents muscle wasting induced by oxidative stress (Yang et al., 2010). 
Besides, MAPK1 expression increases in the skeletal muscles of Richardson’s ground 
squirrels during hibernation (MacDonald and Storey, 2005), further supporting the 
proposition that MAPK1/3 protects skeletal muscle against atrophy. Thus, Mapk1/3 
might play an important role in protecting the skeletal muscle of P. annectens against 
atrophy, especially during the maintenance phase of aestivation. 
1.3.5. General changes in expression of ppargc-1α/Ppargc-1α, myod1/Myod1, 
myog/Myog and mapk/Mapk, which are involved in muscle formation, during 
fasting or muscle disuse  
PPARGC-1α: PPARGC-1α is a critical cofactor for mitochondrial biogenesis (Pérez-
Shindler and Handschin, 2013). The mRNA levels of PPARGC-1α decrease in 
response to muscle atrophy due to fasting, disuse or denervation (Sandri et al., 2006; 
Sacheck et al., 2007). The maintenance of high levels of PPARGC-1α during 
catabolic conditions, whether by transfecting adult myofibres or in transgenic mice, 
spares muscle mass during fasting, denervation, aging, heart failure and sarcopenia 
(Sandri et al., 2006; Wenz et al., 2009; Geng et al., 2011). Overexpression of 
PPARGC-1α in adult muscle fibres inhibits muscle mass loss induced by food 
deprivation and FOXO3 overexpression (Sandri et al., 2006). Moreover, PPARGC-1α 
overexpression in the muscle of transgenic mice was reported to extend lifespan and 
prevent muscle wasting that is characteristic of ageing mice (Wenz et al., 2009). 
PPARGC-1α overexpression in mice glycolytic muscles led to not only inactivation 
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of forkhead transcription factor signaling via increased Akt/protein kinase B 
expression, but also increased expression of both inducible and endothelial nitric 
oxide synthases, SODs and CAT, production of nitric oxide, and reduced oxidative 
stress (Geng et al., 2011). The beneficial effect that PPARGC-1α has on muscle mass 
is due to reduced protein breakdown via inhibition of autophagy-lysosome and 
ubiquitin-proteasome degradation systems (Brault et al., 2010; Bonaldo and Sandri, 
2013). PPARGC-1α inhibits FoxO3 transcriptional activity (Sandri et al., 2006) but 
does not affect protein synthesis. Hence, PPARGC-1α protects muscle from atrophy 
by 1) preventing the excessive activation of protein degradation systems through the 
inhibition of FOXO, a pro-atrophy transcription factor, without perturbing the 
translational machinery; and 2) enhancing nitric oxide antioxidant defenses and 
inactivation of the forkhead transcription factor signaling pathways (Geng et al., 
2011).  
MYOD1 and MYOG: MYOD1 promotes specification and proliferation of 
skeletal muscle, while MYOG promotes myoblast differentiation (Olson, 1992; 
Megeney and Rudnicki, 1995; Seale et al., 2000; Hawke and Garry, 2001; Kitzmann 
and Fernandez, 2001). MYOD1 has been implicated in muscle atrophy induced by 
fasting (Lagirand-Cantaloube et al., 2009) and disuse (Mozdziak et al., 1999; Alway 
et al., 2001; Moresi et al., 2010). Overexpressing a MYOD1 mutant lacking 
FBXO32-mediated ubiquitination decreases muscle atrophy induced by food 
deprivation in mice (Lagirand-Cantaloube et al., 2009), implying that MYOD1 
protects skeletal muscle against atrophy. On the other hand, expression of MYOD1 
and MYOG increase during hindlimb suspension (Mozdziak et al., 1999; Alway et 
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al., 2001) and after denervation (Moresi et al., 2010). Denervated muscle induces 
MYOG, which contributes to muscle atrophy by regulating the expression of 
atrogenes (Macpherson et al., 2011). In muscles of MYOG-null mice which undergo 
denervation to induce atrophy, expression of myogenic regulatory factors and 
atrogenes are greatly reduced (Moresi et al., 2010). However, Smith et al. (2014) 
have recently demonstrated that increases in expression of MYOD1 and MYOG 
occurred much later than the increases in those of atrogenes in the muscle of mice 
during hindlimb suspension. Hence, it has been postulated that increased MYOD1 
and MYOG expression during hindlimb suspension offer protection to myofibres 
instead (Smith et al., 2014).  
MAPK1/3: MAPK1/3 is involved in the regulation of protein synthesis and 
the enhancement of genes involved in glyconeogenesis, angiogenesis and glucose 
transport (Murgia et al., 2000; Koulmann and Bigard, 2006). MAPK1/3 promotes cell 
survival by reducing proteasome activity, myonuclear apoptosis and mitochondrial 
breakdown (Powers et al., 2007). MAPK1/3 has also been implicated in the increase 
in muscle mass and the decrease in MuRF1 expression (Shi et al., 2009). Furthermore, 
inhibition of MAPK1/3 in both slow and fast muscles induces profound atrophy (Shi 
et al., 2009). The MAPK1/3 pathway is preferentially activated in fast skeletal 
muscles (Shi et al., 2007, 2008), and protects skeletal muscle from oxidative stress-
mediated wasting (Yang et al., 2010). MAPK1/3 pathway was reported to counteract 
muscle atrophy through increased protein synthesis by controlling ribosomal RNA 
gene expression (Stefanovsky et al., 2006). However, there is little information on 
how MAPK1/3 responds to muscle atrophy induced by fasting or disuse. 
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1.4. Genes/proteins involved in muscle degradation 
1.4.1. Hdac1 
Histone deacetylases (HDACs) are generally associated with repression of gene 
expression (Ito et al., 2000; Forsberg and Bresnick, 2001; Wade, 2001). There are 
four classes of HDACs (Gallinari et al., 2007). Class I and class II HDACs are 
evolutionarily related and share a common enzymatic mechanism – the hydrolysis of 
the acetyl-lysine amide bond catalyzed by zinc (Gallinari et al., 2007). The class I 
HDACs consists of HDAC1, 2, 3 and 8, and is most closely related to the 
transcriptional regulator RPD3 in yeast (de Ruijter et al., 2003). Class II HDACs, 
which comprises HDAC4, 5, 6, 7, 9 and 10, possess similar domains to HDA1, which 
is another deacetylase found in yeast (Bjerling et al., 2002). Higher organisms also 
express another Zn-dependent HDAC, HDAC11 (Gao et al., 2002). However, 
HDAC11 is phylogenetically different from both class I and II HDACs and is 
classified as a separate class under class IV. Class III HDACs are not evolutionarily 
related to the other three classes of HDACs, and they catalyze the transfer of the 
acetyl group onto the sugar moiety of NAD (Blander and Guarente, 2004).  
Of the class I HDACs, HDAC1 and HDAC2 share the highest similarity (de 
Ruijter et al., 2003). For both enzymes, the catalytic domain is on the N terminus, and 
this domain forms the major part of the proteins (Kao et al., 2000; Cress and Seto, 
2001; Wade, 2001; Li et al., 2002). However, cofactors are required for HDAC 
activity to occur as both HDAC1 and HDAC2 are inactive when they are produced 
using recombinant techniques (de Ruijter et al., 2003). Both enzymes are found 
exclusively in the nucleus, as they lack a nuclear export signal (NES) (Johnstone, 
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2002). Due to their similarity, both HDAC1 and HDAC2 are regulated in a similar 
manner. The activities of both enzymes are regulated by the availability of co-
repressors and phosphorylation (de Ruijter et al., 2003). Mutation of crucial 
phosphorylation sites in HDAC1 leads to a decrease in its activity (Pflum et al., 2001; 
Galasinski et al., 2002).  
1.4.2. FoxO1/3 
FOXO proteins belong to a subclass of Forkhead transcription factors, which are 
characterized by a winged helix DNA-binding domain, the Forkhead box (Kaestner et 
al., 2000). FOXO proteins are transcription factors involved in numerous 
physiological and pathological processes, such as aging, neurological diseases and 
cancer (Greer and Brunet, 2008; Maiese et al., 2008). Invertebrates possess one FoxO 
factor while four FOXO family members, FOXO1, FOXO3, FOXO4 and FOXO6 are 
expressed in mammals. FOXO family members recognized and bind to the conserved 
consensus core motif TTGTTTAC (Furuyama et al., 2000; Xuan and Zhang, 2005). 
They are potent transcriptional activators which promote cell cycle arrest, ROS 
detoxification, damaged DNA repair, apoptosis and autophagy by upregulating 
specific genes (Brunet et al., 1999; Dijkers et al., 2000; Medema et al., 2000; Kops et 
al., 2002; Nemoto and Finkel, 2002; Tran et al., 2002; Lee et al., 2003; Murphy et al., 
2003; Mammucari et al., 2007; Zhao et al., 2007). FOXO proteins are also involved 
in the regulation of cell differentiation in blood, adipose tissue and muscle (Hribal et 
al., 2003; Nakae et al., 2003; Bakker et al., 2004; Miyamoto et al., 2007; Tothova et 
al., 2007). With such diverse cellular functions, it is unsurprising that FOXO proteins 
are regulated by a broad spectrum of external stimuli, including insulin, growth 
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factors, nutrients, cytokines and oxidative stress, through changes in post-
translational modifications (Calnan and Brunet, 2008). These post-translational 
modifications include phosphorylation, acetylation, and ubiquitination, which affect 
the subcellular localization of FOXO proteins (see review by Calnan and Brunet, 
2008).  
Out of the four FOXO family members, FOXO1 and FOXO3 have been 
associated with muscle atrophy. The mRNA expression of FoxO1 and FoxO3 
increases in the muscle of rats after fasting or caloric restriction for 48 h (Furuyama 
et al., 2002; Imae et al., 2003), indicating that nutrient deprivation can induce a 
signaling cascade to elicit the transcription of FOXO factor genes. In various models 
of muscle atrophy, reduced activity of the AKT pathway results in decreased levels of 
phosphorylated FOXO in the cytoplasm and a profound increase of nuclear FOXO 
(Brunet et al., 1999; Sandri et al., 2004; Latres et al., 2005). The translocation and 
activity of FOXO proteins is necessary for upregulating FBXO32, and it has been 
shown that FOXO3, when transfected into skeletal muscles in vivo, is sufficient to 
promote FBXO32 expression and muscle atrophy (Sandri et al., 2004). Furthermore, 
deacetylation of FOXO3a by HDAC1 promotes FBXO32 and MuRF1 expression 
(Beharry et al., 2014). In addition, significantly reduced muscle mass and fibre 
atrophy are observed in FOXO1 transgenic mice, implying that FOXO members are 
sufficient to promote muscle loss (Kamei et al., 2004; Southgate et al., 2007).  
FOXO family members have also been associated with MSTN (McFarlane et 
al., 2006; Allen and Unterman, 2007). MSTN was reported to upregulate essential 
atrophy ubiquitin ligases in muscle cell cultures in a FOXO-dependent manner, as 
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MSTN treatment blocks the IGF1-PI3K-AKT pathway, activating FOXO1 in the 
process and hence increasing FBXO32 expression (McFarlane et al., 2006). 
Conserved sequences sharing multiple binding sites for FOXO proteins have been 
identified in the Mstn promoter from various organisms (Allen and Unterman, 2007; 
Allen and Du, 2008; Dall’Olio et al., 2010). Moreover, some of these binding sites 
were demonstrated to be essential for FOXO1 binding and Mstn expression (Allen 
and Unterman, 2007; Allen and Du, 2008). It is thus believed that MSTN expression 
is controlled by FOXO1, and this supports the view that the MSTN pathway 
synergizes with the AKT-FOXO signaling pathway (Allen and Unterman, 2007).  
1.4.3. Tp53 
Tumour protein 53 (TP53) is known for its tumor suppressor role and is an essential 
regulator of cellular responses to a number of stress signals (Varquez et al., 2008; 
Riley et al., 2008), which include DNA damage and oncogene activation. The 
activation of TP53 by various stress signals leads to either apoptosis or cell-cycle 
arrest in cells (Riley et al., 2008), and the final outcome of the cell is determined by 
the level of TP53. Higher levels of TP53 results in apoptosis while low TP53 levels 
favours cell cycle arrest (Laptenko and Prives, 2006).  
Signal transduction-activated TP53 has two modes of action (Norbury and 
Zhitovsky, 2004; Varquez et al., 2008). TP53 binds to DNA as a tetramer in a 
sequence specific manner (Norbury and Zhitovsky, 2004; Varquez et al., 2008), 
functioning as either a transcriptional activator or transcriptional repressor (Riley et 
al., 2008). This means that TP53 regulates the expression of a large number of target 
genes (Horn and Vousden, 2007; Riley et al., 2008). TP53-induced apoptosis occurs 
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by upregulating pro-apoptotic genes and repressing anti-apoptotic genes (Chakraborty 
et al., 2003; Norbury and Zhitovsky, 2004; Horn and Vousden, 2007), thereby 
promoting apoptosis, which accounts for its tumour suppressor role. However, TP53 
also leads to cell cycle arrest (Alberts et al., 2008) when it transcriptionally activates 
cyclin dependent kinase inhibitor p21Waf1/Cip1 (Horn and Vousden, 2007). This 
inhibits a number of cyclin-dependent kinases regulating cell cycle, thereby arresting 
the cell cycle in the G1 phase (Sherr and Roberts, 1995). 
TP53 can also be activated by nutrient deprivation and oxidative stress 
(Bieging et al., 2014), both processes which may occur in the African lungfish during 
aestivation. Nutrient deprivation activates AMPK, which in turn activates TP53, 
consequently inhibiting proliferation and leading to decreased cell growth (Bieging et 
al., 2014) to facilitate cell survival. Oxidative stress can either induce DNA damage 
which in turn activates TP53, or activate TP53 by affecting the redox state (Méplan et 
al., 2000) and oxidation of TP53 (Augustyn et al., 2007). Mitochondrial ROS, which 
has been implicated in muscle disuse atrophy (Muller et al., 2007; Kavazis et al., 
2009; Min et al., 2011; Powers et al., 2011; Talbert et al., 2013), has been 
demonstrated to be a key component of stress-induced TP53 activation (Karawajew 
et al., 2005). There is increasing evidence that skeletal muscle atrophy is promoted by 
TP53. Transgenic mice expressing an activated TP53 construct age prematurely and 
undergo severe muscle atrophy (Schwarzkopf et al., 2008). On the other hand, a 
global loss of TP53 expression in mice makes them more prone to cancer, but 
increases their resistance to cancer-induced skeletal muscle atrophy (Schwarzkopf et 
al., 2006). Furthermore, various muscle atrophy stimuli such as denervation, aging, 
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unloading, immobilization and Huntington’s disease enhance the expression of TP53 
and TP53 target genes in skeletal muscle, indicating that TP53 plays a critical role in 
muscle wasting under these conditions (Stevenson et al., 2003; Welle et al., 2003, 
2004; Siu and Alway, 2005a, b; Edwards et al., 2007; Ehrnhoefer et al., 2013; Fox et 
al., 2014). It would be of great interest to note the changes in the expression of 
tp53/Tp53 in the skeletal muscle of P. annectens during three phases of aestivation. 
1.4.4. Mstn 
MSTN, also known as growth differentiation factor 8, is part of the transforming 
growth factor (TGF) β superfamily, where members of this superfamily are involved 
in the regulation of a range of cellular processes mediating growth processes in 
vertebrates. MSTN negatively regulates muscle growth (Matsakas and Diel, 2005; 
Joulia-Ekaza and Cabello, 2006; Allen and Unterman, 2007; Ji et al., 2008; Li et al., 
2008). Deleting MSTN in mice results in a significant and widespread increase in 
skeletal muscle mass through muscle hypertrophy and hyperplasia (McPherron et al., 
1997; Lin et al., 2002; Zimmers et al., 2002). Mutations in Mstn of some cattle and 
sheep breeds cause a double-muscling phenotype in these animals (Kambadur et al., 
1997; McPherron and Lee, 1997; Hadjipavlou et al., 2008). Hence, the most critical 
function of MSTN is to regulate skeletal muscle growth.  
Muscle mass preservation is tightly regulated by the delicate balance between 
protein synthesis and muscle degradation. There is increasing evidence that MSTN 
may decrease muscle mass by reducing protein synthesis (Taylor et al., 2001; 
Suryawan et al., 2006; Welle et al., 2006, 2009). MSTN can inhibit protein synthesis 
in both myoblasts and myotubes in vitro (Taylor et al., 2001). Mice with constitutive 
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MSTN deficiency have increased rate of myofibrillar protein synthesis, as compared 
to normal mice (Welle et al., 2006, 2009). Furthermore, follistatin, which inhibits 
MSTN, stimulates protein synthesis in the skeletal muscle of neonatal rats (Suryawan 
et al., 2006). Follistatin overexpression results in increased muscle mass in animals 
(Lee and McPherron, 2001; Haidet et al., 2008). Consistent with MSTN’s inhibitory 
effect on protein synthesis, MSTN negatively regulates the AKT/mammalian target 
of rapamycin signaling pathway, which plays a critical role in regulating protein 
synthesis (Sarbassov et al., 2005; Amirouche et al., 2009; Trendelenburg et al., 2009; 
Sartori et al., 2009; Lipina et al., 2010). In these studies, muscle proteolysis does not 
seem to be affected by MSTN. However, it has been demonstrated the MSTN 
upregulates the ubiquitin-proteasome pathway via FOXO (section 1.4.2), leading to 
increased proteolysis in the muscle (McFarlane et al., 2006). 
MSTN also inhibits both myoblast proliferation and differentiation. MSTN 
inhibits myoblast proliferation by enhancing cyclin D1 protein degradation to arrest 
cell cycle at the G1-phase (Yang et al., 2007). Furthermore, MSTN inhibits myoblast 
differentiation by downregulating the expression of genes involved in muscle 
differentiation, which include Myod1 and Myog (Langley et al., 2002; Rı́os et al., 
2002; Joulia et al., 2003). Instead of promoting differentiation or apoptosis of 
myoblasts (McFarlane et al., 2008), MSTN stimulates quiescence by inhibiting 
MYOD1 activity (Langley et al., 2002; McCroskery et al., 2003; Amthor et al., 2006; 
Manceau et al., 2008). MSTN is involved in muscle atrophy; its expression is 
enhanced in muscle atrophy induced by glucocorticoid (Ma et al., 2003; Allen et al., 
2010) and in skeletal muscle degeneration-related diseases, including HIV infection 
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(Gonzalez-Cadavid et al., 1998) and chronic illnesses (Reardon et al., 2001). 
Increased MSTN expression is observed in the skeletal muscle of mice after hindlimb 
suspension (Carlson et al., 1999), sciatic nerve resection (Shao et al., 2007), 
spaceflight (Allen et al., 2009), and unilateral lower limb suspension (Gustafsson et 
al., 2010). Moreover, in humans, MSTN expression is enhanced after chronic disuse 
(Reardon et al., 2001), and after 5 days of immobilization (Dirks et al., 2014). MSTN 
expression has been demonstrated to remain unchanged in the skeletal muscle of 
hibernating thirteen-lined ground squirrels (Brooks et al., 2011). To date, however, 
there is little information on the expression of MSTN in the skeletal muscle of 
naturally torpid animals, and how the changes in the expression of MSTN, if any, 
facilitate muscle mass preservation in these animals. Since HDAC1 is a regulator of 
FOXO, and since FOXO controls MSTN expression, it is therefore important to study 
the changes in the expression of these three genes/proteins as changes in any of them 
might favour muscle degradation in the skeletal muscle of P. annectens especially 
during the maintenance phase. 
1.4.5. Fbxo32 
FBXO32, commonly known as atrogin-1, is an E3 ubiquitin ligase that is selectively 
expressed in muscles at a relatively low level under normal conditions (Bodine, 2013). 
The function of E3 ubiquitin ligases is to transfer ubiquitin molecules to a substrate 
protein (d’Azzo et al., 2005). This inactivates and marks the substrate protein for 
proteasomal degradation (d’Azzo et al., 2005). FBXO32 can be upregulated in 
skeletal muscle atrophy caused by disuse or denervation (Bodine et al., 2001; 
Sacheck et al., 2007; Suzuki et al., 2007; Kim et al., 2008), sepsis (Frost et al., 2007), 
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glucocorticoid treatment (Tobimatsu et al., 2009), and food deprivation in mammals 
(Jagoe et al., 2002; Lecker et al., 2004), birds (Nakashima et al., 2006) and fish 
(Rescan et al., 2007; Cleveland et al., 2009; Bower et al., 2010). Although it has been 
more than a decade since FBXO32 was found to correlate with muscle atrophy, the 
exact mechanism(s) of how FBXO32 leads to muscle atrophy remains unclear. It has 
been proposed that FBXO32 controls protein synthesis by regulating the translation 
initiation factor, eIF3f (Lagirand-Cantaloube et al., 2008). Nonetheless, skeletal 
muscles of mice with a null deletion of FBXO32 are not larger in size as compared to 
control mice, and eIF3f expression does not increase in FBXO32 null mice (Bodine, 
2013).  
FBXO32 expression is regulated by multiple transcription factors. These 
include the glucocorticoid receptor, FOXO1 and FOXO3 (section 1.4.2) (Sandri et al., 
2004; Sacheck et al., 2007). Glucocorticoid levels increase during fasting (Lecker et 
al., 1999; Braun et al., 2011), and have been demonstrated to upregulate the 
expression FBXO32 (Tomas et al., 1979; Goldberg et al., 1980; Löfberg et al., 2002). 
However, glucocorticoids are unlikely to be responsible for the increase in FBXO32 
expression in mammalian disuse models (Tischler, 1994; Watson et al., 2012).  
FBXO32 deletion spares muscle mass following denervation (Bodine et al., 
2001). Increases in the mRNA expression level of Fbxo32 in the skeletal muscles of 
non-hibernators under conditions of inactivity and unloading have been reported to 
facilitate the ubiquitination of muscle proteins, thereby increasing proteolytic 
degradation by proteasome (Bodine et al., 2001; Sandri et al., 2004; Clarke et al., 
2007; Cohen et al., 2009). By contrast, the stable Fbxo32 mRNA expression and the 
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suppression of proteolytic degradation by proteasome in the skeletal muscles are 
apparently associated with the protection of hibernators from disuse muscle atrophy 
(Velickovska et al., 2005; Velickovska and van Breukelen, 2007; Lee et al., 2010; 
Andres-Mateos et al., 2013; Dang et al., 2016). Since FBXO32 is one of the main 
enzymes determining muscle degradation, it is of interest to investigate the changes 
in the expression of fbxo32/Fbxo32 in the muscle of P. annectens during three phases 
of aestivation. 
1.4.6. General changes in expression of hdac1/Hdac1, foxo/FoxO, tp53/TP53, 
mstn/Mstn and fbxo32/Fbxo32, which are involved in muscle degradation, 
during fasting or muscle disuse  
HDAC1: Class I HDACs are key regulators of FOXO and the muscle-atrophy 
program during both fasting and skeletal muscle disuse (Beharry et al., 2014). 
HDAC1 alone is adequate and required to activate FOXO and induce muscle fibre 
atrophy in vivo, and is required for contractile dysfunction and muscle atrophy 
associated with muscle disuse (Beharry et al., 2014). Furthermore, HDAC1 can 
interact with the bHLH domain of MYOD1 to silence MYOD1-dependent 
transcription of muscle-specific genes by keeping MYOD1 in a deacetylated and 
transcriptionally repressed form (Mal et al., 2001). The deacetylase activity of 
HDAC1 is necessary for muscle atrophy to occur, and has been linked to the 
HDAC1-induction of several atrophy genes, including FBXO32, which requires the 
deacetylation of FOXO3a (Beharry et al., 2014). It was discovered that HDAC1 was 
essential for maintaining normal skeletal muscle structure and function (Moresi et al., 
2012). This was associated with the regulation of autophagic flux and HDAC1-
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dependent induction of several genes associated with autophagy, such as Atg5, 
Gabarap11, Lc3 and p62 (Moresi et al., 2012). Autophagic flux is necessary for 
cellular homeostasis under normal circumstances, but increased autophagic flux 
during catabolism promotes muscle atrophy (Mammucari et al., 2007; Masiero and 
Sandri, 2010). However, autophagy inhibition does not prevent skeletal muscle 
atrophy during denervation and fasting; instead it promotes greater muscle loss 
(Masiero and Sandri, 2010). 
FOXO: The translocation and activity of FOXO family members are 
necessary for the upregulation of Fbxo32. AKT phosphorylation of FOXO proteins 
promotes their nuclear export to the cytoplasm. Decreased activity of the AKT 
pathway observed in various models of muscle atrophy leads to reduced levels of 
phosphorylated FOXO in the cytoplasm and a significant increase of nuclear FOXO 
(see review by Calnan and Brunet, 2008). FOXO3 has been demonstrated to be 
necessary for the upregulation of Fbxo32 in muscle atrophy induced by fasting 
(Mammucari et al., 2007) and denervation (Sandri et al., 2004). Furthermore, FOXO1 
transgenic mice demonstrate significantly reduced muscle mass and fibre atrophy, 
indicating that FOXO members are sufficient to promote muscle loss (Kamei et al., 
2004; Southgate et al., 2007). FOXO is induced during disuse muscle atrophy, and 
FOXO signaling is required to cause muscle wasting (Senf et al., 2010). FOXO 
knockdown by RNAi blocks the upregulation of Fbxo32 expression during muscle 
atrophy and muscle loss (Sandri et al., 2004; Liu et al., 2007). 
TP53: TP53 is a nuclear phosphoprotein and a key regulator of cell survival 
and proliferation. Increases in TP53 activity have been correlated with skeletal 
 45 
 
muscle atrophy in vivo under conditions of stress like inflammation, aging and 
chronic exposure to double-stranded DNA breaks (Schwarzkopf et al., 2006; Edwards 
et al., 2007; Rodier et al., 2007; Schwarzkopf et al., 2008; Didier et al., 2012). 
However, it is unclear if TP53 contributes to muscle atrophy induced by fasting. A 
recent study reported an enhanced TP53-independent p21 expression in the skeletal 
muscle during fasting (Tinkum et al., 2013), indicating that TP53 might not 
contribute towards fasting-induced muscle atrophy. TP53 may also contribute to 
apoptosis-mediated muscle wasting since its expression in the muscle is increased 
after 14 days of space-flight (Ohnishi et al., 1999), and after 7 or 14 days of 
unloading (Siu and Alway, 2005a). Recently, TP53 was identified as an essential 
mediator of immobilization-induced muscle atrophy (Fox et al., 2014). 
MSTN: The mRNA expression of Mstn increased dramatically in the fast-
twitch tibialis anterior muscle of mice deprived of food for 2 days (Allen et al., 2010). 
Levels of Mstn/MSTN increased in the muscle of rodents after hindlimb suspension 
(Carlson et al., 1999), after denervation (Shao et al., 2007), and after 11 days of 
spaceflight (Allen et al., 2009). Similar increases in MSTN/MSTN expression were 
also reported in humans after chronic disuse (Reardon et al., 2001) and after 
unilateral lower limb suspension (Gustafsson et al., 2010). 
FBXO32: Fbxo32 is a E3-ubiquitin ligase involved in the ubiquitination and 
proteolysis of muscle proteins (Glass, 2003; Sacheck et al., 2004; Bodine et al., 2013). 
The mRNA levels of Fbxo32 increases rapidly in various models of atrophy and is 
thought to play a role in initiating the atrophy process in the muscle (Bodine et al., 
2001; Foletta et al., 2011). Fasted mice were reported to have an increase in the 
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mRNA expression of Fbxo32 (Gomes et al., 2001; Sandri et al., 2004). Similarly, an 
upregulation of Fbxo32/FBXO32 was reported in the muscle of mice following 
denervation (Bodine et al., 2001). Similar results were also observed after 
immobilization (Jones et al., 2004; Abadi et al., 2009), after spaceflight in rodents 
(Allen et al., 2009), and after 3 days of unilateral lower limb immobilization in 
humans (Gustafsson et al., 2010). Up-regulation in the mRNA expression level of 
Fbxo32 in the skeletal muscles of non-hibernators under conditions of inactivity and 
unloading facilitate the ubiquitination of muscle proteins, thereby increasing 
proteolytic degradation by proteasome (Bodine et al., 2001; Sandri et al., 2004; 
Clarke et al., 2007; Cohen et al., 2009). 
1.5. Genes/proteins involved in oxidative defense 
1.5.1. Sod 
SOD is an antioxidant enzyme that catalyzes the disproportionation of O2
- to H2O2 
and water (Fridovich, 1986; Fridovich, 1995). As SODs are metalloenzymes, they are 
classified according to the metal ion cofactor required for their activity: the 
copper/zinc type (CuZnSOD), the manganese type (MnSOD), the iron type (FeSOD), 
and the nickel type (NiSOD) (Youn et al., 1996). In eukaryotes, cytosolic CuZnSOD, 
glycosylated extracellular CuZnSOD, and mitochondrial MnSOD have been found 
(Fridovich, 1995), and overexpression of mitochondrial MnSOD or cytosolic 
CuZnSOD increase oxidative stress resistance (Murakami et al., 1997; Shan et al., 
2007; Jang et al., 2009). CuZnSOD can be found abundantly in the cytoplasm 
(Halliwell and Gutteridge, 1989), but it has also been observed in endosomes and the 
mitochondrial intermembrane space (Saito et al., 1989; Kawamata and Manfredi, 
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2010). On the other hand, mitochondrial MnSOD is encoded by the nuclear gene, and 
it is synthesized and translocated into the mitochondrial matrix with mature enzyme 
activity (Wispé et al., 1989). The presence of MnSOD within the mitochondria 
indicates that the superoxide produced in the mitochondria does not cross membranes 
readily, and because of its negative effects on biomolecules, superoxide must be 
dismutated immediately by SOD, preferably at the production site of superoxide. It is 
henceforth thought that MnSOD is a major scavenger of ROS in the mitochondrial 
matrix among the aerobic organisms (Cadenas and Davies, 2000). Furthermore, 
MnSOD is essential for survival – MnSod gene knockout in mice (Williams et al., 
1998) and fruit flies (Duttaroy et al., 2003) is lethal.  
Mitochondrial ROS has been implicated in skeletal muscle disuse, as 
inactivity-induced ROS is produced mainly in the mitochondria (Muller et al., 2007; 
Kavazis et al., 2009; Min et al., 2011; Powers et al., 2011; Talbert et al., 2013). 
Although it would be logical to assume that mitochondria ROS is scavenged by 
MnSod, it is possible that CuZnSOD could scavenge mitochondrial ROS, as there is 
increasing evidence of CuZnSOD being located in the mitochondrial inter-membrane 
space (Saito et al., 1989; Kawamata and Manfredi, 2010). CuZnSOD exists as a 
functional homodimer. The dimerization of each monomer requires disulphide bond 
formation, protein folding, Cu and Zn loading and dimer formation (Hitchler and 
Domann, 2014). It was thought that CuZnSOD processing affects its subcellular 
localization (Hitchler and Domann, 2014). CuZnSOD is imported as a catalytically 
inactive enzyme into the intermembrane space during mitochondrial import, and is 
processed by the copper chaperone for CuZnSOD (CCS) into the active enzyme, and 
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stays trapped in the mitochondria (Leitch et al., 2009; Kawamata and Manfredi, 
2010). The import of CuZnSOD and CCS occurs via a disulphide relay system 
involving the import receptor Mia40 (Reddehase et al., 2009; Kawamata and 
Manfredi, 2010). In addition, stress signals can affect the subcellular localization of 
CuZnSOD. Increased stress can lead to the import of CuZnSOD from the cytosol into 
the nucleus (Zlatković and Filipović, 2011).  
Increases in CuZnSOD activity have been reported in the muscle of 
aestivating snails (Hermes-Lima and Storey, 1995; Salway et al., 2010) and spadefoot 
toads (Grundy and Storey, 1998). It is clear that CuZnSOD plays an important role in 
protecting the skeletal muscle from oxidative damage due to mitochondrial ROS in 
these aestivators.  
1.5.2. Cat 
CAT is an extremely active catalyst produced naturally which degrades H2O2 without 
the consumption of cellular reducing equivalents, thus utilising energy efficiently 
(Ścibior, and Czeczot, 2006). There is a net gain of reducing equivalents, and hence, 
cellular energy. It is therefore not surprising that all aerobic organisms contain CAT. 
It is usually found in peroxisomes of all aerobic organisms, as there are many H2O2-
producing enzymes within peroxisomes (Ścibior, and Czeczot, 2006). This allows for 
rapid degradation of H2O2 before the damaging ROS can diffuse to other parts of the 
cell. Its evolutionary conservation suggests that it is essential in systems that have 
evolved over the centuries, enabling the survival of organisms in aerobic 
environments. CAT is a tetrameric enzyme comprising four identical, tetrahedrally 
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arranged subunits, with a heme group and NADPH in the active centre of each 
subunit (Kirkman and Gaetani, 1984).  
It is thought that CAT plays a critical role in maintaining the integrity of 
muscle (Stauber et al., 1977). Decreases in the activities of CAT occur in the skeletal 
muscles of starved rodents (Di Simplicio et al., 1997) and fasted penguins (Rey et al., 
2008), and in hindlimb unloading models (Lawler et al., 2003). In contrast, an 
increase in the activity of Cat occurs in the foot muscle of aestivating land snails 
(Hermes-Lima and Storey, 1995). These results indicate that CAT could prevent 
muscle atrophy by protecting the skeletal muscle against oxidative damage.  
1.5.3. Gpx 
GPX are considered to be the frontline of defence against ROS. There are two types 
of GPX – the selenium-dependent GPX (SeGPX) and the selenium-independent GPX 
(non-SeGPX). SeGPX, which includes GPX1 to 4, is able to reduce both organic and 
inorganic peroxides such as H2O2, while non-SeGPX (GPX5 to 8) catalyses the 
reduction of organic peroxide only (Almar et al., 1998). The various isozymes are 
found in different cellular locations and vary in substrate specificity as well. The 
selenol in Se-GPX reacts with H2O2 to selenenic acid, which is then reduced by 
reduced glutathione (GSH) to form oxidized glutathione (GSSG) and water (Flohé, 
1989; Toppo et al., 2009; Flohé et al., 2011). GPX1 is the most abundant isozyme, 
found in the cytosol of nearly all mammalian tissues, and has a preferred substrate of 
H2O2; GPX4 is expressed at lower levels in almost every mammalian cell, and prefers 
to reduce lipid hydroperoxides (Brigelius-Flohé, 1999). Among the SeGPX, GPX4 
protects membranes from oxidative damage as it possesses the ability to reduce both 
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H2O2 and hydroperoxides in complex lipids including phospholipids, cholesterol and 
cholesterolester hydroperoxides, even when these lipids are found inserted into 
biomembranes or lipoproteins (Thomas et al., 1990). GPX4 can translate oxidative 
stress into cell death (Seiler et al., 2008).  
Unlike CAT, there are no significant changes in GPX activity or protein 
expression in the skeletal muscle of starved mice (Di Simplicio et al., 1997) or fasted 
penguins (Rey et al., 2008). This suggests that CAT probably plays a more important 
role than GPX in antioxidant defense in cases of food deprivation. However, 
decreases in GPX levels take place in rat muscle upon hindlimb unloading (Lawler et 
al., 2003). In contrast, increases in the activities of SeGpx and total Gpx occur in the 
foot muscle of land snails (Ramos-Vasconcelos et al., 2003; Nowakowska et al., 2011, 
2014) and in the muscle of spadefoot toads (Grundy and Storey, 1998) during 
aestivation. Therefore, Gpx is implicated in protecting the muscle against oxidative 
damage.  
1.5.4. General changes in expression of CuZnsod/CuZnSod, Mnsod/MnSod, 
cat/Cat, gpx1/Gpx1 and gpx4/Gpx4, and levels of several oxidative stress 
markers during fasting or muscle disuse  
SOD: SOD activity decreased in the skeletal muscle of fasted mice (Di Simplicio et 
al., 1997). An increase in CuZnSOD was reported in limb immobilization models 
(Kondo et al., 1991, 1993). This increase is also observed in the skeletal muscles of 
rats upon hindlimb unloading (Lawler et al., 2003). However, the same study (Lawler 
et al., 2003) reported a decrease in MnSOD activity. It was thought that there could 
be an upregulation of superoxide anions in the cytosol instead of the mitochondria in 
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skeletal muscles with unloading, and that the increased CuZnSOD activity could offer 
some protection against superoxide anions (Lawler et al., 2003). 
CAT: CAT activity decreases in the skeletal muscles of starved rodents (Di 
Simplicio et al., 1997) and fasted penguins (Rey et al., 2008). CAT levels decreases 
in hindlimb unloading models and is associated with disuse muscle atrophy (Lawler 
et al., 2003). Overexpression of CAT attenuates disuse-induced atrophy significantly 
by abolishing immobilization-induced transactivation of nuclear factor κB and FOXO 
(Dodd et al., 2010). 
GPX: No significant changes in GPX activity or protein expression has been 
reported in the skeletal muscle of starved mice (Di Simplicio et al., 1997) or fasted 
penguins (Rey et al., 2008). However, in disuse mammalian models, there were 
decreases in GPX levels in rat muscle upon hindlimb unloading (Lawler et al., 2003). 
Oxidative stress biomarkers: Fasting can cause a depletion of extracellular 
glutathione concentrations (Vogt and Richie, 1993; Di Simplicio et al., 1997), which 
can result in fasting-induced muscle atrophy. Increases in xanthine oxidase activity, 
lipid peroxidation and [GSSG]/[GSH] ratio were observed in limb immobilization 
models (Kondo et al., 1991, 1993). Similar increases in lipid peroxidation and protein 
oxidation, together with muscle fibre atrophy, were reported in rodents following 
hindlimb unloading (Lawler et al., 2003; Brocca et al., 2010; Desaphy et al., 2010). 
Prolonged skeletal muscle inactivity due to immobilization leads to chronic increases 






2.1. African lungfishes and aestivation 
Lungfishes are freshwater fishes belonging to the class Sarcoterygii that hold an 
important position in the evolution of vertebrates with regard to the water-land 
transition. This is because lungfishes possess lungs, and some of them can survive 
emersion for a long period. There are six extant lungfishes worldwide, of which four 
(Protopterus annectens, P. aethiopicus, P. amphibicus, and P. dolloi) are found in 
Africa. African lungfishes are obligate air-breathers and can undergo aestivation in 
subterranean mud cocoon for up to four years (Smith, 1931; see Ip and Chew, 2010; 
Ballantyne and Frick, 2010 and Chew et al., 2015 for reviews). Aestivation is a state 
of corporal torpor adopted by some animals to survive in arid conditions at high 
temperature without food and water intake for an extended period (Ip and Chew, 
2010; Chew et al., 2015).  
African lungfishes can be induced to aestivate in completely dried mucus 
cocoon in plastic boxes in the laboratory (Chew et al., 2004; Ip et al., 2005a; Loong et 
al., 2005, 2008a, b, 2012a). There are three phases of aestivation: induction, 
maintenance and arousal. During the induction phase, the aestivating lungfish detects 
environmental cues and turns them into internal signals that will instill the necessary 
behavioural, structural, physiological, and biochemical changes in preparation of 
aestivation. It hyperventilates and secretes mucus which turns into a dry mucus 
cocoon within 6–8 days. Aestivation begins when the lungfish is completely encased 
in a cocoon, and there is a complete cessation of feeding and locomotion. During the 
maintenance phase, the lungfish has to prevent cell death, preserve the biological 
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structures and sustain a slow rate of waste production to avoid polluting the internal 
environment. The lungfish can perpetuate to aestivate under such conditions for more 
than a year in the laboratory. The lungfish can be aroused from aestivation upon the 
addition of water. It struggles out of the cocoon and swims sluggishly to the water 
surface to gulp air. During the arousal phase, it has to excrete the accumulated waste 
products and feed for repair and growth. Feeding begins approximately 7–10 days 
after arousal, and the lungfish grows and develops normally thereafter. It is apparent 
that metabolic changes would vary between the three phases of aestivation, but 
majority of studies in the literature focused predominantly on the maintenance phase. 
2.2. Aestivation and muscle atrophy 
During periods of fasting, energy stores are mobilized from several tissues as a 
provision of nutrients for energy production. Unlike lipids and carbohydrates, 
however, there is no known protein store in animals, and proteins would have to be 
mobilized from biological structures of specific functions. Fasting-induced muscle 
atrophy occurs through enhanced protein degradation and reduced protein synthesis 
in the skeletal muscle (Tomas et al., 1979; Goldberg et al., 1980; Löfberg et al., 2002). 
Similar processes also occur during skeletal muscle disuse, leading to disuse-induced 
muscle atrophy in mammals (Childs, 2003). Various studies have reported an 
immediate decline in the rate of basal protein synthesis after unloading, and this rate 
stays suppressed throughout the period of disuse (Goldspink, 1977; Booth and Seider, 
1979; Paddon-Jones et al., 2006; Glover et al., 2008; Lang et al., 2012; Kelleher et al., 
2013). Decreased protein synthesis is thus a prominent attribute of muscle atrophy in 
mammalian disuse models (Rennie et al., 2010; Marimuthu et al., 2011). Other than 
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decreased protein synthesis, another prominent feature that contributes to disuse 
muscle atrophy in non-hibernating mammals is the induction of protein catabolism 
(Lecker and Goldberg, 2002; Jackman and Kandarian, 2004; Marimuthu et al., 2011). 
Studies have reported a coordinated increase in the expression of genes involved in 
the ubiquitin-proteasome pathway, proteolysis and lysosome proteolysis in skeletal 
muscles of various mammalian models of disuse muscle atrophy (Wittwer et al., 2002; 
Chopard et al., 2009; Bialek et al., 2011). 
During aestivation, there is a complete cessation of feeding and locomotor 
activities in the African lungfish, which results in the possibility of muscle atrophy 
induced by fasting and disuse. However, aestivating P. annectens loses less than 10% 
of its skeletal mass after 6 months of aestivation without food supply (Y. K. Ip, 
unpublished results). It has to preserve its muscle structure and strength by 
suppressing proteolysis and amino acid catabolism during the maintenance phase of 
aestivation so that it can struggle out of the cocoon upon subsequent arousal (Chew et 
al., 2015). Hence, the aestivating African lungfish represents a rare case of a fish 
being able to suppress muscle atrophy despite long periods of fasting and inactivity. 
Without food supply, protein synthesis would either come to a halt or be reduced to 
an extremely low level through endogenous nitrogen recycling. This should 
theoretically exacerbate muscle atrophy resulting from the increased catabolism of 
muscle tissue for energy supply (Yacoe, 1983; Wickler et al., 1987, 1991; Steffen et 
al., 1991). As muscle mass preservation is dependent on the balance between the rate 
of protein synthesis (muscle formation) and the rate of protein degradation (muscle 
degradation), the author aimed to determine the changes in expression of various 
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genes/proteins, which are known to be involved in muscle formation or degradation, 
in the skeletal muscle of P. annectens during three phases of aestivation. 
Prolonged skeletal muscle disuse results in a loss of muscle protein and 
atrophy of muscle fibre, which is associated with increased biomarkers of oxidative 
stress in in humans and many other mammals (Kondo et al., 1991; Arbogast et al., 
2007; Falk et al., 2011; Hussain et al., 2010; Jaber et al., 2011; Levine et al., 2008; 
Min et al., 2011; Powers et al., 2011; Whidden et al., 2009, 2010). Reactive oxygen 
species (ROS) can act as signalling molecules in situations of muscle disuse such as 
immobilization (Kondo et al., 1991, 1993), limb suspension/unloading (Lawler et al., 
2003) and denervation (Muller et al., 2007). Oxidative stress leads to the upregulation 
of several degradative pathways related to skeletal muscle atrophy (Hudson and 
Franklin, 2002; Powers et al., 2005). The role of ROS and oxidative stress in disuse 
atrophy is supported by the attenuation of immobilisation atrophy in mice 
administered with mitochondria-targeting antioxidants (Min et al., 2011). 
Furthermore, a suppression of mitochondrial ROS production in the disused skeletal 
muscle of striped burrowing frogs protects the muscle against potential oxidative 
injury and facilitates muscle mass preservation during aestivation in preparation for 
arousal (Reilly et al., 2014). Although many studies have investigated antioxidant 
levels in muscles of aestivators and hibernators during the maintenance and/or 
arousal phases of aestivation and hibernation, respectively (Ramos-Vasconcelos and 
Hermes-Lima, 2003; Hudson et al., 2006; Allan and Storey, 2012; James et al., 2013; 
Young et al., 2013a, b; Reilly et al., 2014), there is little information on the oxidative 
defense mechanisms or oxidative damages involved. The author decided to determine 
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the changes in expression of various genes/proteins involved in oxidative defense or 
acted as oxidative stress markers in the skeletal muscle of P. annectens during three 
phases of aestivation.  
2.3. Fasting and muscle disuse generally lead to muscle atrophy 
Skeletal muscle atrophy can occur as a result of immobilization and/or starvation in 
multiple animal models. Under these conditions, muscle wasting involves increased 
proteolysis and reduced protein synthesis (Sandri et al., 2004).  
During long periods of food deprivation, there is a need to mobilize energy 
stores from various tissues for energy production. Under adverse conditions, skeletal 
muscle can act as a source of energy, as muscle protein can be broken down to amino 
acids (Daniel, 1977), which can be later converted to glucose. However, this can 
result in skeletal muscle atrophy as reported in several animal models (Wing and 
Goldberg, 1993; Medina et al., 1995; Jagoe et al., 2002; Ørngreen et al., 2003; Allen 
et al., 2010; Seiliez et al., 2011). Muscle atrophy can also occur due to disuse (Fitts et 
al., 1986; Taillandier et al., 1996; Morey-Holton and Globus, 2002; Marimuthu et al., 
2011). In cases of food deprivation, levels of glucocorticoids (endocrine hormones) 
are increased (Lecker et al., 1999; Braun et al., 2011) leading to fasting-induced 
muscle atrophy through increased proteolysis and decreased protein synthesis in the 
muscle (Tomas et al., 1979; Goldberg et al., 1980; Löfberg et al., 2002). However, 
glucocorticoids do not seem to be necessary for muscle atrophy induced by disuse 
(Tischler, 1994) or denervation (Watson et al., 2012). In humans, disuse muscle 
atrophy is attributed to decreased protein synthesis and no significant change in 
protein breakdown in human disuse models (Ferrando et al., 1996; Biolo et al., 2004; 
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Paddon-Jones et al., 2006; Glover et al., 2008), although measuring protein 
degradation in humans is difficult (Bodine, 2013). Unlike human disuse models, 
various studies on hind limb unweighting in rodents have attributed disuse muscle 
atrophy to increased protein breakdown (Taillander et al., 1996; Tawa et al., 1997; 
Bodine et al., 2001; Gomes et al., 2001; Ikemoto et al., 2001). 
Animals that undergo torpor are protected against muscle atrophy despite long 
periods of immobilization and food deprivation (Grundy and Storey, 1998; Hudson 
and Franklin, 2002; Lohuis et al., 2007; Mantle et al., 2009; Cotton and Harlow, 2010; 
Lee et al., 2010; Gao et al., 2012; Andres-Mateos et al., 2013). In the case of African 
lungfishes, they do not consume any food nor is there any locomotor activity during 
the maintenance phase of aestivation. As such, the skeletal muscles of African 
lungfish may undergo atrophy due to both fasting and disuse during aestivation. 
Although it was observed that fasting can initiate physiological and biochemical 
changes in a manner similar to aestivation (Fishman et al., 1986), a drastic increase in 
protein degradation, as in the case of fasting alone (Ip et al., 2005b), does not occur in 
aestivating African lungfishes. Hence, it is apparent that aestivating lungfishes can 
effectively preserve muscle structure and strength during the maintenance phase of 
aestivation (i.e. a period of 6 months in this study), in preparation for arousal, by 
suppressing proteolysis and amino acid catabolism (Chew et al., 2015). In order to 
differentiate the effects of fasting and muscle disuse, it was essential to analyze the 
effects of aestivation on the genes/proteins involved in muscle formation and those 
involved in muscle degradation. 
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2.4. Objectives and hypotheses 
2.4.1. Molecular characterization of various genes/proteins involved in muscle 
formation or muscle degradation in P. annectens  
The first objective of this study was to clone and sequence the cDNA coding region 
of genes known to be involved in muscle formation [peroxisome proliferator-
activated receptor-γ coactivator-1α (ppargc-1α), myogenic differentiation 1 (myod1), 
myogenin (myog), mitogen-activated protein kinases 1 (mapk1) and 3 (mapk3)] and 
muscle degradation [histone deacetylase 1 (hdac1), forkhead box O1 (foxO1), 
forkhead box O3 (foxO3), myostatin (mstn) and F-box protein 32 (fbxo32)] from the 
muscle of P. annectens. Efforts were made to investigate the dendrogamic 
relationship of each gene/protein involved in muscle formation and muscle 
degradation. It was hoped that information obtained would shed light on the 
evolutionary relationship of lungfishes to tetrapods and teleosts. 
2.4.2. Effects of aestivation on the expression of various genes/proteins involved 
in muscle formation or muscle degradation in the skeletal muscle of P. annectens 
The second objective was to determine the mRNA expression levels and, where 
possible, the protein abundances of genes/proteins known to be involved in muscle 
formation (ppargc-1α/Ppargc-1α, myod1/Myod1, myog/Myog, mapk1/Mapk1 and 
mapk3/Mapk3) and muscle degradation (hdac1/Hdac1, foxO1/FoxO1, foxO3/FoxO3, 
tp53/Tp53, mstn/Mstn and fbxo32/Fbxo32) in the muscle of P. annectens during the 
three phases of aestivation. During the induction phase, fasting had just begun and the 
lungfish still exhibited some locomotor activity, especially for the first 1 to 3 days. 
Moreover, the aestivating lungfish performed tissue reconstruction (Chew et al., 
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2015), which could naturally involve increased protein turnover in certain organs. 
There could be an increased supply or mobilization of protein/amino acids from the 
skeletal muscle as the fish was deprived of food. Hence, it was hypothesized that 
muscle formation might be reduced or remain unchanged, while muscle degradation 
may remain unchanged or enhanced, during the induction phase. 
During the maintenance phase, the lack of food supply and locomotor activity 
subjected the skeletal muscle of the aestivating lungfish to possible atrophy induced 
by fasting and muscle disuse, respectively. However, there was a need to preserve 
muscle structure and strength in preparation for arousal (Chew et al., 2015). It was 
thus hypothesized that the expression of genes/proteins involved in muscle formation 
and particularly in muscle degradation could be down-regulated during the 
maintenance phase of aestivation.  
During the arousal phase, fasting continued but the lungfish resumed 
locomotor activity. The aroused fish had to perform tissue 
reconstruction/regeneration which depicted increased protein turnover in certain 
organs, with possible increased protein/amino acid mobilization from the skeletal 
muscle. Hence, the hypothesis tested was that the expression of genes/proteins 
involved in muscle formation would decrease, while the expression of genes/proteins 




2.4.3. Effects of aestivation on the expression of genes/proteins, and their 
activities where applicable, involved in oxidative defense or acted as oxidative 
stress markers in the skeletal muscle of P. annectens 
The third objective was to determine the mRNA and protein expression levels of 
copper-zinc superoxide dismutase (CuZnsod/CuZnSod), manganese superoxide 
dismutase (Mnsod/MnSod), catalase (cat/Cat), glutathione peroxidases 1 (gpx1/Gpx1) 
and 4 (gpx4/Gpx4) in the muscle of P. annectens during the three phases of 
aestivation. In order to assess whether the skeletal muscle of the aestivating fish 
suffered oxidative damages, efforts were also made to determine the specific 
activities of CuZnSod, MnSod, total Sod, Cat, selenium-dependent Gpx (SeGpx), 
total Gpx, glutathione reductase (Gr) and glutathione-S-transferase (Gst), the 
concentrations of total glutathione equivalent (total GSH-eq), reduced and oxidized 
glutathione (GSH and GSSG), and oxidative damage products [lipid hydroperoxides 
(LOOH), thiobarbituric acid reactive substances (TBARS) and carbonyl proteins] in 
the muscle of P. annectens during the three phases of aestivation.  
During the induction phase, P. annectens could be confronted with oxidative 
stress due to hyperventilation and possibly an increased metabolic rate due to tissue 
reconstruction (Chew et al., 2015). It was thus predicted that the expression of certain 
genes/proteins involved in oxidative defense or acted as oxidative stress markers 
would be up-regulated in the skeletal muscle of the aestivating fish during this short 
period. During the maintenance phase, it was hypothesised that the expression of 
certain genes/proteins involved in oxidative defense would be enhanced in the muscle 
to protect it from oxidative damages and related atrophy. Since the skeletal muscle of 
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the aestivating fish had little muscle loss (as compared to human disuse models), the 
expression of oxidative stress markers were hypothesized to remain unchanged or 
decrease in the skeletal muscle during the maintenance phase of aestivation. During 
the arousal phase, there was an increase in oxygen consumption, which could result 
in increased oxidative stress. Up-regulation of various enzymes involved in oxidative 
defense have been reported in aestivators to protect against ischemia-reperfusion 
related oxidative stress associated with the transition from aestivation to arousal 
(Hermes-Lima and Storey, 1995; Hermes-Lima and Zenteno-Savín, 2002; Ramos-
Vasconcelos and Hermes-Lima, 2003; Ramos-Vasconcelos et al., 2005; Nowakowska 
et al., 2009). It was thus hypothesised that the expression of genes/proteins involved 
in oxidative defense would be up-regulated in the skeletal muscle of P. annectens 
during the arousal phase of aestivation.   
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3. Materials and methods 
3.1. Animals 
Specimens of P. annectens (80–120 g body mass) were imported from Central Africa 
through a local fish farm in Singapore. Specimens were maintained in plastic aquaria 
filled with dechlorinated tap water at 25°C in the laboratory. Water was changed 
daily. No attempt was made to separate the sexes. Fish were acclimated to laboratory 
conditions for at least two weeks. During the acclimatization period, fish were fed 
with frozen fish meat. This study was performed in accordance with approved 
protocol IACUC 035/09 granted by the Institutional Animal Care and Use Committee 
of the National University of Singapore. 
3.2. Experimental conditions and collection of samples 
Lungfishes were induced to aestivate at 27–29°C and 85–90% humidity individually 
in plastic tanks (L29 cm x W19 cm x H17.5 cm) containing 15 ml dechlorinated tap 
water (made to Salinity 0.3 with seawater), following the procedure of Chew et al. 
(2004). It took approximately 6 days for the lungfish to be encased in a brown dried 
mucus cocoon. In this study, these 6 days were counted as part of the aestivation 
period. Hence, for a lungfish aestivated for 12 days, it would have spent 
approximately 6 days within the dried mucus cocoon. The lungfish were allowed to 
aestivate for 6 months. In order to maintain a high humidity (>90%) within the tank, 
1–2 ml of water was sprayed onto the side of the tank daily. After 6 months of 
aestivation, some lungfish were aroused by adding 200 ml of water into the tank and 
breaking up the cocoon manually. After a few minutes, the lungfish would swim 
sluggishly in the water; another 800 ml of water was added to cover the fish. Some 
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lungfish were killed with an overdose of neutralized 0.05% MS222 for tissue 
sampling after 3 or 6 days (the induction phase), or after 12 days (the early 
maintenance phase) or 6 months (the prolonged maintenance phase) of aestivation 
(N=4 for each group). Some lungfish were killed after 1, 3 or 6 days of arousal from 6 
months of aestivation (the arousal phase) without food (N=4 for each group). The eye, 
brain, gills, heart, liver, spleen, pancreas, gut, kidney, lung, muscle and skin were 
quickly excised and freeze-clamped with aluminum tongs pre-cooled in liquid 
nitrogen, and kept at -80°C until analysis. The lungfish kept in fresh water (N=4) 
served as controls and were killed after food was withheld for 96 h. 
3.3. Cloning, sequencing, dendrogemic analysis and tissue expression 
3.3.1. Total RNA extraction and cDNA synthesis 
Total RNA was extracted from all the samples extracted from P. annectens using Tri 
ReagentTM (Sigma-Aldrich Co., St. Louis, MO, USA), and purified using the Qiagen 
RNeasy Mini Kit (Qiagen GmbH, Hilden, Germany). RNA was quantified 
spectrophotometrically using a BioSpec-nano (Shimadzu, Tokyo, Japan) and RNA 
integrity assessed electrophoretically before storing at -80°C. Assessment of RNA 
quality to verify RNA integrity prior to cDNA synthesis was performed 
electrophoretically. First strand cDNA was synthesized from 4 µg of total RNA using 
oligo(dT)18 primer and the RevertAid
TM first strand cDNA synthesis kit (Fermentas 
International Inc., Burlington, ON, Canada). 
3.3.2. Polymerase Chain Reaction (PCR) and cloning 
The full coding sequences of tp53, CuZnsod, Mnsod, cat, gpx1 and gpx4 have been 
obtained previously from the author’s laboratory (Ong, 2010; 2011; Ching, 2012). 
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The partial coding sequence of ppargc-1α was obtained from Genbank with the 
accession number FJ710608. 
Partial sequences of myod1, myog, mapk1, mapk3, hdac1, foxO1, foxO3, mstn, 
and fbxo32 were obtained using gene-specific primers (Table 1) designed from the 
highly conserved regions based on multiple alignments of the respective sequences 
from various fish species available in Genbank 
(http://www.ncbi.nlm.nih.gov/Genbank/). PCR was performed using Dreamtaq 
polymerase (Fermentas International Inc.), according to the manufacturer’s 
instructions. The thermal cycling conditions were 95°C for 3 min, followed by 40 
cycles of 95°C for 30 s, 60°C for 30 s, 72°C for 2 min and a final extension of 72°C 
for 10 min. PCR products were separated by gel electrophoresis and bands of 
estimated molecular masses were excised and purified by FavorPrep™ Gel 
Purification Mini Kit (Favorgen Biotech Corp., Ping Tung, Taiwan) according to the 
manufacturer’s instructions. PCR products were cloned into pGEM®-T Easy vector 
(Promega Corporation, Madison, WI, USA). The ligated vector was transformed into 
JM109 competent cells and plated onto Luria-Bertani agar with 100 μg ml−1 
ampicillin, 50 μg ml−1 X-gal and 0.5 mmol l−1 IPTG. Selected white colonies were 
grown overnight in Luria-Bertani broth with ampicillin. The plasmids were extracted 
using the resin-based plasmid miniprep kit (Axygen Biosciences, Union city, CA, 
USA). Sequencing was performed using BigDye® Terminator v3.1 Cycle Sequencing 
Kit (Thermo Fisher Scientific, Waltham, MA, USA) and sequenced using the 
3130XL Genetic Analyzer (Thermo Fisher Scientific). Sequence assembly and 
analysis were performed using Bioedit v7.1.3 (Hall, 1999).  
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Table 1. The primer sequences used for PCR. 
Gene Primer sequence (5’to 3’) 
myod1 Forward: CACATCTCTTTGCTCATTCC 
Reverse: CCCTCTGCTCCTGTTTCT 
myog Forward: GAGCACCCTGATGAACCC 
Reverse: ACTGTGATGCTGTCCACGAT 
mapk1 Forward: GTGTGTTCTTCTAGTCATGG 
Reverse: TTCTGAAGTCCTAGCCCT 
mapk3 Forward: CTCAAATCCCTCAGCAAC 
Reverse: ATCAGCTCTTTCAGTTTCTCC 
hdac1 Forward: GCGGTTGTATAGATAGAGTGAGT 
Reverse: CAAGGAATGCCAATGCTA 
foxO1 Forward: TCGCCATAACTTGTCACTTC 
Reverse: GCCCATTACTGTTGATACCA 
foxO3 Forward: GAACTCAATCCGACACAATCT 
Reverse: CACTGCCCTCATCTTGCT 
mstn Forward: GACGTGCTGGGAGATGAC 
Reverse: CAATAATCCAGTCCCAGCC 





3.3.3. Rapid amplification of cDNA ends (RACE) 
Total RNA (1 µg) isolated from the muscle of freshwater P. annectens was reverse 
transcribed into 5’-RACE-Ready cDNA and 3’-RACE-Ready cDNA using 
SMARTerTM RACE cDNA Amplification kit (Clontech Laboratories, Mountain 
View, CA, USA). RACE-PCR were performed using Advantage® 2 PCR kit 
(Clontech Laboratories), with gene-specific RACE primers (Table 2), designed based 
on partial cDNA sequences of ppargc-1α, myod1, myog, mapk1, mapk3, hdac1, 
foxO1, foxO3, mstn, and fbxo32 to generate the 5’ and 3’ cDNA fragments 
respectively. The cycling conditions involved 30 cycles of 94°C for 30 s, 65°C for 30 
s, and 72°C for 4 min. RACE-PCR products were separated using gel electrophoresis, 
purified and sequenced. Multiple sequencing was performed in both directions to 
obtain the full coding sequence.  
3.3.4. Deduced amino acid sequences and dendrogramic analysis 
The amino acid sequences of Ppargc-1α, Myod1, Myog, Mapk1, Mapk3, Hdac1, 
FoxO1, FoxO3, Mstn, and Fbxo32 were translated from their respective nucleotide 
sequences using ExPASy Proteomic server (http://web.expasy.org/translate/). The 
deduced amino acid sequences were aligned and compared with selected Ppargc-
1α/PPARGC-1α, Myod1/MYOD1, Myog/MYOG, Mapk1/MAPK1, Mapk3/MAPK3, 
Hdac1/HDAC1, FoxO1/FOXO1, FoxO3/FOXO3, Mstn/MSTN, and 
Fbxo32/FBXO32 sequences from various animal species using BioEdit. Potential 
nuclear localization signals were identified using cNLS Mapper (Kosugi et al., 2009) 




Table 2. The primer sequences used for RACE PCR. 
Gene Primer type Primer sequence (5’to 3’) 
ppargc-1α 5’-RACE CAGCAAGTTGGCCTCATTCTCGT 
3’-RACE TGCATTTGCTGCTCTTGAGAATGG 
myod1 5’-RACE GGGTCATCATAGAAGTCATCTGCTGG 
3’-RACE TGTAAAGCCTGCAAGAGAAAGACCAC 
myog 5’-RACE CTGCACTGCTCCATTCTGGACTG 
3’-RACE CAGTCCAGAATGGAGCAGTGCAG 
mapk1 5’-RACE GTGTGCCAACGCTTCTTCCACTT 
3’-RACE CAGTGATGAGCCTACAGCAGAATCACCA 
mapk3 5’-RACE TCGCAGGATCTGGTAGAGGAAGTAG 
3’-RACE ATGAGCCCGTGGCAGAGGAACCC 
hdac1 5’-RACE CCCTCCAGCCCAATTCACTGCAATATCA 
3’-RACE CTTGCGAATGCTTCCTCATGCTCCT 
foxO1 5’-RACE GATTGAGCATCCACCAGGAACTCTTC 
3’-RACE TAAACCCTGCAACCCACCCTCATCAAG 
foxO3 5’-RACE ACTGCTGCGTGAAGTAGGACTGCCA 
3’-RACE CCCAATGCTGTACCCTAGTCCTACCCAT 
mstn 5’-RACE TCCACTTTCAGAGAACGAATGCCT 
3’-RACE AAGAAGGGCTGCAACCATTTCTG 





The sequences of the proteins listed above were aligned using ClustalX2, and 
the various dendrograms were constructed through maximum likelihood analyses. 
Using ModelGenerator v0.85 (Keane et al., 2006), the best-fitting evolutionary model 
under the Akaike Information Criterion for all the proteins listed above was Jones-
Taylor-Thornton. The maximum likelihood analyses were run using RaxML v8.2.5 
(Stamatakis, 2014) with the number of bootstraps listed in Table 3. Trees were 
determined to have converged after a certain number of replicates (Table 3) by the 
bootstrap convergence criterion. The selected animal species and their respective 
amino acid accession numbers used in the dendrogramic analyses are presented in 
Appendix 1.  
3.3.5. Gene expression in various tissues/organs 
PCR was performed on the cDNAs of muscle, heart, brain, eye, gills, kidney, lung, 
skin, liver, spleen, pancreas, and gut of freshwater P. annectens (N=1) using gene-
specific qPCR primers (Table 4) to detect the mRNA expression levels of each gene 
in various tissues. Each PCR was carried out in 10 µl reaction vols. using Dreamtaq 
polymerase (Fermentas International Inc.) with thermal cycling conditions: 95°C for 
3 min, followed by 28 cycles of 95°C for 30 s, 55°C for 30 s, 72°C for 30 s and a 
final extension of 72°C for 10 min. PCR products were then separated by 
electrophoresis in 2% agarose gel. 
3.4. qPCR 
Since it was essential to compare the mRNA expression levels of various genes 
involved in muscle formation, muscle degradation and oxidative defense in the same 
tissue, the method of absolute quantification with reference to a standard curve was   
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Table 3. Best-fitting evolutionary models, number of bootstraps and number of 
replicates required for convergence for dendrogramic analyses. 
Protein Number of bootstraps ran Number of replicates 
required for convergence 
Ppargc-1α 1000 800 
Myod1 and Myog 1000 450 
Mapk1 and Mapk3 1000 950 
Hdac1 1000 400 
FoxO1 and FoxO3 1000 400 
Mstn 8000 7750 





Table 4. Primer sequences used for qPCR. 







































Table 4. (continued) 







































Table 4. (continued) 




























adopted in this study. While relative quantitation methods produce only fold-change 
data, they do not allow the interpretation of which gene being the predominant one 
being expressed in a certain condition. Although absolute quantification provides 
more information, it is not commonly adopted because of the lack of internal standard 
to avoid technical errors, and the necessity to create reliable standards for 
quantification and include these standards in every qPCR. 
RNA (4 μg) from the muscle of P. annectens were extracted using the Qiagen 
RNeasy Plus Mini Kit (Qiagen GmbH), and reverse-transcribed using random 
hexamer primers with RevertAidTM first strand cDNA synthesis kit (Thermo Fisher 
Scientific). To determine the absolute quantity of transcripts of the genes involved in 
muscle formation, muscle degradation and oxidative defense in a qPCR reaction, 
efforts were made to produce a pure amplicon (standard) of a defined region of the 
cDNA, as defined by the gene-specific set of qPCR primers (Table 4), from the 
muscle of P. annectens following the method of Gerwick et al. (2007). PCR was 
performed with a specific set of qPCR primers and cDNA as a template in a final 
volume of 25 μl with the following cycling conditions: initial denaturation 95°C for 3 
min, followed by 40 cycles of 95°C for 30 s, 60°C for 30 s and 72°C for 30 s and 1 
cycle of final extension of 72°C for 10 min. The PCR product was separated in a 2% 
agarose gel then excised and purified. The nucleotide fragments in the purified 
product was cloned using pGEM®-T Easy vector (Promega Corporation). The 
presence of the insert in the recombinant clones was confirmed by sequencing. The 
cloned circular plasmid was quantified using a BioSpec-nano (Shimadzu). 
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qPCR was performed in triplicates using a StepOnePlusTM Real-Time PCR 
System (Thermo Fisher Scientific). The mRNA expression levels of the genes 
involved in muscle formation, muscle degradation and oxidative defense were 
determined using gene-specific qPCR primers (Table 4). The standard cDNA 
(template) was serially diluted (from 106 to 102 specific copies per 2 μl). The qPCR 
reactions contained 5 μl of KAPA SYBR® FAST Master Mix (2X) ABI PrismTM 
(Kapa Biosystems, Woburn, MA, USA), forward and reverse qPCR primers each and 
1 ng of sample cDNA or various quantities of standard in a total volume of 10 μl. 
Cycling conditions were 95°C for 20 s (1 cycle), followed by 40 cycles of 95°C for 3 
s and 62°C for 30 s. Data (Ct values) were collected at each elongation step. A melt 
curve analysis was performed after each run by increasing the temperature from 60°C 
to 95°C in 0.3°C increments to confirm the presence of a single product only. The 
PCR products obtained were also separated in a 2% agarose gel to verify the presence 
of a single band. A standard curve was obtained from plotting threshold cycle (Ct) on 
the Y-axis and the natural log of concentration (copies μl-1) on the X-axis. The Ct 
slope, PCR efficiency, Y-intercept and correlation coefficient (r2) were calculated 
using the default setting of StepOneTM Software v2.1 (Thermo Fisher Scientific). 
Diluted standards were stored at -20°C. The concentrations used and the PCR 
efficiencies of each qPCR primer pair are indicated in Table 4. The quantity of 
transcript in an unknown sample was determined from the linear regression line 




3.5. SDS-PAGE and Western blotting 
A commercial firm (GenScript, Piscataway, NJ, USA) was engaged to raise a rabbit 
polyclonal antibody against the epitope sequence of the translated amino acid 
sequences of Ppargc-1α, Myod1, Myog, Mapk, Hdac1, FoxO1, FoxO3, Mstn, Fbxo32, 
Cat, Gpx1 and Gpx4 of P. annectens. Commercial antibodies for CuZnSod (FL-154: 
sc-11407, Santa Cruz Biotechnology Inc., Texas, USA) and MnSod (DD-17, Sigma-
Aldrich Co.) were purchased. The epitope sequences for each primary antibody are 
indicated in Table 5. 
Western blotting was performed on the muscle samples obtained from the 
control fish and fish that had undergone 6 days, or 6 months of aestivation, or 1 or 3 
days of arousal from 6 months of aestivation. Individual samples were homogenized 
thrice at 24,000 r.p.m. for 20 s each with 10 s intervals in five volumes (w/v) of ice 
cold buffer containing 50 mmol l−1 Tris HCl, (pH 7.4), 1 mmol l−1 EDTA, 150 mmol 
l−1 NaCl, 1 mmol l−1 NaF, 1 mmol l−1 Na3VO4, 1% NP-40, 1% sodium deoxycholate, 
1 mmol l−1 phenylmethylsulfonyl fluoride, and 1× HALT protease inhibitor cocktail 
(Thermo Fisher Scientific) using LabGEN homogenizer 125 (Cole-Parmer Instrument 
Company, Chicago, IL, USA). The homogenate was centrifuged at 10,000 × g for 20 
min at 4°C. The protein concentration in the supernatant obtained was determined 
according to the method of Bradford (1976) and adjusted to 10 μg μl−1 with Laemmli 
buffer (Laemmli, 1970). Samples were heated at 95°C for 5 min, and then kept at -




Table 5. Epitope sequences of translated amino acids based on which antibodies were 
designed against, the amount of protein loaded from the muscle of P. annectens and 
the dilution used for each primary antibody for Western blotting.  
Antibody Epitope sequence Protein 
load (µg) 
Dilution  
Anti-Ppargc-1α CSRSRSPYRHRTRYD 100 1:300 
Anti-Myod1 CETGAEGSPSSPHGG 200 1:300 
Anti-Myog GVEEKLSPVSGISPC 20 1:300 
Anti-Mapk DNVNKIRVAIKKISC 100 1:300 
Anti-Hdac1 CDKTEAKGVKEETKP 100 1:300 
Anti-FoxO1 CSKMTSLPSLSEMSS 20 1:500 
Anti-FoxO3 CRQTPMQTIQENKQT 200 1:500 
Anti-Mstn TEPDFAIPMEGKPKC 200 1:500 
Anti-Fbxo32 VKTGDGWKRYKNDVC 100 1:500 
Anti-CuZnSod Amino acids 1–154 of human 
CuZnSOD (FL-154: sc-11407; 
Santa Cruz Biotechnology Inc.) 
100 1:800 
Anti-MnSod CDVWEHAYYLQYKNVRPD 
(DD-17; Sigma-Aldrich Co.) 
100 1:1000 
Anti-Cat TQKRNPQTNLKDPDC 100 1:500 
Anti-Gpx1 CPDGVPYKRYSRKFL 200 1:500 




The amount of protein load and the dilution used for each primary antibody 
are indicated in Table 5. Proteins were separated by SDS-PAGE according to the 
method of Laemmli (1970) using a vertical mini-slab apparatus (Bio-Rad 
Laboratories, Hercules, CA, USA). Proteins were then electrophoretically transferred 
onto PVDF membranes using a transfer apparatus (Bio-Rad Laboratories).  
For Ppargc-1α, Mapk, Hdac1, FoxO1, FoxO3, Mstn, Fbxo32, MnSod, Gpx1 
and Gpx4, detection was performed using PierceTM SuperSignalTM West Pico Rabbit 
Fast Western Kit (Thermo Fisher Scientific), as per manufacturer’s instructions. 
Bands were visualized by chemiluminescence (Western LightningTM, PerkinElmer 
Life Sciences, Boston, MA, USA) using X-ray film (Thermo Fisher Scientific) and 
were processed by a Kodak X-Omat 3000 RA processor (Kodak, Rochester, NY, 
USA).  
For Myod1, Myog, CuZnSod and Cat, after transfer, each membrane was 
blocked with 10% skim milk in TTBS (0.05% Tween 20 in Tris-buffered saline: 20 
mmol l-1 Tris-HCl; 500 mmol l-1 NaCl, pH 7.6) for 1 h before being incubated 
overnight at 4C with the respective primary antibodies diluted in 1% bovine serum 
albumin in TTBS. For Myod1, Myog and Cat, the membranes were incubated in goat 
anti-rabbit horseradish peroxidase secondary antibody (1:5,000 dilution for Myod1 
and Myog; 1:8,000 dilution for Cat; Santa Cruz Biotechnology Inc.) for 1 h and 
rinsed. Bands were visualized by chemiluminescence (Western LightningTM) using 
X-ray film (Thermo Fisher Scientific) and were processed by a Kodak X-Omat 3000 
RA processor (Kodak). For CuZnSod, the membranes were incubated in goat anti-
rabbit alkaline phosphatase-conjugated secondary antibody (1:8,000 dilution; Santa 
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Cruz Biotechnology Inc.) for 1 h, rinsed and then incubated for 30 min in a solution 
of 5-bromo-4-chloro-3-indolyl phosphate p-toluidine salt and nitro-blue tetrazolium 
chloride (Invitrogen, Carlsbad, CA, USA) for color development. 
The blots were scanned using CanonScan 4400F flatbed scanner in TIFF 
format at 300 dpi resolution. Densitometric quantification of the band intensities was 
performed using ImageJ (version 1.40, NIH), calibrated with a calibrated 37 step 
reflection scanner scale (1″× 8″; Stouffer #R3705-1C). It would be very difficult to 
find a reference protein, the expression of which would be unaffected throughout the 
three phases of aestivation. Hence, results were expressed as arbitrary densitometric 
unit per μg protein, i.e. with reference to the protein abundance, as reported elsewhere 
for ʟ-Gulono-γ-lactone oxidase (Ching et al., 2014), Na+/K+-ATPase (Hiong et al., 
2014), Betaine-homocysteine methyltransferase 1 (Ong et al., 2015) and Coagulation 
factor II/Fibrinogen gamma chain (Hiong et al., 2015a) expression in P. annectens 
during aestivation. 
3.6. Enzyme assays 
The frozen muscle samples were homogenized three times at 24,000 r.p.m. for 20 s 
each with 10 s intervals in 5 volumes (w/v) of ice-cold 50 mmol l−1 potassium 
phosphate buffer containing 0.5 mmol l−1 EDTA at pH 7.2, and 10 μmol l−1 
phenylmethylsulfonyl fluoride (added just before homogenization) using LabGEN 
homogenizer 125 (Cole-Parmer Instrument Company). The homogenates were 
centrifuged at 15,000 × g for 15 min at 5°C to obtain the supernatants, which were 
used directly for various enzyme assays. Protein amounts were determined by the 
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Bradford method (Bradford, 1976) with bovine gamma globulin as the standard for 
comparison. 
3.6.1. Determination of CuZnSod, MnSod and total Sod activities 
Total Sod activities were determined using SOD Assay Kit-WST (19160, Sigma-
Aldrich Co.) according to the manufacturer’s protocol. Bovine SOD (S7571, Sigma-
Aldrich Co.) was diluted according to the kit’s recommendation as the standard for 
comparison. To measure MnSod activity, 0.042 mmol l−1 potassium cyanide was 
added to each sample. CuZnSod is specifically inhibited by potassium cyanide 
(Kasemset and Oberley, 1984). CuZnSod activity for each sample was calculated as 
the difference between total Sod and MnSod activities. Results were expressed in mU 
per mg protein. 
3.6.2. Determination of Cat activity 
The Cat assay mixture contained 50 mmol l−1 potassium phosphate buffer, pH 7.0 and 
10 mmol l−1 H2O2. Sample extracts were added to start the reaction, where the decay 
of H2O2 was followed at 240 nm in a quartz cuvette (ɛ = 0.0394 L mmol−1 cm−1), as 
described by Aebi (1974). The specific activity of Cat was expressed as nmol of H2O2 
decomposed per min per mg protein. 
3.6.3. Determination of SeGpx and total Gpx activities 
Two separate assays were conducted for determining the activities of SeGpx and total 
Gpx. For SeGpx, the reaction was initiated by adding 0.5 mmol l−1 hydrogen peroxide 
(H2O2) to the standard assay mixture of 50 mmol l
−1 potassium phosphate buffer, pH 
7.0, 1 mmol l−1 EDTA, 2 mmol l−1 NaN3, 0.2 mmol l
−1 NADPH, 1 i.u. Gr (Sigma-
Aldrich Co.) and 5 mmol l−1 GSH (Ahmad and Pardini, 1988). The same assay was 
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used to quantify total Gpx, except that H2O2 was replaced with 1.2 mmol l
−1 cumene 
hydroperoxide. The specific activities of SeGpx and total Gpx were expressed in 
nmol NADPH oxidized per min per mg protein. 
3.6.4. Determination of Gr activity 
The assay medium for Gr consisted of 50 mmol l−1 potassium phosphate buffer, pH 
7.4, 1 mmol l−1 EDTA, 0.2 mmol l−1 NADPH and 5 mmol l−1 GSSG, and the rate of 
NADPH oxidation was followed at 340 nm. The specific activity of Gr was expressed 
in nmol of NADPH oxidized per min per mg protein. 
3.6.5. Determination of Gst activity 
Gst was assayed according to Grundy and Storey (1998). The enzyme activity was 
measured by monitoring the rate of formation of S-2,4-dinitrophenylglutathione (a 
conjugate of GSH and 1-chloro-2,4-dinitrobenzene) at 340 nm (ɛ = 9.6 L mmol−1 
cm−1). The reaction was started by adding the supernatant to an assay containing 50 
mmol l−1 potassium phosphate buffer, pH 6.5, 1 mmol l−1 EDTA, 5 mmol l−1 GSH 
and 2 mmol l−1 1-chloro-2,4-dinitrobenzene. The specific activity of Gst was 
expressed in nmol of conjugate generated per min per mg protein. 
3.7. Determination of total and oxidized glutathione 
The frozen tissue sample was homogenized three times at 24,000 r.p.m. using 
LabGEN homogenizer 125 (Cole-Parmer Instrument Company) for 20 s each with 10 
s intervals in 5 volumes (w/v) of ice-cold 5% sulfosalicylic acid which had been 
bubbled in nitrogen gas for 10 min. After bubbling for another 10 s, the homogenate 
was centrifuged at 15,000 × g for 5 min at 4°C. The supernatant was removed, 
neutralized (pH 6.5–7) with 3 mol l−1 Trizma base and separated into two portions for 
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the measurement of total GSHeq and GSSG according to the method of Griffith 
(1980). For total GSHeq, an aliquot of the supernatant was introduced to a reaction 
mixture containing 100 mmol l−1 potassium phosphate buffer, pH 7.5, 0.25 mmol l−1 
NADPH, 4 mmol l−1 EDTA and 0.6 mmol l−1 5,5-dithiobis-2-nitrobenzoic acid 
(DTNB) in a final volume of 1.2 ml. The reaction was initiated by the addition of 0.9 
i.u. Gr (Sigma-Aldrich Co.) and the absorbance monitored at 412 nm. The second 
portion of the supernatant was incubated with 170 mmol l−1 2-vinylpyridine for 1 h at 
30°C to derivatize any GSH present in the sample. GSSG in this portion was 
quantified using the same method. GSH content was calculated as the difference 
between the contents of total GSHeq and GSSG. Results were expressed in nmol per 
g wet mass. 
3.8. Determination of levels of oxidative damage products 
3.8.1. Determination of products of lipid peroxidation 
Two methods were adopted to determine lipid peroxidation in this study. The first 
method used xylenol orange to quantify LOOH (Hermes-Lima et al., 1995). The 
samples were homogenized three times for 20 s each with 10 s intervals, in 20 
volumes (w/v) of HPLC grade methanol using LabGEN homogenizer 125 (Cole-
Parmer Instrument Company) at 24,000 r.p.m. Following that, centrifugation was 
carried out for 5 min at 15,000 × g at 4°C to obtain the supernatant. An assay mixture 
consisting of 0.25 mmol l−1 ferrous sulfate, 25 mmol l−1 sulfuric acid, 0.1 mmol l−1 
xylenol orange (added in the stated order) was incubated for 30 min at 25°C. 
Following incubation, 1 ml of the assay mixture was added to 15 μl of supernatant 
and the reaction was allowed to occur at 25°C for 12 h before the absorbance was 
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determined at 580 nm. Next, 5 μl of 1 mmol l−1 cumene hydroperoxide was added as 
an internal standard and further incubated for 30 min at 25°C before determining the 
absorbance again at 580 nm. The results were calculated according to the equation of 
Hermes-Lima et al. (1995) and the LOOH content expressed as cumene 
hydroperoxide equivalents per g wet mass. 
The second method quantified TBARS as an index of lipid peroxidation 
(Hermes-Lima and Storey, 1995). The frozen sample was homogenized as stated 
above, in 20 volumes (w/v) of ice-cold 1.1% phosphoric acid. Then, 0.4 ml of the 
homogenate was added to an equal volume of a mixture of 1% thiobarbituric acid, 0.1 
mmol l−1 butylated hydroxytoluene solution, 50 mmol l−1 sodium hydroxide, and 0.2 
ml of 7% phosphoric acid. After heating for 15 min at 98°C, the sample was 
vigorously mixed with 1.5 ml of butanol, and centrifuged at 2,000 × g for 5 min using 
a Beckman J2-21/E centrifuge (Beckman Coulter Inc., Fullerton, CA, USA). The 
organic layer was transferred to glass cuvettes, and the optical densities at 532 nm 
and 600 nm were determined using a Shimadzu UV-160A spectrophotometer 
(Shimadzu). Blanks were prepared by replacing the thiobarbituric acid with 3 mmol 
l−1 hydrochloric acid. The results were calculated as Sample (A532 - A600) - Blank (A532 
- A600) as recommended by Ramos-Vasconcelos and Hermes-Lima (2003). TBARS 
was quantified based on the extinction coefficient of 156 L mmol−1 cm−1, and 
expressed in nmol per g wet mass. 
3.8.2. Determination of carbonyl proteins 
The assay for carbonyl protein quantifies the oxidative damage to proteins (Stadtman 
and Levine, 2000). Ice-cold 5% sulfosalicylic acid was used as the homogenization 
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medium for the tissues (1:20, w/v). The homogenized sample was centrifuged at 
15,000 × g for 5 min to obtain the pellet, which was mixed with 10 mmol l−1 2,4-
dinitrophenyl-hydrazine in 2 mmol l−1 hydrochloric acid, vortexed every 15 min and 
kept for 1 h at room temperature. The sample was then centrifuged at 15,000 × g for 3 
min after the addition of 20% trichloroacetic acid. Excess 2,4-dinitrophenyl-
hydrazine was removed by washing the pellet three times using 1 ml of ethanol:ethyl 
acetate (1:1, v/v), followed with the addition of 6 mmol l−1 guanidine chloride. An 
incubation period of 15 min at 37°C was allowed before recording the absorbance at 
360 nm. Sample blanks were prepared using 2 mmol l−1 hydrochloric acid instead of 
2,4-dinitrophenyl-hydrazine. The carbonyl protein content was calculated using the 
extinction coefficient of 22 L mmol−1 cm−1, and expressed in µmol per g wet mass. 
3.9. Statistical analyses  
Results were presented as means ± standard errors of the mean (S.E.M.). Statistical 
analyses were performed using SPSS version 18 (SPSS Inc, Chicago, USA). 
Homogeneity of variance was checked using Levene’s Test. Differences between 
means were tested using one-way analysis of variance followed by multiple 
comparisons of means by either the Tukey or Dunnett T3 post-hoc test, depending on 
the homogeneity of variance of the data set. Differences with P<0.05 were reported 





4.1. Genes/proteins involved in muscle formation 
4.1.1. ppargc-1α/ Ppargc-1α 
4.1.1.1. Nucleotide sequence, translated amino acid sequence and dendrogramic 
analysis 
The complete coding sequence of ppargc-1α from P. annectens comprised 2394 bp. 
The deduced Ppargc-1α sequence consisted of 798 amino acids with an estimated 
molecular mass of 90.8 kDa (Appendix 2a), and shared the highest amino acid 
sequence identity with reptilian PPARGC-1α (65.5–67.2%), followed by mammalian 
PPARGC-1α (65.2–66.3%), coelacanth Ppargc-1α (66.2–66.3%), amphibian Ppargc-
1α (50.3–63.3%), elasmobranch Ppargc-1α (63.1%), and teleost Ppargc-1α (32.8–
48.1%; Table 6).  
An alignment of Ppargc-1α from P. annectens with those of human, rat, frog, 
coelacanth, zebrafish and shark revealed high conservation in most of the important 
domains (Fig. 1). Amino acid positions reported henceforth will be in relation to the 
ruler represented in the figure. The two activation domains (AD), AD1 (position 32–
42) and AD2 (position 85–98) are highly conserved in all species compared. The 
LXXLL motif, essential in mediating nuclear receptor-coactivator interactions, was 
also highly conserved in all species compared. The PPAR-γ binding domain showed 
the least conservation among other domains, with fish and elasmobranch Ppargc-1α 
being the most dissimilar to those of other organisms. While all three p38-MAPK 
phosphorylation sites (T309, S312, T349) were conserved in all species compared, 
only one of the two AMPK phosphorylation sites (T179, S621) was conserved among 
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them. S621 was well conserved, while T179 was conserved only in tetrapods (Fig. 1). 
The Ppargc-1α of P. annectens also contained a conserved RNA-binding domain and 
two domains rich in serine and arginine residues, also known as SR-rich domains.  
The Ppargc-1α of P. annectens was grouped in a clade together with 
PPARGC-1α of tetrapods, Ppargc-1α of L. chalumnae and Ppargc-1α of 
elasmobranches, separated from Ppargc-1α of teleosts (Fig. 2). 
4.1.1.2. Gene expression of ppargc-1α in various tissues/organs 
The expression of ppargc-1α was the highest in the kidney, heart and gills of P. 
annectens kept in fresh water (Fig. 3). The expression of ppargc-1α was also detected 
in the muscle, brain, eye, skin, liver, pancreas and gut, but was undetectable in the 
lung and spleen. 
4.1.1.3. mRNA expression of ppargc-1α 
There were significant decreases in the mRNA expression level of ppargc-1α in the 
muscle of P. annectens after 3 days (by 45.7%; P<0.05) or after 6 months of 
aestivation (by 36.4%; P<0.05), as compared to the freshwater control (Fig. 4a). By 
contrast, there was a significant increase in the mRNA expression of ppargc-1α after 
6 days of arousal from 6 months of aestivation (2.59-fold; P<0.05; Fig. 4b). 
4.1.1.4. Protein abundance of Ppargc-1α 
There were no significant changes in the protein abundance of Ppargc-1α in the 
muscle of P. annectens after 6 days or 6 months of aestivation, or after 1 day or 3 




Table 6. The percentage similarity between the deduced amino acid sequence of 
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (Ppargc-1α) 
from the muscle of Protopterus annectens and PPARGC-1α/Ppargc-1α sequences 
from other animal species obtained from GenBank (accession numbers in brackets). 
Sequences are arranged in a descending order of similarity. 
Classification Species Similarity 
Reptiles Pelodiscus sinensis PPARGC-1α isoform 2 
(XP_006138222.1) 
67.2% 
 Chelonia mydas PPARGC-1α (XP_007058167.1) 66.5% 
 Pelodiscus sinensis PPARGC-1α isoform 1 
(XP_006138221.1) 
65.5% 
Mammals Homo sapiens PPARGC-1α (NP_037393.1) 66.3% 
 Rattus norvegicus PPARGC-1α (NP_112637.1) 65.6% 
 Mus musculus PPARGC-1α (NP_032930.1) 65.2% 
Coelacanth Latimeria chalumnae Ppargc-1α (XP_005997925.1) 66.3% 
Amphibian Xenopus (Silurana) tropicalis Ppargc-1α isoform 1 
(XP_002936759.2) 
63.3% 
 Xenopus (Silurana) tropicalis Ppargc-1α isoform 2 
(XP_004911281.1) 
63.2% 
Elasmobranch Callorhinchus milii Ppargc-1α (XP_007887233.1) 63.1% 
Teleosts Ictalurus punctatus Ppargc-1α (AHH38878.1) 48.1% 
 Esox lucius Ppargc-1α (XP_012995921.1) 47.8% 
 Cynoglossus semilaevis Ppargc-1α (XP_008324663.1) 47.5% 
 Fundulus heteroclitus Ppargc-1α isoform 3 
(XP_012720393.1) 
47.1% 
 Esox lucius Ppargc-1α isoform 1 (XP_012995919.1) 46.4% 
 Larimichthys crocea Ppargc-1α (XP_010732114.1) 46.3% 
 Esox lucius Ppargc-1α isoform 2 (XP_012995920.1) 46.3% 
 Oryzias latipes Ppargc-1α isoform 3 
(XP_011485675.1) 
44.9% 
 Danio rerio Ppargc-1α (XP_002667577.3) 44.0% 
 Takifugu rubripes Ppargc-1α (XP_011605089.1) 42.1% 
 Oryzias latipes Ppargc-1α isoform 1 
(XP_011485673.1) 
33.5% 






Fig. 1. Molecular characterization of peroxisome proliferator-activated receptor 
gamma, coactivator 1 alpha (Ppargc-1α) from the muscle of Protopterus 
annectens. Multiple amino acid alignment of Ppargc-1α from the muscle of P. 
annectens with six other known PPARGC-1α/Ppargc-1α from Homo sapiens 
(NP_037393.1), Rattus norvegicus (NP_112637.1), Xenopus (Silurana) tropicalis 
(XP_002936759.2), Latimeria chalumnae (XP_005997925.1), Danio rerio 
(XP_002667577.3) and Callorhinchus milii (XP_007887233.1). Identical amino acids 
are indicated by shaded residues. The yellow boxes represent the activation domains 
(AD) 1 and 2. An LXXLL motif is underlined. The open box indicates the PPARγ-
binding domain. The open triangles indicate the three p38 mitogen-activated protein 
kinase phosphorylation sites (T309, S312, T349), while the closed triangles indicate 
the two AMP kinase phosphorylation sites (T179, S621). Two serine-arginine-rich 












Fig. 2. A dendrogram of peroxisome proliferator-activated receptor gamma, 
coactivator 1 alpha (PPARGC-1α/Ppargc-1α) including that of Protopterus 
annectens. Numbers presented at each branch point represent bootstrap percentages 





Fig. 3. The gene expression of peroxisome proliferator-activated receptor gamma, 
coactivator 1 alpha (ppargc-1α) in various tissues/organs of Protopterus annectens. 
Expression of ppargc-1α were examined in the muscle (M), heart (H), brain (B), eye 
(E), gills (Gi), kidney (K), Lung (Lu), skin (Sk), liver (Li), spleen (Sp), pancreas (P), 
and gut (Gu) of Protopterus annectens (N=1) kept in fresh water. 
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Fig. 4. mRNA expression levels of peroxisome proliferator-activated receptor-γ 
coactivator-1α (ppargc-1α) in the muscle of Protopterus annectens. Absolute 
quantification (×102 copies of transcript per ng total RNA) of ppargc-1α transcripts in 
the muscle of P. annectens kept in (a) fresh water on day 0 (FW; control), after 3 or 6 
days (d; the induction phase), or 12 d or 6 months (mon; the maintenance phase) of 
aestivation; (b) fresh water on day 0 (FW; control), after 6 mon (the maintenance 
phase) of aestivation, or after 1 d, 3 d or 6 d of arousal (Ar; the arousal phase) from 6 
mon of aestivation. Results represent means ± S. E. M (N=4). Means not sharing the 










































































































Fig. 5. Protein abundance of Peroxisome proliferator-activated receptor gamma, 
coactivator 1 alpha (Ppargc-1α) in the muscle of Protopterus annectens. Protein 
abundance of Ppargc-1α in the muscle of P. annectens kept in fresh water on day 0 
(FW; control), after 6 days (d; induction phase) or 6 months (mon; maintenance 
phase) of aestivation in air, or after 1 d or 3 d of arousal (Ar; arousal phase) from 6 
mon of aestivation in air. (a) An example of immunoblot of Ppargc-1α. (b) The 
protein abundance of Ppargc-1α expressed as arbitrary densitometric units per 100 µg 
protein. Results represent mean ± S.E.M. (N=3). Means not sharing the same letter 














































































4.1.2. myod1 and myog/Myod1 and Myog 
4.1.2.1. Nucleotide sequence, translated amino acid sequence and dendrogramic 
analysis 
The complete coding sequence of myod1 from P. annectens consisted of 831 bp. The 
putative Myog sequence comprised 277 amino acids with an estimated molecular 
mass of 31.1 kDa (Appendix 2b), and shared the highest amino acid sequence identity 
with Myod1 of L. chalumnae (84.8%), followed by amphibian Myod1 (67.6–75.7%), 
teleost Myod1 (44.0–75.3%), Myod1 of C. milii (74.1%) and mammalian MYOD1 
(59.6–61.3%; Table 7). An alignment of Myod1 from P. annectens with 
MYOD1/Myod1 of human, mouse, frog, zebrafish and shark revealed a high 
conservation of the bHLH domain (Fig. 6). The basic region of the bHLH domain 
was conserved in all 6 species. The LXXLL motif was found to be conserved in the 
Myod1 of P. annectens. The myogenic recognition motif (MRM), which contains two 
adjacent amino acids, alanine and threonine, was highly conserved in all species 
compared.  
The complete coding sequence of myog from P. annectens consisted of 711 
bp. The deduced Myog sequence comprised 237 amino acids with an estimated 
molecular mass of 26.8 kDa (Appendix 2c), and shared the highest amino acid 
sequence identity with Myog of L. chalumnae (67.9%), followed by MYOG of P. 
sinensis (67%), amphibian Myog (65.8–66.2%), mammalian MYOG (59.9–60.3%), 
teleost Myog (51.9–58.6%) and Myog of H. signifer (46.6%; Table 8). An alignment 
of P. annectens Myog with those of human, frog, coelacanth, zebrafish and stingray 
showed high conservation in the basic helix-loop-helix (bHLH), alanine-threonine 
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dipeptide, histidine/cysteine-rich and C-terminal helix III domains (Fig. 7). This 
suggested that Myog of P. annectens possessed similar myogenic regulatory 
functions as human MYOG. 
The Myod1 of P. annectens was grouped in a clade together with MYOD1 of 
tetrapods, Myod1 of L. chalumnae and the cartilaginous fish C. milii, separated from 
Myod1 of teleosts (Fig. 8). The Myog of P. annectens was grouped in a clade 
together with MYOG of amphibians and Myog of L. chalumnae, separated from 
MYOG of mammals and P. sinensis, and Myog of teleosts and H. signifer (Fig. 8). 
4.1.2.2. Gene expression of myod1 in various tissues/organs 
The expression of myod1 was the highest in the skeletal muscle of P. annectens kept 
in fresh water; it was weakly detected in the eye and skin, but undetectable in the gills, 
heart, brain, kidney, lung, liver, spleen, pancreas and gut (Fig. 9a). Similarly, the 
skeletal muscle of P. annectens kept in fresh water had the highest myog expression 
level, and myog expression was weak in the eye but undetectable in other organs (Fig. 
9b). 
4.1.2.3. mRNA expression of myod1 and myog 
There was a significant increase in the mRNA expression level of myod1 in the 
muscle of P. annectens after 3 days of aestivation (2.02-fold; P<0.05), as compared 
to the control (Fig. 10a). However, there was a significant decrease in the mRNA 
expression level of myod1 in the muscle of P. annectens after 12 days of aestivation 
(by 59%; P<0.05). The mRNA expression of myod1 remained unchanged in the 
muscle of P. annectens during the arousal phase (Fig. 10b).  
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There were significant increases in the mRNA expression level of myog in the 
muscle of P. annectens after 3 days (1.55-fold; P<0.05) or 6 days (1.45-fold; P<0.05) 
or after 6 months of aestivation (1.61-fold; P<0.05), as compared to the control (Fig. 
11a). Likewise, there was a significant increase in the mRNA expression level of 
myog in the muscle of P. annectens after 6 days of arousal from 6 months of 
aestivation (2.51-fold; P<0.05), as compared to the freshwater control (Fig. 11b).  
4.1.2.4. Protein abundance of Myod1 and Myog 
A significant increase in the protein abundance of Myod1 in the muscle of P. 
annectens occurred after 6 months of aestivation (1.58-fold; P<0.05), as compared to 
the control (Fig. 12). In contrast, there were no significant changes in the protein 
abundance of Myog in the muscle of P. annectens after 6 days or 6 months of 




Table 7. The percentage similarity between the deduced amino acid sequence of 
myogenic differentiation 1 (Myod1) from the muscle of Protopterus annectens and 
MYOD1/Myod1 sequences from other animal species obtained from GenBank 
(accession numbers in brackets). Sequences are arranged in a descending order of 
similarity. 
  
Classification Species Similarity 
Coelacanth Latimeria chalumnae Myod1 (XP_005990556.1) 84.8% 
Amphibians Xenopus laevis Myod1A (NP_001079366.1) 75.7% 
 
Xenopus (Silurana) tropicalis Myod1 (NP_988972.1) 75.7% 
 
Xenopus laevis Myod1B (NP_001081292.1) 67.6% 
Teleosts Danio rerio Myod1 (AAI14262.1) 75.3% 
 
Cyprinus carpio Myod1 (BAA33565.1) 75.3% 
 
Megalobrama amblycephala Myod1 (AHW49178.1) 74.6% 
 
Salmo salar Myod1 (CAD89607.1) 70.1% 
 
Oncorhynchus mykiss Myod1 (Q91205.1) 70.1% 
 
Salmo salar Myod2 (NP_001117026.1) 69.1% 
 
Takifugu rubripes Myod1 (BAE79389.1) 57.3% 
 
Hippoglossus hippoglossus Myod1 (CAF34063.1) 44.0% 
Elasmobranch Callorhinchus milii Myod1 (XP_007885677.1) 74.1% 
Mammals Mus musculus MYOD1 (AAI03620.1) 61.3% 
 
Rattus norvegicus MYOD1 (AAI27481.1) 61.3% 
Homo sapiens MYOD1 (AAH64493.1) 59.6% 
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Fig. 6. Molecular characterization of myogenic differentiation 1 (Myod1) from 
the muscle of Protopterus annectens. Multiple amino acid alignment of Myod1 from 
the muscle of P. annectens with five other known MYOD1/Myod1 from Homo 
sapiens (AAH64493.1), Mus musculus (AAI03620.1), Xenopus (Silurana) tropicalis 
(NP_988972.1), Danio rerio (AAI14262.1) and Callorhinchus milii 
(XP_007885677.1). Identical amino acids are indicated by shaded residues. The open 
box indicates the basic helix-loop-helix domain, and the basic region 
(DRRKAATMRERRR) is underlined. The LXXLL motif is denoted with a dash line. 








Table 8. The percentage similarity between the deduced amino acid sequence of 
myogenin (Myog) from the muscle of Protopterus annectens and MYOG/Myog 
sequences from other animal species obtained from GenBank (accession numbers in 
brackets). Sequences are arranged in a descending order of similarity. 
Classification Species Similarity 
Coelacanth  Latimeria chalumnae Myog (XP_005987662.1) 67.9% 
Reptile Pelodiscus sinensis MYOG (BAJ53267.1) 67.0% 
Amphibians Xenopus laevis Myog (NP_001079326.1) 66.2% 
 Xenopus (Silurana) tropicalis Myog 
(NP_001016725.1) 
65.8% 
Mammals  Homo sapiens MYOG (NP_002470.2) 60.3% 
 Mus musculus MYOG (AAB59676.1) 59.9% 
 Rattus norvegicus MYOG (NP_058811.2) 59.9% 
Teleosts Ictalurus furcatus Myog (AAS48404.1) 58.6% 
 Ictalurus punctatus Myog (AAS48084.1) 58.6% 
 Ameiurus catus Myog (AAS67040.1) 58.3% 
 Sternopygus macrurus Myog (AAQ97203.1) 58.3% 
 Cyprinus carpio Myog (BAA33564.1) 57.6% 
 Tachysurus fulvidraco Myog (ADP24122.1) 57.5% 
 Devario aequipinnatus Myog (ABB00908.1) 57.3% 
 Danio rerio Myog (NP_571081.1) 56.9% 
 Epinephelus coioides Myog (ADJ95349.1) 53.5% 
 Oreochromis niloticus Myog (NP_001266455.1) 53.5% 
 Sparus aurata Myog (ABR22022.1) 53.5% 
 Oreochromis aureus Myog (ADA84044.1) 53.1% 
 Hippoglossus hippoglossus Myog (CAD32316.1) 52.7% 
 Paralichthys olivaceus Myog (ABO43958.1) 52.7% 
 Sander lucioperca Myog (AEN02543.1) 52.7% 
 Siniperca chuatsi Myog (ADX41684.1) 52.3% 
 Morone saxatilis Myog (AAL66388.1) 52.2% 
 Salmo salar Myog (NP_001117072.1) 52.1% 
 Trachidermus fasciatus Myog (AFP28936.1) 51.9% 




Fig. 7. Molecular characterization of myogenin (Myog) from the muscle of 
Protopterus annectens. Multiple amino acid alignment of Myog from the muscle of 
P. annectens with five other known MYOG/Myog from Homo sapiens 
(NP_002470.2), Xenopus laevis (NP_001079326.1), Latimeria chalumnae 
(XP_005987662.1), Danio rerio (NP_571081.1) and Himantura signifer (KX494984). 
Identical amino acids are indicated by shaded residues. The basic helix-loop-helix 
domain is indicated by an open box and the basic region is indicated by a dotted line 
(positions 85–100). The His/Cys-rich domain (positions 81–97) is underlined and the 
Helix III domain (positions 230–243) is indicated by a yellow box. The alanine-









Fig. 8. A dendrogram of myogenic differentiation 1 (MYOD1/Myod1) and 
myogenin (MYOG/Myog) including those of Protopterus annectens. Numbers 
presented at each branch point represent bootstrap percentages from 1000 replicates. 
Myogenic regulatory factor (MRF) from Phallusia mammillata is used as the 




Fig. 9. The gene expression of myogenic differentiation 1 (myod1) and myogenin 
(myog) in various tissues/organs of Protopterus annectens. Expression of (a) 
myod1 and (b) myog were examined in the muscle (M), heart (H), brain (B), eye (E), 
gills (Gi), kidney (K), Lung (Lu), skin (Sk), liver (Li), spleen (Sp), pancreas (P), and 
gut (Gu) of Protopterus annectens (N=1) kept in fresh water. 
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Fig. 10. mRNA expression levels of myogenic differentiaton 1 (myod1) in the 
muscle of Protopterus annectens. Absolute quantification (×103 copies of transcript 
per ng total RNA) of myod1 transcripts in the muscle of P. annectens kept in (a) fresh 
water on day 0 (FW; control), after 3 or 6 days (d; the induction phase), or 12 d or 6 
months (mon; the maintenance phase) of aestivation; (b) fresh water on day 0 (FW; 
control), after 6 mon (the maintenance phase) of aestivation, or after 1 d, 3 d or 6 d of 
arousal (Ar; the arousal phase) from 6 mon of aestivation. Results represent means ± 







































































































Fig. 11. mRNA expression levels of myogenin (myog) in the muscle of Protopterus 
annectens. Absolute quantification (×102 copies of transcript per ng total RNA) of 
myog transcripts in the muscle of P. annectens kept in (a) fresh water on day 0 (FW; 
control), after 3 or 6 days (d; the induction phase), or 12 d or 6 months (mon; the 
maintenance phase) of aestivation; (b) fresh water on day 0 (FW; control), after 6 
mon (the maintenance phase) of aestivation, or after 1 d, 3 d or 6 d of arousal (Ar; the 
arousal phase) from 6 mon of aestivation. Results represent means ± S. E. M (N=4). 




































































































Fig. 12. Protein abundance of myogenic differentiation 1 (Myod1) in the muscle 
of Protopterus annectens. Protein abundance of Myod1 in the muscle of P. 
annectens kept in fresh water on day 0 (FW; control), after 6 days (d; induction 
phase) or 6 months (mon; maintenance phase) of aestivation in air, or after 1 d or 3 d 
of arousal (Ar; arousal phase) from 6 mon of aestivation in air. (a) An example of 
immunoblot of Myod1. (b) The protein abundance of Myod1 expressed as arbitrary 
densitometric units per 200 µg protein. Results represent mean ± S.E.M. (N=3). 
Means not sharing the same letter are significantly different (P<0.05).  
(a) 











































































Fig. 13. Protein abundance of myogenin (Myog) in the muscle of Protopterus 
annectens. Protein abundance of Myog in the muscle of P. annectens kept in fresh 
water on day 0 (FW; control), after 6 days (d; induction phase) or 6 months (mon; 
maintenance phase) of aestivation in air, or after 1 d or 3 d of arousal (Ar; arousal 
phase) from 6 mon of aestivation in air. (a) An example of immunoblot of Myog. (b) 
The protein abundance of Myog expressed as arbitrary densitometric units per 20 µg 
protein. Results represent mean ± S.E.M. (N=3). Means not sharing the same letter 
are significantly different (P<0.05).  
(a) 








































































4.1.3. mapk1 and mapk3/Mapk1 and Mapk3 
4.1.3.1. Nucleotide sequences, translated amino acid sequences and 
dendrogramic analyses 
The complete coding sequence of mapk1 and mapk3 from P. annectens consisted of 
1092 bp and 1140 bp respectively. The deduced Mapk1 sequence comprised 364 
amino acids with an estimated molecular mass of 41.9 kDa (Appendix 2d), and 
shared the highest amino acid sequence identity with amphibian Mapk1 (92.8–93.4%), 
followed by mammalian MAPK1 (92.3–92.5%), Mapk1 of L. chalumnae (91.5%), 
MAPK1 of C. p. bellii (91.3%), teleost Mapk1 (80.6–90.5%) and Mapk1 of C. milii 
(88.6%; Table 9). The putative Mapk3 sequence consisted of 380 amino acids and 
had an estimated molecular mass of 43.2 kDa (Appendix 2e). The Mapk3 of P. 
annectens shared the highest amino acid sequence identity with MAPK3 of C. p. 
bellii (91.5%), followed by mammalian MAPK3 (78.9–86.6%) and teleost Mapk3 
(80.6–86.3%; Table 10). 
Both Mapk1 and Mapk3 of P. annectens were analyzed together as they 
possessed similar domains. A comparison of P. annectens Mapk1 and Mapk3 with 
MAPK1/Mapk1 and MAPK3/Mapk3 from various organisms revealed a highly 
conserved kinase domain (Fig. 14), which consist of the signature TXY motif. This 
motif comprises the regulatory residues T221 and Y223 (reference in accordance to 
the ruler in Fig. 14). A conserved nuclear translocation signal (NTS) was found in all 
MAPK/Mapk compared, indicating that Mapk1 and Mapk3 of P. annectens could be 
translocated to the nucleus. In addition, the cytoplasmic retention sequence 
(CRS)/common docking (CD) motif reported in human MAPK1 (Rubinfeld et al., 
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1999; Tanoue et al., 2000) was found to be highly conserved for all MAPK/Mapk 
compared.  
The Mapk1 of P. annectens was grouped in a clade together with MAPK1 of 
tetrapods and Mapk1 of L. chalumnae, separated from Mapk1 of teleosts (Fig. 15). 
Likewise, the Mapk3 of P. annectens was grouped in a clade together with MAPK3 
of tetrapods, separated from Mapk3 of teleosts (Fig. 15). 
4.1.3.2. Gene expression of mapk1 and mapk3 in various tissues/organs 
The brain of P. annectens kept in fresh water had the highest expression level of 
mapk1 (Fig. 16a). The expression of mapk1 was detected in the heart, eye, gills, 
kidney, lung, skin, liver, spleen, pancreas and gut, and barely detectable in the muscle. 
The brain and gills of freshwater P. annectens had the highest expression level of 
mapk3 (Fig. 16b). The expression of mapk3 was detected in the muscle, heart, eye, 
kidney, lung, skin, liver, spleen, pancreas and gut.  
4.1.3.3. mRNA expression of mapk1 and mapk3 
There was a significant decrease in the mRNA expression level of mapk1 in the 
muscle of P. annectens after 6 months of aestivation (by 48.8%; P<0.05), as 
compared to the freshwater control (Fig. 17a). By contrast, there was a significant 
increase in the mRNA expression of mapk1 after 3 days of arousal from 6 months of 
aestivation (3.25-fold; P<0.05), as compared to the control (Fig. 17b). 
There were significant decreases in the mRNA expression levels of mapk3 in 
the muscle of P. annectens after 3 days (by 51.3%; P<0.05) or 6 days (by 61.6%; 
P<0.05) or 12 days (by 69.1%; P<0.05) or after 6 months of aestivation (by 62.7%; 
P<0.05), as compared to the control (Fig. 18a). Similarly, there were significant 
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decreases in the mRNA expression of mapk3 after 1 day (by 74.1% P<0.05) or 3 days 
(by 53.7%; P<0.05) or 6 days of arousal from 6 months of aestivation (by 55.2%; 
P<0.05) as compared to the freshwater control (Fig. 18b). 
4.1.3.4. Protein abundance of Mapk 
There were no significant changes in the protein abundance of Mapk in the muscle of 
P. annectens after 6 days or 6 months of aestivation, or after 1 day or 3 days of 




Table 9. The percentage similarity between the deduced amino acid sequence of 
mitogen-activated protein kinase 1 (Mapk1) from the muscle of Protopterus 
annectens and MAPK1/Mapk1 sequences from other animal species obtained from 
GenBank (accession numbers in brackets). Sequences are arranged in a descending 
order of similarity. 
Classification Species Similarity 
Amphibians Xenopus (Silurana) tropicalis Mapk1 (NP_001017127.1) 93.4% 
 Xenopus laevis Mapk1 (NP_001083548.1) 92.8% 
Mammals Homo sapiens MAPK1 (NP_620407.1) 92.5% 
 Bos taurus MAPK1 (NP_786987.1) 92.5% 
 Mus musculus MAPK1 (NP_036079.1) 92.3% 
 Rattus norvegicus MAPK1 (NP_446294.1) 92.3% 
Coelacanth Latimeria chalumnae Mapk1 (XP_005990239.1) 91.5% 
Teleosts Danio rerio Mapk1 (NP_878308.2) 90.5% 
 Oreochromis niloticus Mapk1 (XP_003444522.1) 90.2% 
 Maylandia zebra Mapk1 (XP_004555701.1) 90.2% 
 Fundulus heteroclitus Mapk1 (XP_012720765.1) 89.9% 
 Poecilia formosa Mapk1 (XP_007547416.1) 89.4% 
 Clupea harengus Mapk1 (XP_012671405.1) 89.4% 
 Poecilia reticulata Mapk1 (XP_008417574.1) 89.4% 
 Notothenia coriiceps Mapk1 (XP_010778600.1) 81.4% 
 Astyanax mexicanus Mapk1 (XP_007229493.1) 80.6% 
Elasmobranch Callorhinchus milii Mapk1 (AFP02819.1) 88.6% 




Table 10. The percentage similarity between the deduced amino acid sequence of 
mitogen-activated protein kinase 3 (Mapk3) from the muscle of Protopterus 
annectens and MAPK3/Mapk3 sequences from other animal species obtained from 
GenBank (accession numbers in brackets). Sequences are arranged in a descending 
order of similarity. 
Classification Species Similarity 
Reptile Chrysemys picta bellii MAPK3 (XP_005290239.1) 91.5% 
Mammals Mus musculus MAPK3 (NP_036082.1) 86.6% 
 Rattus norvegicus MAPK3 (NP_059043.1) 86.3% 
 Homo sapiens MAPK3 isoform 1 (NP_002737.2) 86.0% 
 Bos taurus MAPK3 (NP_001103488.1) 85.0% 
 Homo sapiens MAPK3 isoform 2 (NP_001035145.1) 78.9% 
Teleosts Scleropages formosus Mapk3 (KKX11163.1) 86.3% 
 Astyanax mexicanus Mapk3 (XP_007234538.1) 86.2% 
 Danio rerio Mapk3 (NP_958915.1) 85.7% 
 Clarias batrachus Mapk3 (AKC01948.1) 84.4% 
 Stegastes partitus Mapk3 (XP_008303580.1) 80.8% 
 Larimichthys crocea Mapk3 (KKF25582.1) 80.6% 





Fig. 14. Molecular characterization of mitogen-activated protein kinase 1 
(Mapk1) and Mapk3 from the muscle of Protopterus annectens. Multiple amino 
acid alignment of Mapk1 and Mapk3 from the muscle of P. annectens with Homo 
sapiens MAPK1 (NP_620407.1), H. sapiens MAPK3 isoform 1 (NP_002737.2), Mus 
musculus MAPK1 (NP_036079.1), M. musculus MAPK3 (NP_036082.1), Xenopus 
laevis Mapk1 (NP_001083548.1), Latimeria chalumnae Mapk1 (XP_005990239.1), 
Danio rerio Mapk1 (NP_878308.2), D. rerio Mapk3 (NP_958915.1) and 
Callorhinchus milii Mapk1 (AFP02819.1). Identical amino acids are indicated by 
shaded residues. The open box indicates the kinase domain. The dotted line indicates 
the activation loop. The conserved TXY motif is underlined, and the regulatory 
residues that undergo phosphorylation are denoted by open triangles. The nuclear 
translocation signal (NTS) is indicated by the yellow box. The cytoplasmic retention 













Fig. 15. A dendrogram of mitogen-activated protein kinase 1 (MAPK1/Mapk1) 
and 3 (MAPK3/Mapk3) including those of Protopterus annectens. Numbers 
presented at each branch point represent bootstrap percentages from 1000 replicates. 




Fig. 16. The gene expression of mitogen-activated protein kinase 1 (mapk1) and 
mapk3 in various tissues/organs of Protopterus annectens. Expression of (a) mapk1 
and (b) mapk3 were examined in the muscle (M), heart (H), brain (B), eye (E), gills 
(Gi), kidney (K), Lung (Lu), skin (Sk), liver (Li), spleen (Sp), pancreas (P), and gut 
(Gu) of Protopterus annectens (N=1) kept in fresh water. 
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Fig. 17. mRNA expression levels of mitogen-activated protein kinase 1 (mapk1) in 
the muscle of Protopterus annectens. Absolute quantification (copies of transcript 
per ng total RNA) of mapk1 transcripts in the muscle of P. annectens kept in (a) fresh 
water on day 0 (FW; control), after 3 or 6 days (d; the induction phase), or 12 d or 6 
months (mon; the maintenance phase) of aestivation; (b) fresh water on day 0 (FW; 
control), after 6 mon (the maintenance phase) of aestivation, or after 1 d, 3 d or 6 d of 
arousal (Ar; the arousal phase) from 6 mon of aestivation. Results represent means ± 
































































































Fig. 18. mRNA expression levels of mitogen-activated protein kinase 3 (mapk3) in 
the muscle of Protopterus annectens. Absolute quantification (×102 copies of 
transcript per ng total RNA) of mapk3 transcripts in the muscle of P. annectens kept 
in (a) fresh water on day 0 (FW; control), after 3 or 6 days (d; the induction phase), or 
12 d or 6 months (mon; the maintenance phase) of aestivation; (b) fresh water on day 
0 (FW; control), after 6 mon (the maintenance phase) of aestivation, or after 1 d, 3 d 
or 6 d of arousal (Ar; the arousal phase) from 6 mon of aestivation. Results represent 










































































































Fig. 19. Protein abundance of mitogen-activated protein kinase (Mapk) in the 
muscle of Protopterus annectens. Protein abundance of Mapk in the muscle of P. 
annectens kept in fresh water on day 0 (FW; control), after 6 days (d; induction 
phase) or 6 months (mon; maintenance phase) of aestivation in air, or after 1 d or 3 d 
of arousal (Ar; arousal phase) from 6 mon of aestivation in air. (a) An example of 
immunoblot of Mapk. (b) The protein abundance of Mapk is expressed as arbitrary 
densitometric units per 100 µg protein. Results represent mean ± S.E.M. (N=3). 
Means not sharing the same letter are significantly different (P<0.05).  
(a) 








































































4.2. Genes/proteins involved in muscle degradation 
4.2.1. hdac1/Hdac1 
4.2.1.1. Nucleotide sequence, translated amino acid sequence and dendrogramic 
analysis 
The complete coding sequence of hdac1 from P. annectens consisted of 1488 bp. The 
putative Hdac1 protein sequence consisted of 496 amino acids and had an estimated 
molecular mass of 56.5 kDa (Appendix 2f). The Hdac1 of P. annectens shared the 
highest amino acid sequence identity with amphibian Hdac1 (88.3–89.3%), followed 
by teleosts Hdac1 (81.2–89.1%), mammalian HDAC1 (87.9–88.1%), and 
elasmobranch Hdac1 (86.8%; Table 11). 
Amino acid positions reported here are in reference to the ruler as presented in 
Fig. 20. A comparison of P. annectens Hdac1 with HDAC1/Hdac1 of human, mouse, 
frog, zebrafish and shark demonstrated a high conservation in the HDAC association 
domain (HAD; position 1–52) and the active site at the N terminus (position 54–326), 
especially for the zinc binding sites (D177, H179, D265) and the residues that form 
the active site pocket (H141, H142, G150, F151, D175, D177, H179, D182, F206, 
D265, L272; Fig. 20). The two serine residues, S422 and S424, which were well 
conserved for all species compared, are phosphorylated by casein kinase 2 (CSNK2). 
Out of the six lysine residues (K219, K221, K433, K439, K440 and K442) which 
undergo acetylation in human HDAC1, all but K433 were conserved in P. annectens. 
This particular site had been substituted by arginine in P. annectens. A predicted 
nuclear localization sequence (NLS) was found in the Hdac1 of P. annectens and was 
in the same region as the known NLS for human HDAC1. Three potential NES were 
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also found in the Hdac1 of P. annectens, bearing the signature conserved leucine-rich 
motifs (LXXLXL and/or LXXXLXXL; Fig. 20). 
The Hdac1 of P. annectens was grouped in a clade together with HDAC1 of 
tetrapods, separated from Hdac1 of teleosts (Fig. 21).  
4.2.1.2. Gene expression of hdac1 in various tissues/organs 
The highest expression of hdac1 was observed in the gills of P. annectens kept in 
fresh water (Fig. 22). Besides the gills, the expression of hdac1 was detected in the 
muscle, heart, brain, eye, kidney, lung, skin, liver, spleen, pancreas and gut. 
4.2.1.3. mRNA expression of hdac1  
There were no significant changes in the mRNA expression of hdac1 in the muscle of 
P. annectens during the induction, maintenance or arousal phases when compared to 
the freshwater control (Fig. 23). 
4.2.1.4. Protein abundance of Hdac1 
There was a significant increase in the protein abundance of Hdac1 in the muscle of P. 
annectens after 3 days of arousal from 6 months of aestivation (4.13-fold; P<0.05), as 




Table 11. The percentage similarity between the deduced amino acid sequence of 
histone deacetylase 1 (Hdac1) from the muscle of Protopterus annectens and 
HDAC1/Hdac1 sequences from other animal species obtained from GenBank 
(accession numbers in brackets). Sequences are arranged in a descending order of 
similarity. 
Classification Species Similarity 
Amphibians Xenopus (Silurana) tropicalis Hdac1 (AAH90604.1) 89.3% 
 Xenopus laevis Hdac1 (NP_001079396.1) 88.3% 
Teleosts Danio rerio Hdac1 (NP_775343.1) 89.1% 
 Notothenia coriiceps Hdac1 (XP_010770908.1) 87.5% 
 Cynoglossus semilaevis Hdac1 (XP_008314048.1) 87.5% 
 Stegastes partitus Hdac1 (XP_008282430.1) 87.3% 
 Takifugu rubripes Hdac1 (AAL89665.1) 86.7% 
 Esox lucius Hdac1 isoform X1 (XP_010877522.1) 86.6% 
Mammals Mus musculus HDAC1 (NP_032254.1) 88.1% 
 Rattus norvegicus HDAC1 (NP_001020580.1) 88.1% 
 Homo sapiens HDAC1 (NP_004955.2) 87.9% 




Fig. 20. Molecular characterization of histone deacetylase 1 (Hdac1) from the 
muscle of Protopterus annectens. Multiple amino acid alignment of Hdac1 from the 
muscle of P. annectens with five other known HDAC1/Hdac1 from Homo sapiens 
(NP_004955.2), Mus musculus (NP_032254.1), Xenopus (Silurana) tropicalis 
(AAH90604.1), Danio rerio (NP_775343.1) and Callorhinchus milii (AFO97213.1). 
Identical amino acids are indicated by shaded residues. The HDAC association 
domain is denoted with dotted lines. The open box indicates the catalytic domain. 
Open triangles denote the residues that form the active site pocket. Zinc binding sites 
are indicated by open circles. The known nuclear localization sequence (NLS) for H. 
sapiens and M. musculus and the predicted NLS for P. annectens are underlined. The 
yellow boxes indicate the potential nuclear export signal (NES) domains. The arrows 
denote the serine residues that are phosphorylated by casein kinase 2, while the lysine 









Fig. 21. A dendrogram of histone deacetylase 1 (HDAC1/Hdac1) including that 
of Protopterus annectens. Numbers presented at each branch point represent 
bootstrap percentages from 1000 replicates. Hdac1 from Strongylocentrotus 




Fig. 22. The gene expression of histone deacetylase 1 (hdac1) in various 
tissues/organs of Protopterus annectens. Expression of hdac1 were examined in the 
muscle (M), heart (H), brain (B), eye (E), gills (Gi), kidney (K), Lung (Lu), skin (Sk), 
liver (Li), spleen (Sp), pancreas (P), and gut (Gu) of Protopterus annectens (N=1) 











Fig. 23. mRNA expression levels of histone deacetylase 1 (hdac1) in the muscle of 
Protopterus annectens. Absolute quantification (x102 copies of transcript per ng total 
RNA) of hdac1 transcripts in the muscle of P. annectens kept in (a) fresh water on 
day 0 (FW; control), after 3 or 6 days (d; the induction phase), or 12 d or 6 months 
(mon; the maintenance phase) of aestivation; (b) fresh water on day 0 (FW; control), 
after 6 mon (the maintenance phase) of aestivation, or after 1 d, 3 d or 6 d of arousal 






























































































Fig. 24. Protein abundance of histone deacetylase 1 (Hdac1) in the muscle of 
Protopterus annectens. Protein abundance of Hdac1 in the muscle of P. annectens 
kept in fresh water on day 0 (FW; control), after 6 days (d; induction phase) or 6 
months (mon; maintenance phase) of aestivation in air, or after 1 d or 3 d of arousal 
(Ar; arousal phase) from 6 mon of aestivation in air. (a) An example of immunoblot 
of Hdac1. (b) The protein abundance of Hdac1 is expressed as arbitrary densitometric 
units per 100 µg protein. Results represent mean ± S.E.M. (N=3). Means not sharing 
the same letter are significantly different (P<0.05).  
(a) 










































































4.2.2. foxO1 and foxO3/FoxO1 and FoxO3 
4.2.2.1. Nucleotide sequences, translated amino acid sequences and 
dendrogramic analyses 
The complete coding sequences of foxO1 and foxO3 from P. annectens consisted of 
1932 bp and 2001 bp respectively. The deduced FoxO1 sequence comprised 644 
amino acids with an estimated molecular mass of 70.1 kDa (Appendix 2g), while the 
putative FoxO3 sequence consisted of 667 amino acids and had an estimated 
molecular mass of 71.9 kDa (Appendix 2h). The FoxO1 of P. annectens shared the 
highest amino acid sequence identity with mammalian FOXO1 (62.0–63.7%), 
followed by amphibian FoxO1 (61.2%) and zebrafish FoxO1b (51.2%; Table 12). 
Likewise, the FoxO3 of P. annectens shared the highest amino acid sequence identity 
with mammalian FOXO3 (64.0–64.1%), followed by amphibian FoxO3 (62.9%) and 
zebrafish FoxO3 (52.2%; Table 12). It was observed that both FoxO1 and FoxO3 of 
P. annectens shared less than 38% sequence identity to other members of the 
FOXO/FoxO family (Table 12). 
Analysis of multiple amino acid alignment of FOXO1/FoxO1 and 
FOXO3/FoxO3 revealed four main domains in FOXO proteins: (1) a forkhead DNA 
binding domain (DBD); (2) a NLS located downstream of the forkhead DNA binding 
domain; (3) a NES and (4) a C terminus transactivation domain (Fig. 25). The 
forkhead DBD and the transactivation domains showed high conservation in all 
sequences compared. The FoxO1 and FoxO3 of P. annectens contained a NLS and a 
NES each, which were in similar regions as the known NLS and NES in human 
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FOXO1 and FOXO3. This indicated that the FoxO1 and FoxO3 of P. annectens 
could be localized to both the nucleus and cytoplasm. 
FOXO proteins are regulated by several post-translational modifications, 
including phosphorylation and acetylation. There were three AKT kinase and serum 
and glucocorticoid-inducible kinase (SGK) consensus phosphorylation sites in P. 
annectens FoxO1 and FoxO3 (T32, S266, S333; Fig. 25). All three AKT sites 
contained the AKT consensus phosphorylation motif, RXRXXS/T, which was highly 
conserved for all FOXO/FoxO compared. Phosphorylation of FOXO1 by AKT at 
S333 allows for the binding of CSNK1, which then sequentially phosphorylates 
FOXO1 at S336 and S339 (Rena et al., 2002, 2004). While S336 is conserved for all 
sequences compared, S339 was substituted by glycine in P. annectens FoxO1 but 
remained conserved in P. annectens FoxO3. S343, which was highly conserved in all 
FOXO/FoxO sequences compared, can be phosphorylated by dual tyrosine 
phosphorylated regulated kinase-1A (DYRK1A). Acetylation of FOXO at sites K256, 
K259, K273, K276, K307 and K611 are mediated by p300 or cyclic-AMP responsive 
element binding (CREB)-binding protein (CBP), all of which were conserved in P. 
annectens FoxO1 and FoxO3.  
MAPK1 and MAPK3 target S311, S364 and S455 in FOXO3 (Yang et al., 
2008a, b), where all but S455 were conserved in P. annectens FoxO3 (Fig. 25). S455 
was substituted by proline in the FoxO3 of P. annectens. FOXO3 is also targeted by 
AMPK at T193, S427, S443, S596, S631 and S673. In P. annectens FoxO3, T193, 




A dendrogram for both FoxO1 and FoxO3 including those of P. annectens 
was generated despite a lack of available FOXO/FoxO sequences in GenBank. The 
dendrogram agrees with the sequence identity, grouping the different members of the 
FOXO/FoxO family together; the FoxO1 of P. annectens was grouped together with 
other known FOXO1/FoxO1, separated from FOXO3/FoxO3 and FOXO4/FoxO4, 
while the FoxO3 of P. annectens was grouped together with other known 
FOXO3/FoxO3, separated from FOXO1/FoxO1 and FOXO4/FoxO4 (Fig. 26).  
4.2.2.2. Gene expression of foxO1 and foxO3 in various tissues/organs 
The highest expression of foxO1 was observed in the gills and liver of P. annectens 
kept in fresh water (Fig. 27a). The expression of foxO1 was detected in the muscle, 
heart, brain, eye, kidney, skin, spleen, pancreas and gut, but undetected in the lung. 
The expression of foxO3 was the highest in the heart, brain, eye and gills of P. 
annectens kept in fresh water (Fig. 27b). The expression of foxO3 was detected in the 
muscle, kidney, lung, skin, liver, spleen, pancreas and gut. 
4.2.2.3. mRNA expression of foxO1 and foxO3 
There were significant decreases in the mRNA expression levels of foxO1 in the 
muscle of P. annectens after 6 days (by 44.2%; P<0.05) or 12 days (by 36.4%; 
P<0.05) or after 6 months of aestivation (by 60.6%; P<0.05), as compared to the 
freshwater control (Fig. 28a). By contrast, there was a significant increase in the 
mRNA expression of foxO1 after 6 days of arousal from 6 months of aestivation 
(4.23-fold; P<0.05; Fig. 28b). 
There were significant increases in the mRNA expression levels of foxO3 in 
the muscle of P. annectens after 3 days (2.08-fold; P<0.05) or 6 days of aestivation 
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(1.64-fold; P<0.05), as compared to the control (Fig. 29a). There was a significant 
increase in the mRNA expression of foxO3 after 6 days of arousal from 6 months of 
aestivation (2.28-fold; P<0.05; Fig. 29b). 
4.2.2.4. Protein abundance of FoxO1 and FoxO3 
There was a significant decrease in the protein abundance of FoxO1 in the muscle of 
P. annectens after 1 day of arousal from 6 months of aestivation (by 79.5%; P<0.05), 
as compared to the freshwater control (Fig. 30). In contrast, there were no significant 
changes in the protein abundance of FoxO3 in the muscle of P. annectens after 6 days 
or 6 months of aestivation, or after 1 day or 3 days of arousal from 6 months of 




Table 12. The percentage similarity between the deduced amino acid sequence of 
forkhead box O1 (FoxO1) and FoxO3 from the muscle of Protopterus annectens and 
FOXO/FoxO sequences from other animal species obtained from GenBank 
(accession numbers in brackets). Sequences are arranged in a descending order of 
similarity to P. annectens FoxO1. 






Lungfish P. annectens FoxO1 100% 35.1% 
 P. annectens FoxO3 35.1% 100% 
Mammals Mus musculus FOXO1 
(NP_062713.2) 
63.7% 37.4% 
 Homo sapiens FOXO1 (AAH21981.1) 62.0% 36.8% 
 Homo sapiens FOXO3 (AAH68552.1) 36.1% 64.1% 
 Mus musculus FOXO3 
(NP_062714.1) 
35.7% 64.0% 
 Homo sapiens FOXO4 isoform 1 
(NP_005929.2) 
31.8% 30.6% 
 Rattus norvegicus FOXO4 
(NP_001100413.1) 
31.0% 30.3% 
 Mus musculus FOXO4 
(NP_061259.1) 
30.7% 30.3% 
 Homo sapiens FOXO4 isoform 2 
(NP_001164402.1) 
29.3% 28.0% 
Amphibians Xenopus laevis FoxO1 
(NP_001086417.1) 
61.2% 37.4% 
 Xenopus laevis FoxO3 
(NP_001086418.1) 
36.1% 62.9% 
 Xenopus laevis FoxO4 (ACO24746.1) 34.0% 33.0% 
Teleosts Danio rerio FoxO1b (AAI63020.1) 51.2% 30.8% 




Fig. 25. Molecular characterization of forkhead box O1 and O3 (FoxO1 and 
FoxO3) from the muscle of Protopterus annectens. Multiple amino acid alignment 
of FoxO1 and FoxO3 from the muscle of P. annectens with Homo sapiens FOXO1 
(AAH21981.1), H. sapiens FOXO3 (AAH68552.1), Mus musculus FOXO1 
(NP_062713.2), M. musculus FOXO3 (NP_062714.1), Xenopus laevis FoxO1 
(NP_001086417.1), X. laevis FoxO3 (NP_001086418.1), Danio rerio FoxO1b 
(AAI63020.1) and D. rerio FoxO3 (NP_571160.1). Identical amino acids are 
indicated by shaded residues. The forkhead DNA-binding domain is indicated with an 
open box. Regions of nuclear localization sequence (NLS) and nuclear export 
sequence (NES) are indicated by yellow boxes, with the sequences (known for human 
and predicted for P. annectens) underlined. The open triangles indicate the residues in 
both FOXO1 and FOXO3 that are phosphorylated by protein kinase AKT/serum-and 
glucocorticoid-inducible kinase, while the dotted lines indicate the AKT consensus 
phosphorylation motif (RXRXXS/T). In both FOXO1 and FOXO3, the open circles 
denote the residues that are phosphorylated by casein kinase 1, while the open square 
indicates the serine residue that is phosphorylated by dual tyrosine phosphorylated 
regulated kinase-1A. Lysine residues which undergo acetylation by p300/cyclic-AMP 
responsive element binding (CREB)-binding protein in both FOXO1 and FOXO3 are 
denoted by the symbol #. The symbol ‡ indicates the serine residues in FOXO3 that 
undergo phosphorylation by mitogen-activated protein kinases 1 and 3. The residues 
that undergo AMP-activated protein kinase phosphorylation in FOXO3 are indicated 
by arrows. The transactivation domain for both FOXO1 and FOXO3 is double-















Fig. 26. A dendrogram of forkhead box O (FOXO/FoxO) including those of 
Protopterus annectens. Numbers presented at each branch point represent bootstrap 
percentages from 1000 replicates. FoxO from Cerapachys biroi is used as the 




Fig. 27. The gene expression of forkhead box O1 (foxO1) and O3 (foxO3) in 
various tissues/organs of Protopterus annectens. Expression of (a) foxO1 and (b) 
foxO3 were examined in the muscle (M), heart (H), brain (B), eye (E), gills (Gi), 
kidney (K), Lung (Lu), skin (Sk), liver (Li), spleen (Sp), pancreas (P), and gut (Gu) 
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Fig. 28. mRNA expression levels of forkhead box O1 (foxO1) in the muscle of 
Protopterus annectens. Absolute quantification (×102 copies of transcript per ng total 
RNA) of foxO1 transcripts in the muscle of P. annectens kept in (a) fresh water on 
day 0 (FW; control), after 3 or 6 days (d; the induction phase), or 12 d or 6 months 
(mon; the maintenance phase) of aestivation; (b) fresh water on day 0 (FW; control), 
after 6 mon (the maintenance phase) of aestivation, or after 1 d, 3 d or 6 d of arousal 
(Ar; the arousal phase) from 6 mon of aestivation. Results represent means ± S. E. M 



































































































Fig. 29. mRNA expression levels of forkhead box O3 (foxO3) in the muscle of 
Protopterus annectens. Absolute quantification (×102 copies of transcript per ng total 
RNA) of foxO3 transcripts in the muscle of P. annectens kept in (a) fresh water on 
day 0 (FW; control), after 3 or 6 days (d; the induction phase), or 12 d or 6 months 
(mon; the maintenance phase) of aestivation; (b) fresh water on day 0 (FW; control), 
after 6 mon (the maintenance phase) of aestivation, or after 1 d, 3 d or 6 d of arousal 
(Ar; the arousal phase) from 6 mon of aestivation. Results represent means ± S. E. M 







































































































Fig. 30. Protein abundance of forkhead box O1 (FoxO1) in the muscle of 
Protopterus annectens. Protein abundance of FoxO1 in the muscle of P. annectens 
kept in fresh water on day 0 (FW; control), after 6 days (d; induction phase) or 6 
months (mon; maintenance phase) of aestivation in air, or after 1 d or 3 d of arousal 
(Ar; arousal phase) from 6 mon of aestivation in air. (a) An example of immunoblot 
of FoxO1. (b) The protein abundance of FoxO1 is expressed as arbitrary 
densitometric units per 20 µg protein. Results represent mean ± S.E.M. (N=3). Means 
not sharing the same letter are significantly different (P<0.05).  
(a) 









































































Fig. 31. Protein abundance of forkhead box O3 (FoxO3) in the muscle of 
Protopterus annectens. Protein abundance of FoxO3 in the muscle of P. annectens 
kept in fresh water on day 0 (FW; control), after 6 days (d; induction phase) or 6 
months (mon; maintenance phase) of aestivation in air, or after 1 d or 3 d of arousal 
(Ar; arousal phase) from 6 mon of aestivation in air. (a) An example of immunoblot 
of FoxO3. (b) The protein abundance of FoxO3 is expressed as arbitrary 
densitometric units per 200 µg protein. Results represent mean ± S.E.M. (N=3).  
(a) 







































































4.2.3.1. Gene expression of tp53 in various tissues/organs 
The gills, kidney, skin, liver and spleen of P. annectens kept in fresh water had the 
highest expression levels of tp53 (Fig. 32). The expression of tp53 was detected in the 
brain, eye, pancreas and gut, weakly detectable in the muscle and lung but 
undetectable in the heart. 
4.2.3.2. mRNA expression of tp53 
There was a significant increase in the mRNA expression of tp53 in the muscle of P. 
annectens after 6 days of aestivation (2.29-fold; P<0.05), as compared to the control 
(Fig. 33a). There were significant increases in the mRNA expression levels of tp53 in 
the muscle of P. annectens after 1 day (1.75-fold; P<0.05) or 3 days (3.36-fold; 
P<0.05) or 6 days of arousal from 6 months of aestivation (4.37-fold; P<0.05), as 




Fig. 32. The gene expression of tumour protein 53 (tp53) in various tissues/organs 
of Protopterus annectens. Expression of tp53 were examined in the muscle (M), 
heart (H), brain (B), eye (E), gills (Gi), kidney (K), Lung (Lu), skin (Sk), liver (Li), 












Fig. 33. mRNA expression levels of tumour protein 53 (tp53) in the muscle of 
Protopterus annectens. Absolute quantification (×102 copies of transcript per ng total 
RNA) of tp53 transcripts in the muscle of P. annectens kept in (a) fresh water on day 
0 (FW; control), after 3 or 6 days (d; the induction phase), or 12 d or 6 months (mon; 
the maintenance phase) of aestivation; (b) fresh water on day 0 (FW; control), after 6 
mon (the maintenance phase) of aestivation, or after 1 d, 3 d or 6 d of arousal (Ar; the 
arousal phase) from 6 mon of aestivation. Results represent means ± S. E. M (N=4). 




































































































4.2.4.1. Nucleotide sequence, translated amino acid sequence and dendrogramic 
analysis 
The complete coding sequence of mstn from P. annectens comprised 1128 bp. The 
deduced Mstn sequence consisted of 376 amino acids with an estimated molecular 
mass of 42.9 kDa (Appendix 2i), and shared the highest amino acid sequence identity 
with mammalian MSTN (69.1–70.8%), followed by coelacanth Mstn (66.5%), teleost 
Mstn (31.1–62.5%) and amphibian Mstn (61.6%; Table 13).  
A comparison of the Mstn from P. annectens with MSTN/Mstn of human, 
mouse, frog, coelacanth and zebrafish showed that P. annectens Mstn consisted of a 
conserved TGF-β propeptide domain, a RXXR proteolytic cleavage site (RSRR) and 
a bioactive TGF-β domain (Fig. 34). The proteolytic site allows the mature peptide to 
be released. The Mstn of P. annectens also contained nine cysteine residues after the 
proteolytic site that were conserved in all Mstn and inhibin/activin-like members of 
the TGF-β family. A putative signal peptide was predicted in the NH2-terminus, and 
cleavage was predicted to occur between amino acid positions 21 and 22 of P. 
annectens Mstn. 
The Mstn of P. annectens was grouped in a clade together with Mstn of L. 
chalumnae and MSTN of tetrapods, separated from Mstn of teleosts (Fig. 35). 
4.2.4.2. Gene expression of mstn in various tissues/organs 
The muscle and eye of P. annectens kept in fresh water had the highest expression 
levels of mstn (Fig. 36). The expression of mstn was not detected in the heart, brain, 
gills, kidney, lung, skin, liver, spleen, pancreas and gut. 
 150 
 
4.2.4.3. mRNA expression of mstn 
There were significant increases in the mRNA expression levels of mstn in the 
muscle of P. annectens after 6 days (3.23-fold; P<0.05) or 12 days of aestivation 
(4.06-fold; P<0.05), as compared to the control (Fig. 37a). By contrast, the mRNA 
expression of mstn remained unchanged in the muscle of P. annectens during the 
arousal phase (Fig. 37b). 
4.2.4.4. Protein abundance of Mstn 
There was a significant decrease in the protein abundance of Mstn in the muscle of P. 
annectens after 1 day of arousal from 6 months of aestivation (by 41.4%; P<0.05) 




Table 13. The percentage similarity between the deduced amino acid sequence of 
myostatin (Mstn) from the muscle of Protopterus annectens and MSTN/Mstn 
sequences from other animal species obtained from GenBank (accession numbers in 
brackets). Sequences are arranged in a descending order of similarity. 
Classification Species Similarity 
Mammals Homo sapiens MSTN (ABI48513.1) 70.8% 
 Mus musculus MSTN (AAI05675.1) 69.6% 
 Rattus norvegicus MSTN (AAB86691.1) 69.1% 
Coelacanth Latimeria chalumnae Mstn (XM_005996542.1) 66.5% 
Teleosts Labeo fimbriatus Mstn (AEN75197.1) 62.5% 
 Cyprinus carpio Mstn 1a (ACY01745.1) 62.3% 
 Danio rerio Mstn (AAB86693.1) 62.3% 
 Oncorhynchus mykiss Mstn 1a (AAZ85121.1) 62.0% 
 Salmo salar Mstn 1b (CAC59700.1) 61.7% 
 Salmo salar Mstn 1a (ABN72586.1) 61.7% 
 Catla catla Mstn (AEN75196.1) 61.5% 
 Oncorhynchus mykiss Mstn 1b (ABA42586.1) 61.5% 
 Cyprinus carpio Mstn 1b (ACY01746.1) 61.2% 
 Takifugu rubripes Mstn 1 (AAR88255.1) 59.4% 
 Cynoglossus semilaevis Mstn (ABU25352.1) 58.1% 
 Ameiurus catus Mstn (AAS48405.1) 57.3% 
 Clarias macrocephalus Mstn (AFS49710.1) 56.7% 




Fig. 34. Molecular characterization of myostatin (Mstn) from the muscle of 
Protopterus annectens. Multiple amino acid alignment of Mstn from the muscle of P. 
annectens with five other known MSTN/Mstn from Homo sapiens (ABI48513.1), 
Mus musculus (AAI05675.1), Xenopus (Silurana) tropicalis (XP_002931542.1), 
Latimeria chalumnae (XM_005996542.1) and Danio rerio (AAB86693.1). Identical 
amino acids are indicated by shaded residues. The signal peptide (21 amino acids 
long) is underlined. The open box indicates the proteolytic cleavage site (RXXR), 
which separates the TGF-β propeptide domain (position 39–260) from the TGF-β 
domain (position 284–379). The arrows indicate the conserved cysteine residues 









Fig. 35. A dendrogram of myostatin (MSTN/Mstn) including that of Protopterus 
annectens. Numbers presented at each branch point represent bootstrap percentages 
from 8000 replicates. Mstn from Nematostella vectensis is used as the outgroup for 




Fig. 6. The gene expression of myostatin (mstn) in various tissues/organs of 
Protopterus annectens. Expression of mstn were examined in the muscle (M), heart 
(H), brain (B), eye (E), gills (Gi), kidney (K), Lung (Lu), skin (Sk), liver (Li), spleen 











Fig. 37. mRNA expression levels of myostatin (mstn) in the muscle of Protopterus 
annectens. Absolute quantification (copies of transcript per ng total RNA) of mstn 
transcripts in the muscle of P. annectens kept in (a) fresh water on day 0 (FW; 
control), after 3 or 6 days (d; the induction phase), or 12 d or 6 months (mon; the 
maintenance phase) of aestivation; (b) fresh water on day 0 (FW; control), after 6 
mon (the maintenance phase) of aestivation, or after 1 d, 3 d or 6 d of arousal (Ar; the 
arousal phase) from 6 mon of aestivation. Results represent means ± S. E. M (N=4). 
























































































Fig. 38. Protein abundance of myostatin (Mstn) in the muscle of Protopterus 
annectens. Protein abundance of Mstn in the muscle of P. annectens kept in fresh 
water on day 0 (FW; control), after 6 days (d; induction phase) or 6 months (mon; 
maintenance phase) of aestivation in air, or after 1 d or 3 d of arousal (Ar; arousal 
phase) from 6 mon of aestivation in air. (a) An example of immunoblot of Mstn. (b) 
The protein abundance of Mstn is expressed as arbitrary densitometric units per 200 
µg protein. Results represent mean ± S.E.M. (N=3). Means not sharing the same letter 
are significantly different (P<0.05).  
(a) 












































































4.2.5.1. Nucleotide sequence, translated amino acid sequence and dendrogramic 
analysis 
The complete coding sequence of fbxo32 from P. annectens consisted of 1062 bp. 
The deduced Fbxo32 sequence comprised 354 amino acids with an estimated 
molecular mass of 41.8 kDa (Appendix 2j), and shared the highest amino acid 
sequence identity with reptilian FBXO32 (58.2–80.3%) and coelacanth Fbxo32 
(80.3%), followed by mammalian FBXO32 (77.8–79.2%), elasmobranch Fbxo32 
(77%), teleost Fbxo32 (69.4–72.8%) and amphibian Fbxo32 (62.1%; Table 14).  
An alignment of Fbxo32 from P. annectens with those from human, mouse, 
frog, rainbow trout and shark revealed that it contained a SV40-type monopartite 
NLS containing the basic amino acids KKRRK, which was highly conserved for all 
protein sequences compared (Fig. 39). The Fbxo32 from P. annectens was also found 
to contain a putative bipartite NLS located between position 276–304 (with reference 
to the ruler in Fig. 39), suggesting that P. annectens Fbxo32 could be localized to the 
nucleus. A conserved F-box domain was also found in P. annectens Fbxo32. A 
leucine-charged domain (LCD) containing an inverted LXXLL motif was found to be 
conserved in the Fbxo32 of P. annectens. 
The Fbxo32 of P. annectens was grouped in a clade together with FBXO32 of 
tetrapods, Fbxo32 of L. chalumnae and Fbxo32 of the cartilaginous fish, C. milii, 
separated from Fbxo32 of teleosts (Fig. 40). 
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4.2.5.2. Gene expression of fbxo32 in various tissues/organs 
The muscle of P. annectens kept in fresh water had the highest expression level of 
fbxo32 (Fig. 41). Apart from the muscle, fbxo32 expression was detected in the heart, 
brain, eye, gills, kidney, lung, skin, liver, spleen, pancreas and gut. 
4.2.5.3. mRNA expression of fbxo32 
Significant increases in the mRNA expression levels of fbxo32 were observed in the 
muscle of P. annectens after 3 days (4.81-fold; P<0.05) or 6 days (2.5-fold; P<0.05), 
or 12 days of aestivation (1.82-fold; P<0.05), as compared to the control (Fig. 42a). 
There were significant increases in the mRNA expression levels of fbxo32 after 1 day 
(2.29-fold; P<0.05) or 6 days of arousal from 6 months of aestivation (4.34-fold; 
P<0.05; Fig. 42b). 
4.2.5.4. Protein abundance of Fbxo32 
There were significant decreases in the protein abundance of Fbxo32 in the muscle of 
P. annectens after 6 days (by 64.6%; P<0.05), or after 1 day of arousal from 6 





Table 14. The percentage similarity between the deduced amino acid sequence of F-
box protein 32 (Fbxo32) from the muscle of Protopterus annectens and 
FBXO32/Fbxo32 sequences from other animal species obtained from GenBank 
(accession numbers in brackets). Sequences are arranged in a descending order of 
similarity. 
Classification Species Similarity 
Reptiles Chrysemys picta bellii FBXO32 (XP_005288831.1) 80.3% 
 Pelodiscus sinensis FBXO32 isoform X1 
(XP_006137545.1) 
80.1% 
 Chelonia mydas FBXO32 (XP_007070931.1) 72.3% 
 Pelodiscus sinensis FBXO32 isoform X2 
(XP_006137546.1) 
58.2% 
Coelacanth Latimeria chalumnae Fbxo32 isoform X1 
(XP_006000858.1) 
80.3% 
Mammals Homo sapiens FBXO32 isoform 1 (NP_478136.1) 79.2% 
 Rattus norvegicus FBXO32 (NP_598205.1) 78.2% 
 Mus musculus FBXO32 (NP_080622.1) 77.8% 
Elasmobranch Callorhinchus milii Fbxo32 (XP_007898752.1) 77.0% 
Teleosts Poecilia reticulata Fbxo32 (XP_008430324.1) 72.8% 
 Astyanax mexicanus Fbxo32 (XP_007250892.1) 72.2% 
 Danio rerio Fbxo32 (NP_957211.1) 71.9% 
 Larimichthys crocea Fbxo32 (XP_010738325.1) 71.7% 
 Oncorhynchus mykiss Fbxo32 (NP_001180255.1) 71.3% 
 Stegastes partitus Fbxo32 (XP_008275201.1) 70.8% 
 Salmo salar Fbxo32 (NP_001171956.1) 70.5% 
 Esox lucius Fbxo32 (XP_010891067.1) 70.2% 
 Notothenia coriiceps Fbxo32 (XP_010780879.1) 69.4% 




Fig. 39. Molecular characterization of F-box protein 32 (Fbxo32) from the 
muscle of Protopterus annectens. Multiple amino acid alignment of Fbxo32 from the 
muscle of P. annectens with five other known FBXO32/Fbxo32 from Homo sapiens 
(NP_478136.1), Mus musculus (NP_080622.1), Xenopus (Silurana) tropicalis 
(AAH92557.1), Oncorhynchus mykiss (NP_001180255.1) and Callorhinchus milii 
(XP_007898752.1). Identical amino acids are indicated by shaded residues. The open 
box indicates the F-box domain. The putative nuclear localization sequences are 
underlined. The leucine-charged domain is denoted by a yellow box, with the 








Fig. 40. A dendrogram of F-box protein 32 (FBXO32/Fbxo32) including that of 
Protopterus annectens. Numbers presented at each branch point represent bootstrap 
percentages from 1000 replicates. Fbxo32 from Strongylocentrotus purpuratus is 




Fig. 41. The gene expression of F-box protein 32 (fbxo32) in various 
tissues/organs of Protopterus annectens. Expression of fbxo32 were examined in the 
muscle (M), heart (H), brain (B), eye (E), gills (Gi), kidney (K), Lung (Lu), skin (Sk), 
liver (Li), spleen (Sp), pancreas (P), and gut (Gu) of Protopterus annectens (N=1) 
kept in fresh water. 
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Fig. 42. mRNA expression levels of F-box protein 32 (fbxo32) in the muscle of 
Protopterus annectens. Absolute quantification (x 104 copies of transcript per ng 
total RNA) of fbxo32 transcripts in the muscle of P. annectens kept in (a) fresh water 
on day 0 (FW; control), after 3 or 6 days (d; the induction phase), or 12 d or 6 months 
(mon; the maintenance phase) of aestivation; (b) fresh water on day 0 (FW; control), 
after 6 mon (the maintenance phase) of aestivation, or after 1 d, 3 d or 6 d of arousal 
(Ar; the arousal phase) from 6 mon of aestivation. Results represent means ± S. E. M 







































































































Fig. 43. Protein abundance of F-box protein 32 (Fbxo32) in the muscle of 
Protopterus annectens. Protein abundance of Fbxo32 in the muscle of P. annectens 
kept in fresh water on day 0 (FW; control), after 6 days (d; induction phase) or 6 
months (mon; maintenance phase) of aestivation in air, or after 1 d or 3 d of arousal 
(Ar; arousal phase) from 6 mon of aestivation in air. (a) An example of immunoblot 
of Fbxo32. (b) The protein abundance of Fbxo32 expressed as arbitrary densitometric 
units per 100 µg protein. Results represent mean ± S.E.M. (N=3). Means not sharing 
the same letter are significantly different (P<0.05).  
(a) 














































































4.3. Genes/proteins involved in oxidative defense 
4.3.1. CuZnsod and Mnsod/CuZnSod and MnSod 
4.3.1.1. Gene expression of CuZnsod and Mnsod in various tissues/organs 
The expression of CuZnsod was detected in the muscle, heart, brain, eye, gills, kidney, 
lung, skin, liver, spleen, pancreas and gut of P. annectens kept in fresh water (Fig. 
44a). The gills of freshwater P. annectens had the highest expression level of Mnsod 
(Fig. 44b). Besides the gills, Mnsod expression was detected in the muscle, heart, 
brain, eye, kidney, lung, skin, liver, spleen, pancreas and gut. 
4.3.1.2. mRNA expression of CuZnsod and Mnsod 
There were significant decreases in the mRNA expression levels of CuZnsod in the 
muscle of P. annectens after 3 days (by 27.9%; P<0.05) or 6 days (by 29.2%; P<0.05) 
or 12 days (by 48%; P<0.05) or after 6 months of aestivation (by 38.8%; P<0.05), as 
compared to the control (Fig. 45a). The mRNA expression of CuZnsod after 1 day of 
arousal from 6 months of aestivation was not significantly different from that of the 
control, but decreased significantly (by 36.1%; P<0.05) after 3 days of arousal from 6 
months of aestivation, before returning to the control level after 6 days of arousal 
from 6 months of aestivation (Fig. 45b). 
There were significant decreases in the mRNA expression levels of Mnsod in 
the muscle of P. annectens after 3 days (by 35.6%; P<0.05) or 6 days (by 34.3%; 
P<0.05) or 12 days (by 38.4%; P<0.05) or after 6 months of aestivation (by 64.2%; 
P<0.05), as compared to the control (Fig. 46a). The mRNA expression of Mnsod 
decreased significantly after 1 day (by 54.8%; P<0.05) or 6 days of arousal from 6 
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months of aestivation (by 38.2%; P<0.05), as compared to the freshwater control (Fig. 
46b). 
4.3.1.3. Protein abundance of CuZnSod and MnSod 
There were significant increases in the protein abundance of CuZnSod in the muscle 
of P. annectens after 6 months of aestivation (2.7-fold; P<0.05), or after 1 day (2.76-
fold; P<0.05) or 3 days of arousal from 6 months of aestivation (2.03-fold; P<0.05), 
as compared to the freshwater control (Fig. 47). 
There were no significant changes in the protein abundance of MnSod in the 
muscle of P. annectens after 6 days or 6 months of aestivation, or after 1 day or 3 




Fig. 44. The gene expression of copper-zinc superoxide dismutase (CuZnsod) and 
manganese sod (Mnsod) in various tissues/organs of Protopterus annectens. 
Expression of (a) CuZnsod and (b) Mnsod were examined in the muscle (M), heart 
(H), brain (B), eye (E), gills (Gi), kidney (K), Lung (Lu), skin (Sk), liver (Li), spleen 
(Sp), pancreas (P), and gut (Gu) of Protopterus annectens (N=1) kept in fresh water. 
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Fig. 45. mRNA expression levels of copper-zinc superoxide dismutase (CuZnsod) 
in the muscle of Protopterus annectens. Absolute quantification (×102 copies of 
transcript per ng total RNA) of CuZnsod transcripts in the muscle of P. annectens 
kept in (a) fresh water on day 0 (FW; control), after 3 or 6 days (d; the induction 
phase), or 12 d or 6 months (mon; the maintenance phase) of aestivation; (b) fresh 
water on day 0 (FW; control), after 6 mon (the maintenance phase) of aestivation, or 
after 1 d, 3 d or 6 d of arousal (Ar; the arousal phase) from 6 mon of aestivation. 
Results represent means ± S. E. M (N=4). Means not sharing the same letter are 














































































































Fig. 46. mRNA expression levels of manganese superoxide dismutase (Mnsod) in 
the muscle of Protopterus annectens. Absolute quantification (×102 copies of 
transcript per ng total RNA) of Mnsod transcripts in the muscle of P. annectens kept 
in (a) fresh water on day 0 (FW; control), after 3 or 6 days (d; the induction phase), or 
12 d or 6 months (mon; the maintenance phase) of aestivation; (b) fresh water on day 
0 (FW; control), after 6 mon (the maintenance phase) of aestivation, or after 1 d, 3 d 
or 6 d of arousal (Ar; the arousal phase) from 6 mon of aestivation. Results represent 












































































































Fig. 47. Protein abundance of copper-zinc superoxide dismutase (CuZnSod) in 
the muscle of Protopterus annectens. Protein abundance of CuZnSod in the muscle 
of P. annectens kept in fresh water on day 0 (FW; control), after 6 days (d; induction 
phase) or 6 months (mon; maintenance phase) of aestivation in air, or after 1 d or 3 d 
of arousal (Ar; arousal phase) from 6 mon of aestivation in air. (a) An example of 
immunoblot of CuZnSod. (b) The protein abundance of CuZnSod expressed as 
arbitrary densitometric units per 100 µg protein. Results represent mean ± S.E.M. 
(N=3). Means not sharing the same letter are significantly different (P<0.05).  
(a) 














































































Fig. 48. Protein abundance of manganese superoxide dismutase (MnSod) in the 
muscle of Protopterus annectens. Protein abundance of MnSod in the muscle of P. 
annectens kept in fresh water on day 0 (FW; control), after 6 days (d; induction 
phase) or 6 months (mon; maintenance phase) of aestivation in air, or after 1 d or 3 d 
of arousal (Ar; arousal phase) from 6 mon of aestivation in air. (a) An example of 
immunoblot of MnSod. (b) The protein abundance of MnSod expressed as arbitrary 
densitometric units per 100 µg protein. Results represent mean ± S.E.M. (N=3).  
(a) 







































































4.3.2.1. Gene expression of cat in various tissues/organs 
The highest expression level of cat was observed in the liver of P. annectens kept in 
fresh water (Fig. 49). Besides the liver, cat expression was detected in the muscle, 
heart, brain, eye, gill, kidney, lung, skin, spleen, pancreas and gut. 
4.3.2.2. mRNA expression of cat 
There were no significant changes in the mRNA expression levels of cat in the 
muscle of P. annectens during the induction, maintenance and arousal phases when 
compared to the freshwater control (Fig. 50). 
4.3.2.3. Protein abundance of Cat 
There were significant increases in the protein abundance of Cat in the muscle of P. 
annectens after 6 days of aestivation (4.11-fold; P<0.05) or after 1 day of arousal 
from 6 months of aestivation (4.97-fold; P<0.05), as compared to the freshwater 




Fig. 49. The gene expression of catalase (cat) in various tissues/organs of 
Protopterus annectens. Expression of cat were examined in the muscle (M), heart 
(H), brain (B), eye (E), gills (Gi), kidney (K), Lung (Lu), skin (Sk), liver (Li), spleen 











Fig. 50. mRNA expression levels of catalase (cat) in the muscle of Protopterus 
annectens. Absolute quantification (×102 copies of transcript per ng total RNA) of 
cat transcripts in the muscle of P. annectens kept in (a) fresh water on day 0 (FW; 
control), after 3 or 6 days (d; the induction phase), or 12 d or 6 months (mon; the 
maintenance phase) of aestivation; (b) fresh water on day 0 (FW; control), after 6 
mon (the maintenance phase) of aestivation, or after 1 d, 3 d or 6 d of arousal (Ar; the 
arousal phase) from 6 mon of aestivation. Results represent means ± S. E. M (N=4). 






























































































Fig. 51. Protein abundance of catalase (Cat) in the muscle of Protopterus 
annectens. Protein abundance of Cat in the muscle of P. annectens kept in fresh 
water on day 0 (FW; control), after 6 days (d; induction phase) or 6 months (mon; 
maintenance phase) of aestivation in air, or after 1 d or 3 d of arousal (Ar; arousal 
phase) from 6 mon of aestivation in air. (a) An example of immunoblot of Cat. (b) 
The protein abundance of Cat expressed as arbitrary densitometric units per 100 µg 
protein. Results represent mean ± S.E.M. (N=3). Means not sharing the same letter 
are significantly different (P<0.05). 
(a) 














































































4.3.3. gpx1 and gpx4/Gpx1 and Gpx4 
4.3.3.1. Gene expression of gpx1 and gpx4 in various tissues/organs 
The highest expression levels of gpx1 were detected in the gills, kidney and skin of 
freshwater P. annectens (Fig. 52a). The expression of gpx1 was detected in the 
muscle, heart, brain, eye, lung, liver, spleen, pancreas and gut. The expression of 
gpx4 was detected in the muscle, heart, brain, eye, gills, kidney, lung, skin, liver, 
spleen, pancreas and gut of P. annectens kept in fresh water (Fig. 52b).  
4.3.3.2. mRNA expression of gpx1 and gpx4 
There were significant decreases in the mRNA expression levels of gpx1 in the 
muscle of P. annectens after 3 days (by 73.1%; P<0.05) or 6 days (by 57.6%; P<0.05) 
or 12 days (by 69.2%; P<0.05) or after 6 months of aestivation (by 66.2%; P<0.05), 
as compared to the freshwater control (Fig. 53a). The mRNA expression of gpx1 
decreased significantly after 1 day (by 67.9%; P<0.05) or 3 days of arousal from 6 
months of aestivation (by 70.2%; P<0.05), and returned to the control level after 6 
days of arousal from 6 months of aestivation (Fig. 53b). 
There was a significant increase in the mRNA expression level of gpx4 in the 
muscle of P. annectens after 6 months of aestivation (2.46-fold; P<0.05), as 
compared to the freshwater control (Fig. 54a). A significant increase in the mRNA 
expression level of gpx4 occurred after 3 days of arousal from 6 months of aestivation 
(2.21-fold; P<0.05; Fig. 54b). 
4.3.3.3. Protein abundance of Gpx1 and Gpx4 
The protein abundance of Gpx1 in the muscle of P. annectens increased significantly 
after 3 days of arousal from 6 months of aestivation (3.04-fold; P<0.05), as compared 
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to the freshwater control (Fig. 55). The protein abundance of Gpx4 in the muscle of P. 
annectens increased significantly after 6 months of aestivation (6-fold; P<0.05), as 




Fig. 52. The gene expression of glutathione peroxidase 1 (gpx1) and 4 (gpx4) in 
various tissues/organs of Protopterus annectens. Expression of (a) gpx1 and (b) 
gpx4 were examined in the muscle (M), heart (H), brain (B), eye (E), gills (Gi), 
kidney (K), Lung (Lu), skin (Sk), liver (Li), spleen (Sp), pancreas (P), and gut (Gu) 
of Protopterus annectens (N=1) kept in fresh water. 
 
 100 bp 
ladder 









Fig. 53. mRNA expression levels of glutathione peroxidase 1 (gpx1) in the muscle 
of Protopterus annectens. Absolute quantification (copies of transcript per ng total 
RNA) of gpx1 transcripts in the muscle of P. annectens kept in (a) fresh water on day 
0 (FW; control), after 3 or 6 days (d; the induction phase), or 12 d or 6 months (mon; 
the maintenance phase) of aestivation; (b) fresh water on day 0 (FW; control), after 6 
mon (the maintenance phase) of aestivation, or after 1 d, 3 d or 6 d of arousal (Ar; the 
arousal phase) from 6 mon of aestivation. Results represent means ± S. E. M (N=4). 































































































Fig. 54. mRNA expression levels of glutathione peroxidase 4 (gpx4) in the muscle 
of Protopterus annectens. Absolute quantification (×102 copies of transcript per ng 
total RNA) of gpx4 transcripts in the muscle of P. annectens kept in (a) fresh water 
on day 0 (FW; control), after 3 or 6 days (d; the induction phase), or 12 d or 6 months 
(mon; the maintenance phase) of aestivation; (b) fresh water on day 0 (FW; control), 
after 6 mon (the maintenance phase) of aestivation, or after 1 d, 3 d or 6 d of arousal 
(Ar; the arousal phase) from 6 mon of aestivation. Results represent means ± S. E. M 
































































































Fig. 55. Protein abundance of glutathione peroxidase 1 (Gpx1) in the muscle of 
Protopterus annectens. Protein abundance of Gpx1 in the muscle of P. annectens 
kept in fresh water on day 0 (FW; control), after 6 days (d; induction phase) or 6 
months (mon; maintenance phase) of aestivation in air, or after 1 d or 3 d of arousal 
(Ar; arousal phase) from 6 mon of aestivation in air. (a) An example of immunoblot 
of Gpx1. (b) The protein abundance of Gpx1 expressed as arbitrary densitometric 
units per 200 µg protein. Results represent mean ± S.E.M. (N=3). Means not sharing 
the same letter are significantly different (P<0.05).  
(a) 












































































Fig. 56. Protein abundance of glutathione peroxidase 4 (Gpx4) in the muscle of 
Protopterus annectens. Protein abundance of Gpx4 in the muscle of P. annectens 
kept in fresh water on day 0 (FW; control), after 6 days (d; induction phase) or 6 
months (mon; maintenance phase) of aestivation in air, or after 1 d or 3 d of arousal 
(Ar; arousal phase) from 6 mon of aestivation in air. (a) An example of immunoblot 
of Gpx4. (b) The protein abundance of Gpx4 expressed as arbitrary densitometric 
units per 200 µg protein. Results represent mean ± S.E.M. (N=3). Means not sharing 
the same letter are significantly different (P<0.05).  
(a) 











































































4.3.4. Activities of various enzymes involved in oxidative defense in the muscle of 
P. annectens during three phases of aestivation 
4.3.4.1. Sod 
There were no significant changes in the activities of CuZnSod and total Sod after 6 
days or 6 months of aestivation, or after 3 days of arousal from 6 months of 
aestivation as compared to the control (Table 15). There was a significant increase in 
the activity of MnSod (12.2-fold; P<005) after 3 days of arousal from 6 months of 
aestivation (Table 15). 
4.3.4.2. Cat 
There were no significant changes in Cat activity after 6 days or 6 months of 
aestivation, or after 3 days of arousal from 6 months of aestivation when compared to 
the freshwater control (Table 15). 
4.3.4.3. Gpx 
There were significant increases in the activities of SeGpx (4.08-fold; P<005) and 
total Gpx (8.20-fold; P<0.05) after 6 months of aestivation when compared to the 
control (Table 15). The activities of SeGpx and total Gpx returned to the control 
levels after 3 days of arousal from 6 months of aestivation. 
4.3.4.4. Gr 
There was a significant increase in the activity of Gr after 6 days of aestivation (2.36-
fold; P<0.05), as compared to the control, after which it returned to the control level 
after 6 months of aestivation or after 3 days of arousal from 6 months of aestivation 








Table 15. Specific activities [nmol min-1 mg-1 protein except superoxide dismutase (Sod)] of copper-zinc Sod (CuZnSod; mU mg-1 
protein), manganese Sod (MnSod), total Sod, catalase (Cat), selenium-dependent glutathione peroxidase (SeGpx), total Gpx, 
glutathione reductase (Gr), and glutathione-S-transferase (Gst) from the muscle of Protopterus annectens kept in fresh water on day 0 
(FW; control), after 6 days (d; induction phase) or 6 months (mon; maintenance phase) of aestivation in air, or after 3 d of arousal (Ar; 
arousal phase) from 6 mon of aestivation in air. Results represent mean ± S.E.M. (N=4). Means not sharing the same letter are 





6 d  
(Induction phase) 
6 mon  
(Maintenance phase) 
3 d Ar 
(Arousal phase) 
CuZnSod 24.28 ± 3.58 27.63 ± 4.92 45.85 ± 10.70 27.63 ± 6.66 
MnSod 0.78 ± 0.28a 0.86 ± 0.31a 1.15 ± 0.32a 9.51 ± 1.78b 
Total Sod 25.08 ± 3.40 28.45 ± 4.99 47.00 ± 10.52 37.15 ± 5.85 
Cat 480 ± 69ab 754 ± 122b 268 ± 81a 394 ± 101ab 
SeGpx 2.80 ± 0.53a 6.39 ± 0.36ab 11.4 ± 3.3b 4.00 ± 0.35a 
Total Gpx 1.39 ± 0.30a 0.93 ± 0.43a 11.4 ± 3.8b 1.72 ± 0.59a 
Gr 0.275 ± 0.018a 0.650 ± 0.048b 0.303 ± 0.034a 0.383 ± 0.079a 





There were no significant changes in Gst activity after 6 days or 6 months of 
aestivation, or after 3 days of arousal from 6 months of aestivation when compared to 
the freshwater control (Table 15). 
4.3.5. Total GSHeq, GSH, GSSG and GSSG/GSH in the muscle of P. annectens 
during three phases of aestivation 
The content of total GSHeq in the muscle of P. annectens increased significantly after 
6 months of aestivation (3.86–fold; P<0.05), or after 3 days of arousal from 6 months 
of aestivation (3.11–fold; P<0.05), as compared to the control (Table 16). Likewise, 
there were significant increases in the content of GSH in the muscle of P. annectens 
after 6 months of aestivation (3.71–fold; P<0.05), or after 3 days of arousal from 6 
months of aestivation (3.08–fold; P<0.05), as compared to the freshwater control. 
There were significant increases in the GSSG content in the muscle of P. annectens 
after 6 days (20.0–fold; P<0.05), or 6 months of aestivation (89.0–fold; P<0.05), as 
compared to the freshwater control. The GSSG/GSH ratio increased significantly 
after 6 days (44.0–fold; P<0.05), or 6 months of aestivation (28.6–fold; P<0.05), as 








Table 16. Contents (nmol g-1 wet mass) of total glutathione equivalents (total GSHeq), reduced glutathione (GSH), oxidized 
glutathione (GSSG) and the GSSG/GSH ratio in the muscle of Protopterus annectens kept in fresh water on day 0 (FW; control), after 
6 days (d; induction phase) or 6 months (mon; maintenance phase) of aestivation in air, or after 3 d of arousal (Ar; arousal phase) from 






6 d  
(Induction phase) 
6 mon  
(Maintenance phase)  




8.41 ± 1.90a 5.43 ± 0.25a 32.5 ± 5.1b 26.2 ± 0.4b 
GSH 
 
8.40 ± 1.90a 5.12 ± 0.24a 31.2 ± 4.5b 25.8 ± 0.4b 
GSSG 
 
0.00750 ± 0.00750a 0.150 ± 0.021b 0.668 ± 0.329c 0.155 ± 0.118abc 
GSSG/GSH 
 





4.3.6. Oxidative damage products in the muscle of P. annectens during three 
phases of aestivation 
There were no significant changes in the contents of LOOH and TBARS in the 
muscle of P. annectens during the three phases of aestivation, as compared to the 
freshwater control (Fig. 57). However, there were significant decreases in the content 
of carbonyl proteins in the muscle of P. annectens after 6 months of aestivation (by 
45.1%; P<0.05), or after 3 days of arousal from 6 months of aestivation (by 26.4%; 




Fig. 57. Oxidative damage products in the muscle of Protopterus annectens. 
Contents of lipid hydroperoxides (µmol cumene hydroperoxide equivalents (CHE) g-
1 wet mass; ), thiobarbituric acid reactive substances (TBARS; nmol g-1 wet mass; 
) and carbonyl proteins (µmol g-1 wet mass; ) in the muscle of P. annectens kept 
in fresh water on day 0 (FW; control), after 6 days (d; induction phase) or 6 months 
(mon; maintenance phase) of aestivation in air, or after 3 d of arousal (Ar; arousal 
phase) from 6 mon of aestivation in air. Results represent mean ± S.E.M. (N=4). 
Means not sharing the same letter (a, b, c for TBARS and x, y, z for carbonyl proteins) 











































































5.1. Molecular characterization of various genes/proteins involved in muscle 
formation and degradation from P. annectens 
5.1.1. Molecular characterization of proteins involved in muscle formation 
5.1.1.1. Ppargc-1α  
The N terminus of Ppargc-1α containing the ADs and the LXXLL motif is well 
conserved in the Ppargc-1α of P. annectens. The ADs are crucial to to PPARGC-1α 
transcriptional activity (Sadana and Park, 2007), and facilitate the transcriptional 
activation of target genes by recruiting histone remodeling proteins upon interaction 
with DNA-bound proteins (Puigserver et al., 1999, 2003). The deletion of AD1 and 
AD2 results in a decrease in the induction of various PPARGC-1α-regulated genes 
such as phosphoenolpyruvate carboxykinase and carnitine palmitoyltransferase-I, but 
does not affect the recruitment of PPARGC-1α to its target genes (Sadana and Park, 
2007). The negatively-charged amino acids and leucine residues are important for the 
transcriptional induction of the target genes of PPARGC-1α (Sadana and Park, 2007). 
The LXXLL motif, essential for the interactions with members of the nuclear 
hormone receptor superfamily (Vega et al., 2000; Wu et al., 2002a; Oberkofler et al., 
2003), mediates essential interactions of PPARGC-1α with nuclear receptors (Heery 
et al., 1997; Puigserver et al., 1998). Although this motif is found in the N terminus, it 
does not play a role in the transcriptional activation function of PPARGC-1α 
(Puigserver et al., 1999; Zhang et al., 2004), which has been attributed to the N 
terminus (Huss et al., 2002).  
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The PPAR-γ binding domain is relatively well-conserved in the Ppargc-1α of 
P. annectens and across species (LeMoine et al., 2010), indicating similar binding 
capacities. The PPAR-γ binding domain mediates ligand-independent interactions 
with nuclear receptors during brown fat differentiation (Puigserver et al., 1998).  
p38-MAPK and AMPK phosphorylation regulates PPARGC-1α activity. p38 
stress-activated MAPK phosphorylation of PPARGC-1α not only results in increased 
stability and half-life (Puigserver et al., 2001), but also enhances the transcription of 
PPARGC-1α (Knutti et al., 2001). The three p38-MAPK phosphorylation sites are in 
a region previously demonstrated to play a key regulatory role in PPARGC-1α 
binding to transcription factors (Puigserver et al., 1999). As these sites are conserved 
in the Ppargc-1α of P. annectens, it can be deduced that p38-Mapk regulates Ppargc-
1α via phosphorylation at these sites. In murine muscle cells, AMPK phosphorylation 
of PPARGC-1α promotes mitochondrial biogenesis (Jäger et al., 2007). Mutations of 
both regulatory sites abolish PPARGC-1α coactivating activity on its own promoter 
(Jäger et al., 2007). The presence of two conserved sites in the PPARGC-1α/ Ppargc-
1α of tetrapods but only one conserved site (T179) in the Ppargc-1α of other species, 
including that of P. annectens, suggests that there may be potential differences in the 
responsiveness of PPARGC-1α to AMPK in these species (LeMoine et al., 2010). 
This might have critical consequences on the role of PPARGC-1α/Ppargc-1α in 
metabolic pathways mediated by AMPK, as observed in the absence of Ppargc-1α 
induction in zebrafish subjected to endurance training (McClelland et al., 2006). 
The C terminus of PPARGC-1α contains RNA-binding domains which are 
actively involved in mRNA processing and elongation (Puigserver et al., 1998, 2003; 
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Rodgers et al., 2005). Proteins containing paired RNA-binding domains and SR-rich 
domains can interact with the C-terminal domain of RNA polymerase II, and this 
indicates a putative link between transcription and RNA processing (Yuryev et al., 
1996). It has been shown that PPARGC-1α forms a complex with the phosphorylated 
form of RNA polymerase II and other factors involved in elongation which includes 
cyclin-dependent kinase 9 and cyclin T, indicating that the RNA-binding domain and 
SR-rich domain in the C terminus of PPARGC-1α are responsible for maintaining 
these interactions (Monsalve et al., 2000). As the Ppargc-1α of P. annectens 
comprises conserved RNA-binding domain and SR-rich domains, it is likely to 
interact with RNA polymerase II in a similar manner.  
5.1.1.2. Myod1 
The Myod1 of P. annectens consists of three conserved motifs – bHLH, MRM and 
LXXLL. The bHLH motif serves as an interface for dimerization of Myod1, which 
brings the basic regions of Myod1 together, forming a bipartite DNA-binding domain 
that recognizes the E-box sequence CANNTG, which activates muscle transcription 
(Davis et al., 1990; Brennan et al., 1991; Edmondson et al., 1992). The MRM within 
the bHLH region confers both myogenic potential and susceptibility to inhibition 
induced by TGF-β (Martin et al., 1992). Although the MRM is crucial for the 
activation of muscle-specific transcription, it is not necessary for DNA binding 
(Davis et al., 1990; Brennan et al., 1991; Weintraub et al., 1991). The core LXXLL 
motif sequence in the Myod1 of P. annectens allows it to bind to Fbxo32. Fbxo32 
associates with Myod1 via an inverted LXXLL motif located in a series of helical 
leucine-charged residue-rich domains (Tintignac et al., 2005). A mutation (L164Q) in 
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the LXXLL motif can repress Myod1 ubiquitination and degradation induced by 
Fbxo32 (Tintignac et al, 2005).  
5.1.1.3. Myog 
The conserved bHLH domain in the Myog of P. annectens allows for ubiquitous 
bHLH protein binding, which forms complexes that bind to the DNA sequence E-box 
and activate muscle-specific transcription (Davis et al., 1990; Brennan et al., 1991; 
Edmondson et al., 1992). The Myog of P. annectens consists of a sub-domain of 12 
amino acids (positions 103–114 in reference to Fig. 11) of the basic region 
(RRRAATLREKRR) necessary for DNA binding and heterodimerization with the 
bHLH protein E12 (Codina et al., 2008). The alanine-threonine dipeptide containing 
A107 and T108 is necessary in conferring muscle specificity to the basic domain 
(Brennan et al., 1991; Davis and Weintraub, 1992; Heidt et al., 2007). The alanine-
threonine dipeptide, histidine/cysteine rich domain and helix III domain are the 
functional domains responsible for transcriptional activation, chromatin remodeling, 
nuclear localization and heterodimerization in myogenic regulatory factors, which 
includes MYOG (Vandromme et al., 1995; Gerber et al., 1997; Delgado-Olguín et al., 
2011; Izzi et al. 2013). The conservation of the bHLH, alanine-threonine dipeptide, 
histidine/cysteine-rich and helix III domains indicates a high evolutionary constraint 
and the importance of the function of MYOG/Myog in vertebrates (Rescan, 2001; 
Berghella et al., 2008). 
5.1.1.4. Mapk 
The Mapk1 and Mapk3 of P. annectens consist of the signature TXY motif in the 
activation loop which comprises the regulatory residues T221 and Y223 (reference in 
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accordance to the ruler in Fig. 16). Human MAPK activity is tightly controlled by the 
dual phosphorylation of T183 and Y185 (corresponding to T221 and Y223 according 
to the ruler in Fig. 16), which leads to over 1000-fold activation of MAPK1 and 
MAPK3 (Ahn et al., 1991; Payne et al., 1991; Robbins and Cobb, 1992; Robbins et 
al., 1993). Both covalently bound phosphates are essential in maintaining high 
activity (Seger et al., 1992; Robbins et al., 1993). It has been reported that the 
replacement of T183 with alanine or Y185 with phenylalanine abolishes MAPK 
activity (Robbins et al., 1993). Mutating the phosphorylated residues to glutamate, 
however, does not yield a constitutively active MAPK, which is the case for some 
protein kinases (Mansour et al., 1994). Robbins et al. (1993) and Zhang et al. (1994) 
demonstrated that once tyrosine was phosphorylated in the mutant MAPK1/T183E, 
the mutated enzyme had 10% of the activity of the wild type MAPK, indicating that 
glutamate could mimic phosphothreonine but not phosphotyrosine (Canagarajah et al., 
1997). 
Nuclear localization of proteins is primarily mediated by a NLS present 
within the sequence of these nuclear proteins (Schlenstedt, 1996). Importins, which 
are special carrier proteins, facilitate protein transport across the nuclear pore 
complexes (NPC; Tran and Wente, 2006). However, not all cytonuclear shuttling 
proteins contain the NLS; some nuclear proteins use NLS-independent mechanisms 
for their passage through the NPC. One such mechanism is the presence of a NTS in 
the sequence of cytonuclear shuttling proteins, which have been identified in human 
MAPK1 (Chuderland et al., 2008), which lacks a canonical NLS. A mutation or 
deletion of three residues (SPS) in the NTS results in cytoplasmic retention of the 
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mutants (Chuderland et al., 2008). The NTS is phosphorylated upon stimulation and 
induces nuclear translocation of MAPK1 (Chuderland et al., 2008). The 
phosphorylated SPS domain acts by binding to importin7 and MAPK1 is released 
from nuclear pore proteins, consequently facilitating the nuclear translocation of 
MAPKs (Chuderland et al., 2008). Since the SPS domain is present in both Mapk1 
and Mapk3 of P. annectens, it can be deduced that both Mapks of P. annectens are 
localized to the nucleus via the SPS domain.  
The Mapk1 and Mapk3 of P. annectens consist of the CRS/CD motif outside 
the catalytic region, which comprises hydrophobic and negatively-charged residues 
essential in establishing hydrophobic and electrostatic interactions with the 
hydrophobic and positively charged residues of D domains, respectively (Tanoue et 
al., 2000; Enslen and Davis, 2001). D domains are one of the two docking motifs 
involved in MAPK interactions with their substrates, activators and inactivating 
phosphatases (see Tanoue and Nishida, 2003 for review). A replacement of the 
negatively charged amino acids with neutral ones disrupts the docking interactions 
(Tanuoe et al., 2000). As the docking interactions of MAPKs with their substrates, 
activators and phosphatases are mutually exclusive, the docking interactions through 
the CRS/CD domain can regulate the signal transduction of the MAPK cascade 
(Tanoue and Nishida, 2003).  
5.1.2. Molecular characterization of proteins involved in muscle degradation 
5.1.2.1. Hdac1 
The Hdac1 of P. annectens has highly conserved domains–(1) the HAD necessary for 
HDAC1 homodimerisation, enzymatic activity and association with HDAC2 and 
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other proteins (Taplick et al., 2001; Luo et al., 2009); (2) the zinc-binding catalytic 
domain which contains several conserved histidine and aspartate residues and forms 
the active site pocket of HDAC1 (Finnin et al., 1999; Taplick et al., 2001; 
Marmorstein, 2001); (3) a lysine-rich C terminus containing the NLS (Taplick et al., 
2001); and (4) three leucine-rich NES motifs (Kim et al., 2010). Deletion/mutation 
experiments have demonstrated that the N terminus HAD is essential for HDAC1 
homodimerisation and enzyme activity (Taplick et al., 2001). A mutant HDAC1 
without the NLS motif can be translocated to the nucleus by associating with an intact 
HDAC1 protein (Taplick et al., 2001). A structural study by Finnin et al. (1999) has 
revealed the conserved residues which make up the active site, and these residues are 
also conserved in the Hdac1 of P. annectens. The active site consists of a tubular 
pocket, a zinc-binding site and two aspartate-histidine charge-relay systems (Finnin et 
al., 1999). A site-directed mutagenesis of the histidine and aspartate residues in the 
charge-relay system abolishes the deacetylase activity (Hassig et al., 1998; Kadosh 
and Struhl, 1998). The deacetylase activity is manifested only after incubation with 
zinc chloride in vitro (Finnin et al., 1999), which is consistent with the proposition 
that HDAC1 activity required a metal cofactor (Hassig et al., 1998). The conservation 
of the core residues in the HAD and the active site pocket in the Hdac1 of P. 
annectens indicates it possesses deacetylase activity. 
It has been established that the C terminus of Xenopus Hdac1 is essential for 
the nuclear location of HDAC1 (Ryan et al., 1999; Vermaak et al., 1999). Indeed, the 
deletion of the C terminus of mouse HDAC1 results in the cytoplasmic retention of 
the mutant (Taplick et al., 2001). The C terminus, which is rich in charged amino 
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acids, is essential for the nuclear localization of HDAC1 in the absence of the HAD 
(Taplick et al., 2001). The NLS of mouse HDAC1 shares high similarity with the c-
myc NLS (Dang and Lee, 1988) and is responsible for the transporting of GFP into 
the nucleus (Taplick et al., 2001). HDAC1 can also be exported out of the nucleus 
(Kim et al., 2010). A mutation of the NES in HDAC1 interferes with the formation of 
a complex with chromosome region maintenance 1 (CRM1), and prevents the nuclear 
export of the mutant HDAC1 (Kim et al., 2010). As the mouse HDAC1 NLS motif is 
identical to the NLS of human HDAC1 and similar to the predicted NLS in P. 
annectens Hdac1, it can be deduced that the Hdac1 of P. annectens is localized to the 
nucleus. Furthermore, the presence of conserved NES motifs in the Hdac1 of P. 
annectens, which is similar to the NES originally described in viral proteins (Wen et 
al., 1995), indicates that it can be exported out of the nucleus by forming a complex 
with CRM1. 
The HDAC1 protein is a target for a number of post-translational 
modifications such as phosphorylation and acetylation (Pflum et al., 2001; Qiu et al., 
2006). CSNK2, the main kinase responsible for HDAC1 phosphorylation (Cai et al., 
2001; Sun et al., 2007), phosphorylates S421 and S423 of HDAC1 (corresponding to 
S422 and S424 according to the ruler in Fig. 23), which are conserved in the Hdac1 
of P. annectens. This indicated that the Hdac1 of P. annectens can be phosphorylated 
through these two serine residues by CSNK2. Mutations in these two serine residues 
lead to reduced deacetylase and transcriptional repression activities, as well as 
weakened interaction with RbAP48, Sin3a, CoREST and MTA-2 (Pflum et al., 2001). 
CSNK2-dependent phosphorylation of HDAC1 is constitutive throughout the cell 
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cycle, althought it is dispensable for the intrinsic HDAC1 activity in vitro (Cai et al., 
2001; Karwowska-Desaulniers et al., 2007). An increase in CSNK2-dependent 
phosphorylation of HDAC1 in response to hypoxic conditions is correlated with 
increased HDAC enzymatic activity (Pluemsampant et al., 2008), suggesting that 
phosphorylation is an essential signaling factor of various pathways which converge 
on HDAC1 to deliver the appropriate biological responses. 
An acetylation of HDAC1 leads to a dramatic reduction in its enzymatic and 
repression activities both in vivo and in vitro (Qiu et al., 2006). Six lysine residues 
can undergo acetylation in HDAC1 (Qiu et al., 2006). All these lysine residues, 
except K433 which is replaced with arginine, are conserved in the Hdac1 of P. 
annectens. It has been established that K433 is the key residue for HDAC1 
acetylation (Qiu et al., 2006; Luo et al., 2009). A similar phenomenon can be 
observed in HDAC2, but HDAC2 is not acetylated in vitro by p300 although all other 
lysine residues were conserved in HDAC2 (Luo et al., 2009). A mutation of R433 to 
lysine leads to the acetylation of HDAC2 by p300 in vitro, though to a lesser extent 
compared to HDAC1 (Luo et al., 2009). This suggests that the Hdac1 of P. annectens 
could be refractory to acetylation by p300, and might undergo acetylation by other 
acetyltransferases such as CBP and histone acetyltransferases instead.  
5.1.2.2. FoxO 
The nuclear-cytoplasmic shuttling of FOXO proteins is regulated by phosphorylation, 
which disrupts FOXO transcriptional activities and promotes FOXO protein 
degradation. FOXO proteins undergo phosphorylation by several kinases–AKT (also 
referred to as protein kinase B), SGK, CSNK1 and DYRK1A. Both AKT and SGK 
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are known to target the same substrate motifs (Brunet et al., 1999, 2001), but it is 
unclear if one can substitute for the other in FOXO regulation. Although both AKT 
and SGK phosphorylation of FOXO lead to the cytoplasmic localization and 
inhibition, AKT preferentially phosphorylates S256 (corresponding to S266 in Fig. 28) 
while SGK prefers S319 (corresponding to S333 in Fig. 28) (Brunet et al., 2001). 
Upon phosphorylation by AKT or SGK, FOXO3 binds to 14-3-3 proteins and 
remains in the cytoplasm, thus abolishing its function as a transcription factor (Brunet 
et al., 1999, 2001). The majority of the 14-3-3 proteins are localized to the cytoplasm, 
but they bind to FOXO proteins in the nucleus (Brunet et al., 2002) before being 
exported into the cytoplasm. 14-3-3 mediates the masking of the NLS in FOXO 
proteins, preventing the re-entry of FOXO into the nucleus (Brunet et al., 2002; Zhao 
et al., 2004). Moreover, the phosphorylation of FOXO at S256 introduces a negative 
charge in the basic NLS, contributing to the cytoplasmic retention of FOXO (Rena et 
al., 2001). As all three phosphorylation sites are conserved in both FoxO proteins of 
P. annectens, it is probable that P. annectens FoxO1 and FoxO3 can be 
phosphorylated by Akt and Sgk, and similarly exported to the cytoplasm by binding 
to 14-3-3 proteins.  
The phosphorylation of FOXO1 by AKT at site 319 (corresponding to S333 in 
Fig. 28) creates a consensus sequence for the binding with CSNK1, which 
subsequently leads to the phosphorylation of S322 and S325 (corresponding to S336 
and S339 in Fig. 28) and potentiates the export of FOXO1 to the cytoplasm (Rena et 
al., 2002, 2004). Phosphorylation of sites S322 and S325 would enhance the 
formation of FOXO1 with the export machinery (Ran and Exportin/Crm1) to promote 
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nuclear export (Rena et al., 2002; Zhao et al., 2004). Since both S336 and S339 are 
conserved in the FoxO3 of P. annectens, it is highly likely that FoxO3 of P. 
annectens can be phosphorylated by CSNK1. By contrast, only S336 is conserved in 
the FoxO1 of P. annectens. Hence either the FoxO1 of P. annectens is 
phosphorylated by CSNK1 at only one site, or there is another phosphorylation site 
targeted by CSNK1 yet to be identified. 
FOXO consists of a site (S329) which can be phosphorylated by DYRK1A; 
this is independent of AKT or CSNK1 activity and is unaffected by growth signals 
(Woods et al., 2001). This site is conserved in both FoxO proteins of P. annectens. A 
mutation of this serine residue (S329, corresponding to S343 in Fig. 28) to alanine 
results in the retention of FoxO1 in the nucleus (Woods et al., 2001). The 
phosphorylation of several serine residues near S329, together with S329, stabilizes 
the interaction with the nuclear export protein Ran, thereby promoting nuclear export 
of FoxO1 (Rena et al., 2002). 
FOXO activity is also modulated by acetylation, and all known acetylation 
sites are conserved in both FoxO1 and FoxO3 of P. annectens. However, the effect of 
acetylation on FOXO activity is still unclear. Acetylation was reported to enhance 
FOXO activity (Brunet et al., 2004; Motta et al., 2004), while other studies 
demonstrated impaired FOXO activity upon acetylation (Brunet et al., 2004; Motta et 
al., 2004; Daitoku et al., 2004; van der Horst et al., 2004). Although acetylation of 
FOXO is generally thought to be inhibitory, the recruitment of CBP/p300 to promoter 
regions by FOXO proteins induces histone acetylation, acting as a positive signal for 
transcription initiation (Daitoku et al., 2004). Transient transfection experiments 
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reveal that p300 potently stimulates FOXO1-induced transcription of IGF-binding 
protein-1 (Perrot and Rechler, 2005). Yet, an acetylation of FOXO, mediated by 
CBP/p300 (Brunet et al., 2004; Daitoku et al., 2004; van der Heide and Smidt, 2005; 
Wang et al., 2012), was demonstrated to reduce DNA binding and to increase its 
sensitivity to phosphorylation by AKT which provides negative regulation 
(Matsuzaki et al., 2005). CBP/p300 does not only serves as an essential cofactor 
(Nasrin et al., 2000; Kwon et al., 2004) in FOXO-mediated transcriptional activity, 
but also inhibits FOXO activity by acetylation (van der Heide and Smidt, 2005; Wang 
et al., 2012). FOXO acetylation also inhibits ubiquitination, and as both 
ubiquitination and acetylation occur on lysine residues, these two post-translational 
modifications can be inversely correlated as they compete for the same lysine 
residues (Daitoku et al., 2011). 
One of the growth factor-controlled inhibitory pathways involves the 
phosphorylation of FOXO3 by MAPK1/3, which results in MDM2-mediated 
ubiquitination and FOXO3 protein degradation (Yang et al., 2008a, b). The mutation 
of the three serine residues to alanine leads to decreased phosphorylation by MAPK 
and increased resistance to degradation by MDM2 (Yang et al., 2008a, b). For the 
FoxO3 of P. annectens, one of the serine residues in the phosphorylation cluster 
S295/345/426 (corresponding to S311/364/455 in Fig. 28) is replaced with proline. 
However, a serine residue is present next to this particular proline residue, which 
corresponded to the MAPK phosphorylation consensus motif of serine/threonine-
proline (Davis, 1993; Songyang et al., 1996), in the FoxO3 of P. annectens. This 
motif is present in all three phosphorylation sites. Hence, it is probable that S454 
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(according to the ruler in Fig. 28) is one of the three targets of MAPK1/3 (together 
with the other two serine residues) in the FoxO3 of P. annectens. 
AMPK phosphorylates nuclear FOXO3 in response to nutrient deprivation, 
increasing the transcriptional activity of FOXO3 and possibly modulating differential 
promoter recognition without affecting localization (Greer et al., 2007). Greer et al. 
(2007) has identified at least six regulatory phosphorylation sites that are targeted by 
AMPK, where four of these are conserved in the FoxO3 of P. annectens. The other 
two sites are substituted with asparagine, which is not a known target for 
phosphorylation. Mutation of these six sites to alanine leads to an 84% reduction in 
phosphorylation in the mutant as compared with the wildtype FOXO3 (Greer et al., 
2007). S413 (corresponding to S443 in Fig. 28) is a key residue in activating the 
transcriptional activity of FOXO3 upon phosphorylation by AMPK (Greer et al., 
2007). The replacement of this key residue and another serine residue by asparagine 
in the FoxO3 of P. annectens indicates that AMPK phosphorylation may occur at 
some other serine/threonine residues. Indeed, it has been reported that there are other 
phosphorylation sites, especially at the C terminus, in FOXO3, as the 6A mutant can 
still be phosphorylated to some extent by AMPK (Greer et al., 2007). Although the 
exact mechanism of FOXO3 transcriptional activation by AMPK remains uncertain, 
AMPK phosphorylation of FOXO3 can increase the interaction with CBP/p300, 
which affects FOXO3 activity and promoter recognition through acetylation (Wang et 
al., 2012). AMPK phosphorylation of FOXO has been associated with neuronal cell 
death (Davila et al., 2012), FOXO-induced autophagy (Chiacchiera and Simone, 2009) 




The Mstn of P. annectens consists of a signal peptide for secretion, a propeptide 
domain, a furin cleavage site (RSRR) and a bioactive domain consisting of nine 
cysteine residues which are characteristic of vertebrate MSTN/Mstn and inhibins 
(McPherron et al., 1997; see review by Lee, 2004 and Joulia-Ekaza and Cabello 
2006). The proteolytic furin cleavage site serves to release the processed mature 
peptide. The cysteine residues in the bioactive domain are essential for the 
dimerization of the two MSTN subunits (Hu et al., 1998; Daopin et al., 1992). The 
conservation of the above mentioned sites across various animal species including P. 
annectens indicated a conservation of function in the Mstn of P. annectens. 
5.1.2.4. Fbxo32 
Fbxo32 from P. annectens has a F-box functional domain. F-box proteins usually 
contain a carboxy-terminal substrate-recognition domain, which allows F-box 
proteins to be further classified into one of three families (Jin et al., 2004). F-box 
proteins that contain Trp-Asp repeats belong to the FBW family, while F-box 
proteins containing leucine-rich repeats belong to the FBL family. Both families 
recognize phosphorylated protein substrates (Smith et al., 1999; Kobe and Kajava, 
2001; Enkhbayar et al., 2004). F-box proteins in the FBX family lack specific binding 
domains and contain various other protein-protein interaction domains at the 
carboxyl-terminus, like zinc-finger, carbohydrate interacting (CASH) or proline-rich 
domains (Kipreos and Pagano, 2000; Cardozo and Pagano, 2004; Jin et al., 2004). 
Since the Fbxo32 of P. annectens lacks specific protein recognition domains, it 
belongs to the FBX family of F-box proteins (Jin et al., 2004). Although there are no 
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specific protein recognition domains, several protein substrates which undergo 
ubiquitination by FBXO32 have been identified, such as MyoD (Tintignac et al., 
2005) and the subunit eIF3-f of the eukaryotic initiation factor eIF3 complex 
(Lagirand-Cantaloube et al., 2008; Csibi et al., 2009) in the skeletal muscle. 
The Fbxo32 of P. annectens also consists of a putative bipartite NLS and a 
SV40-type monopartite NLS which are well conserved, and is a strong indication that 
the Fbxo32 of P. annectens is localized to the nucleus. Other mammalian (Gomes et 
al., 2001) FBXO32 and fish (Bower et al., 2010) Fbxo32 also contain NLS. 
The Fbxo32 of P. annectens has a conserved LCD with an inverted LXXLL 
motif. The inverted LXXLL motif mediates direct binding to a LXXLL motif found 
in Myod family members (Tintignac et al., 2005), which results in the FBXO32-
induced ubiquitination and degradation of Myod1. 
5.2. Dendrogramic analyses of various proteins involved in muscle formation 
and degradation from P. annectens 
Lungfishes share similarities with both amphibians and fishes, and are important 
animals for studies on the transition between fishes and tetrapods. Lungfishes are 
considered by many evolutionists as a sister group of amphibians (Forey, 1986), and 
many molecular phylogenetic studies support this view, favouring lungfishes as the 
closest living relatives of tetrapods (Zardoya et al., 1998; Tohyama et al., 2000; 
Takezaki et al., 2004; Hallstrom and Janke, 2009; Amemiya et al., 2013). Indeed, the 
various putative proteins involved in muscle formation and degradation in P. 
annectens were phylogenetically closer to tetrapods than to fishes. This supports the 
notion that lungfish is the intermediary form between fishes and tetrapods. As the 
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closest living sister group of land vertebrates, lungfishes would logically have some 
genes/proteins which are closer to those of other fishes such as carbamoyl phosphate 
synthetase III (Loong et al., 2012a) and argininosuccinate synthase (Chng et al., 
2014), and other genes/proteins which share greater similarity with those of tetrapods, 
like argininosuccinate lyase (Chng et al., 2014), Na+/K+-ATPase α-subunit isoforms 
(Hiong et al., 2013), ʟ-gulono-γ-lactone oxidase (Ching et al., 2014), betaine-
homocysteine S-methyltransferase 1 (Ong et al., 2015) and coagulation factor 2 and 
fibrinogen gamma chain (Hiong et al., 2015a). 
In this study, proteins involved in muscle formation in P. annectens were 
phylogenetically closer to tetrapods than to teleosts. Various domains of Ppargc-1α 
exhibited asymmetric evolutionary dynamics (LeMoine et al., 2010). Evolution of the 
middle domains was significantly faster in teleosts than in tetrapods as compared to 
the domains at each end, and was suggested to be due to divergent evolutionary 
pressures over these domains (LeMoine et al., 2010). Most fish Ppargc-1α have 
serine-rich insertions and a glutamine-rich insertion of variable length in the middle 
region (LeMoine et al., 2010), which are absent in lungfish and tetrapods. This 
supports the notion that the Ppargc-1α of P. annectens is phylogenetically closer to 
those of tetrapods than to those of fish. This holds true for both muscle regulatory 
factors, Myod1 and Myog, of P. annectens. Results from this study corroborate 
previous phylogenetic analyses (Macqueen and Johnston, 2006, 2008; Zhu et al., 
2014), where fish Myod1 and Myog is separated from tetrapod MYOD1/Myod1 and 
MYOG/Myog respectively. Besides, no other isoforms of Myod1 or Myog were 
found in the muscle of P. annectens, which is similar to mammals but not fishes. 
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Multiple paralogs of Myod1 were reported in Oncorhynchus mykiss (Delalande and 
Rescan, 1999) and Salmo salar (Bower and Johnston, 2010). The same phenomenon 
was also observed for P. annectens Mapk1 and Mapk3, and corroborates previous 
phylogenetic analyses, where the teleost subgroups are isolated from tetrapods for 
each MAPK isoform (Krens et al., 2006; Li et al., 2011). 
Similarly, proteins involved in muscle degradation in P. annectens were also 
phylogenetically closer to tetrapods than to teleosts. Phylogenetic analysis 
demonstrates that the evolution of HDACs preceded the evolution of histones, 
suggesting that the primary targets of HDACs may not be histones (Gregoretti et al., 
2004). Currently, more than 50 non-histone proteins have been identified as targets of 
HDACs (Dokmanovic and Marks, 2005; Rosato and Grant, 2005; Minucci and 
Pelicci, 2006; Marks and Breslow, 2007; Xu et al., 2007), and they encompass 
proteins which play regulatory roles in cell proliferation, cell migration and cell death. 
The various classes of HDACs are conserved across divergent organisms, and are 
more closely related to their own class than to any other class of HDACs (Gregoretti 
et al., 2004). Previous phylogenetic studies of HDACs have focused on the 
classification and function instead of the evolution of individual HDACs (Gregoretti 
et al., 2004; Bradner et al., 2010). This is the first study that gives an indication of the 
evolution of HDAC1 across vertebrates, and demonstrates that P. annectens Hdac1 is 
phylogenetically closer to tetrapods than to teleosts. This also holds true for Mstn and 
Fbxo32 of P. annectens. There is evidence demonstrating that the evolution of fish 
mstn has been subjected to different duplication events (Kerr et al., 2005). Results 
from this study on P. annectens corroborate previous reports where tetrapod 
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MSTN/Mstn is separated from fish mstn (Kerr et al., 2005; Rodgers and Garikipati, 
2008). Unlike mammalian MSTN, there are two copies of fish mstn (mstn1 and 
mstn2). This is due to an early genome duplication event before the teleost radiation 
but after the divergence of ray- and lobe-finned fishes (Amores et al., 1998; 
Postlethwait et al., 1998). Although efforts were made to find mstn isoforms in the 
muscle of P. annectens, only 1 isoform was found, indicating that P. annectens mstn 
may not have undergone duplication, as in the case of tetrapods MSTN. Previous 
studies demonstrate that teleost Fbxo32 is separated from tetrapod FBXO32 
(Cleveland and Evenhuis, 2010; Tacchi et al., 2010), and this is consistent with 
results from this study, further supporting the notion that the lungfish is the 
intermediary form between teleosts and tetrapods.  
5.3. Ongoing transcription and translation of certain genes and proteins in P. 
annectens during aestivation 
From the physiological point of view, aestivation is usually associated with metabolic 
depression, as metabolic fuel conservation is essential during long periods of torpor 
without food intake (Storey, 2002). Strong global suppression of gene expression and 
protein synthesis are integral parts of hypometabolism because transcription and 
translation are energy-intensive processes (Storey and Storey, 2010). However, it 
cannot be assumed that all protein syntheses are suppressed in every organ during the 
prolonged maintenance phase of aestivation. Certain genes or proteins are expected to 
be upregulated to overcome the various challenges associated with aestivation. 
Indeed, many more genes were upregulated than down-regulated in the brain of P. 
annectens during the induction and maintenance phases of aestivation, although one 
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would expect exactly the opposite during metabolic depression (Hiong et al., 2013). 
Although more genes related to protein synthesis were down-regulated than up-
regulated in the liver of P. annectens during the maintenance phase of aestivation, 
this indicates that there is no complete suppression of the capacity of protein 
synthesis (Hiong et al., 2015b). Likewise, the mRNA expression levels of carbamoyl 
phosphate synthase III (Loong et al., 2012b), argininosuccinate synthetase and 
argininosuccinate lyase (Chng et al., 2014) increase in the liver of P. annectens 
during aestivation. Similarly, up- and down-regulation of the mRNA expression 
levels and/or protein abundance of Na+/K+-ATPase alpha-subunit isoforms (Hiong et 
al., 2013), ʟ-gulono-γ-lactone oxidase (Ching et al., 2014), betaine-homocysteine 
methyltransferase 1 (Ong et al., 2015), coagulation factor II, fibrinogen gamma chain 
(Hiong et al., 2015a), heat shock protein 90, phospho-Akt, protein kinase B, nitric 
oxide synthase and hypoxia inducible factor 1α (Garofalo et al., 2015) have been 
observed in various organs/tissues of P. annectens during the three phases of 
aestivation. Results from this study demonstrated up- and down-regulation in the 
mRNA expression levels and/or protein abundance of various genes/proteins 
involved in muscle formation, muscle degradation and oxidative defense in the 
muscle of P. annectens during the three phases of aestivation. Thus, despite a general 
decrease in protein synthesis, there could be increases in syntheses of certain proteins 
in specific organs of P. annectens during aestivation as mentioned by Ip and Chew 
(2010).  
The cellular machinery is responsible for directing gene and protein 
expression programs, and encompasses a diverse array of noncoding RNAs and 
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proteins whose complex interplay drives gene expression, handling of mRNA 
transcripts, protein synthesis, and post-translational processing to produce the final 
functional protein and deposit it in the correct subcellular destination (Tessier and 
Storey, 2014). Specifically, gene expression is regulated by epigenetic factors, signal 
transduction pathways, transcription factors and other components of the 
transcriptional apparatus, mRNA processing factors, components of the translational 
machinery, and the subcellular distribution of each of these factors (Tessier and 
Storey, 2014). The production and maintenance of protein are established by a 
dynamic balance of regulation of linked processes, which range from mRNA 
transcription, processing and degradation to protein translation, localization, 
modification and programmed destruction (Vogel and Marcotte, 2012). mRNA 
expression levels have been commonly used as proxies for the abundances and 
activities of the corresponding proteins, with the assumption that transcript 
abundances are the main determinant of protein abundances (Vogel and Marcotte, 
2012). Although cellular protein concentrations correlate with the abundance of their 
corresponding mRNAs in both bacteria and eukaryotes, the correlation is not strong; 
they usually show a squared Pearson correlation coefficient of ~0.40, indicating that 
~40% of the variation in protein abundance can be explained by knowing mRNA 
expression levels (de Sousa Abreu et al., 2009; Maier et al., 2009). The remaining 
~60% of the variation can be accounted for by a combination of post-transcriptional 
regulation and measurement noise (de Sousa Abreu et al., 2009; Maier et al., 2009; 
Csárdi et al., 2015). It is therefore unsurprising that the changes in the mRNA 
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expression levels may not correlate with the changes in the corresponding protein 
abundances in the muscle of P. annectens during the three phases of aestivation. 
Compared to aestivation, hibernation is described as a reversible state of 
suspended animation utilized as a survival strategy to survive long periods of winter 
with limited food (Wang and Lee, 1996). Hibernators display regulatory mechanisms 
which allow for a global reduction of transcription (Morin and Storey, 2006) and 
translation (Frerichs et al., 1998) during hibernation, but a small subset of stress-
responsive pathways are activated to overcome the stresses associated with 
hibernation (Hittel and Storey, 2001; Eddy et al., 2005b, Yan et al., 2008). Moreover, 
it has been demonstrated that the total pool of mRNA remains stable (Frerichs et al., 
1998), and that there are discrepancies between mRNA and protein expression 
profiles (Shao et al., 2010). These studies indicate that mRNA substrate availability 
alone neither provides a full understanding of the differential regulation of the 
hibernator proteome nor explains the inhibition of protein synthesis (Tessier and 
Storey, 2014). There are three regulatory mechanisms proposed, which are involved 
in the control of gene/protein expression and allow the hibernating cell to survive the 
stresses associated with cycles of torpor-arousal such as hypothermia and ischemia-
reperfusion (Tessier and Storey, 2014). The first regulatory mechanism involves 
mRNA processing factors and other interacting proteins, which could protect and 
stabilize mRNA pools, and control the translation rate during torpor and arousal of 
hibernation (Tessier and Storey, 2014). Next, as a complementary mechanism to 
attain global reductions in translation, the regulation of initiation and elongation 
translation factors could be utilized to promote the preferential synthesis of essential 
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proteins and facilitate the evasion of cap-dependent inhibition (Tessier and Storey, 
2014). Lastly, there could be a strict regulation of the subcellular organization and 
distribution of mRNA factors in intracellular compartments such as the nucleus and 
cytoplasm, allowing various components to differentially associate with cellular 
structures in aspects which regulate their activity, availability and net cellular 
response during hibernation (Tessier and Storey, 2014). It is interesting to note that 
the myocytes in the trabeculae associated with the free ventricular wall of P. dolloi 
demonstrated structural signs of low transcriptional and metabolic activity 
(heterochromatin, mitochondria of the dense type) in freshwater fish (Icardo et al., 
2008). However, there was a partial reversal of these signs in aestivating lungfish 
(euchromatin, mitochondria with a light matrix), suggesting that aestivation triggered 
an increase in transcriptional and synthetic myocardial activities, particularly at the 
level of the ventricular septum (Icardo et al., 2008). Moreover, there were signs of 
hemodynamic remodeling in the heart of P. annectens during aestivation, as observed 
from the increases in endothelial-like nitric oxide synthase and heat-shock protein 90 
(Amelio et al., 2013). It would seem that, similar to hibernation, during aestivation, 
the mRNA factors are compartmentalized in the nucleus and the subcellular 
organization and distribution of the transcriptional and/or translational machineries 
are strictly regulated, hence controlling gene and protein expression. Hence, 
aestivation cannot be considered as the result of a general metabolic depression; 
instead, aestivation encompasses the complex interplay between up-regulation and 
down-regulation of various cellular activities. Aestivation would logically entail 
variations in rates of protein degradation and protein synthesis, reconstructing cells 
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and tissues via a rapid protein turnover. As protein abundances are more direct 
determinants of cellular functions compared to mRNA expression levels (Vogel and 
Marcotte, 2012), the subsequent discussion will focus mainly on protein abundances. 
Any discussion on mRNA expression levels will only be done when necessary. 
5.4. Molecular changes in expression of ppargc-1α/Ppargc-1α, myod1/Myod1, 
myog/Myog and mapk/Mapk, which are involved in muscle formation, occurring 
in the muscle of P. annectens during the three phases of aestivation 
In general, genes/proteins involved in muscle formation are expected to be down-
regulated in the skeletal muscle during periods of fasting or disuse. Indeed, there 
were decreases in the expression of PPARGC-1α/PPARGC-1α (Sandri et al., 2006; 
Sacheck et al., 2007). Furthermore, MAPK1/3 inhibition in both slow and fast 
muscles induces profound atrophy (Shi et al., 2009). However, there was an up-
regulation in the expression of MYOD1/MYOD1 and MYOG/MYOG (Mozdziak et 
al., 1999; Alway et al., 2001; Moresi et al., 2010) in the skeletal muscle of rodents 
experiencing starvation or muscle disuse. It was thought that these changes help to 
protect skeletal muscle from atrophy induced by disuse or fasting (refer to section 
1.3.5). Yet, previous studies have reported an up-regulation in the expression of 
PPARGC-1α/PPARGC-1α and MAPK/MAPK in the skeletal muscles of hibernating 
bats and squirrels (Eddy and Storey, 2003; Eddy et al., 2005a; MacDonald and Storey, 
2005; Xu et al., 2013), demonstrating the protective effect of these genes/proteins in 
the skeletal muscle. These observations, together with results from this study, have 




Table 17. Comparison of changes in expression of various genes/proteins involved in 
muscle formation in response to fasting-induced muscle atrophy, disuse-induced 
muscle atrophy (includes denervation, hindlimb suspension and unloading), 
hibernation and the three phases of aestivation. Decreases in expression are denoted 
with ‘-’, while increases in expression are denoted with ‘+’. No significant changes in 
expression are denoted with ‘0’. ‘N.A.’ denotes no information is available. 
Genes/Proteins Fasting Disuse Hibernation 
Aestivation 
Induction Maintenance Arousal 
ppargc-1α/ 
Ppargc-1α 
- - + 0 0 0 
myod1/Myod1 N.A. + N.A. 0 + 0 
myog/Myog N.A. + N.A. 0 0 0 





5.4.1. Induction phase 
The induction phase lasted 6 to 9 days before the formation of a completely dried 
mucus cocoon, implying that the fasting is not severe. During this period, the skeletal 
muscles are still in use as there would still be occasional body movement, especially 
on the first 1 to 3 days. Furthermore, the aestivating fish has to undergo tissue 
reconstruction (Chew et al., 2015), which depicts an increase in protein turnover in 
certain organs, with perhaps an increased supply or mobilization of protein/amino 
acids from the skeletal muscle due to a lack of food supply. Hence, it is logical to 
predict that muscle formation may be reduced or remain unchanged. Indeed, results 
from this study demonstrated that there was a stable expression of Ppargc-1α, Myod1, 
Myog and Mapk1/3 in the muscle of P. annectens during the induction phase, which 
differs from the response to disuse or fasting in human or animal models (Table 17). 
This could be due to the short period of fasting and the incompleteness of muscle 
disuse, and consequently protein synthesis remained unchanged in the skeletal muscle 
of P. annectens during this period.  
5.4.2. Maintenance phase 
The maintenance phase of aestivation lasted for 6 months for the experimental fish in 
this study. During this period, fasting was severe and there was absolutely no 
locomotor activity, subjecting the skeletal muscles to possible atrophy induced by 
disuse and/or fasting. However, aestivating fish would have to preserve muscle 
structure and strength throughout the maintenance phase in preparation for arousal 
(Chew et al., 2015), suggesting that protein degradation is likely suppressed together 
with stable or reduced protein synthesis due to food deprivation. It is thus logical to 
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predict that muscle formation may remain unchanged or reduced. Indeed, in this 
study, the expression of Ppargc-1α, Myog and Mapk1/3 remained stable in the 
muscle of P. annectens during the maintenance phase, which differs from the 
response to disuse or fasting in human or animal models (Table 17). Interestingly, 
these results also differ from those reported in hibernators. In hibernators, various 
studies reported increases in the expression of Ppargc-1α/PPARGC-1α during 
hibernation, where there is little muscle atrophy (Eddy and Storey, 2003; Eddy et al., 
2005a; Xu et al., 2013). An increase in MAPK1 expression also occurs in the skeletal 
muscles of Richardson’s ground squirrels during hibernation (MacDonald and Storey, 
2005). Since maintaining protein synthesis is involved in muscle mass preservation 
during hibernation inactivity (Fedorov et al., 2014; Hindle et al., 2015), the stable 
expression of Ppargc-1α, Myog and Mapk1/3 is likely to contribute to muscle mass 
preservation through maintaining protein synthesis. 
The increase in Myod1 expression in the muscle of P. annectens during the 
maintenance phase was similar to results reported in mammalian disuse models 
(Table 17). However, a recent study demonstrated that increased MYOD1 expression 
might protect myofibres from atrophy induced by hindlimb suspension instead (Smith 
et al., 2014). MYOD1 is a master regulatory gene of muscle differentiation, and can 
convert non-muscle cells to muscle cells (Weintraub et al., 1989). Since it is 
necessary for P. annectens to preserve muscle structure and strength in preparation 
for arousal, it is logical to deduce that Myod1 contributes to muscle mass 
preservation by converting non-muscle cells to muscle cells during the maintenance 
phase of aestivation. 
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5.4.3. Arousal phase 
During the early arousal phase of aestivation, P. annectens resumes some locomotor 
activity. As P. annectens would only start feeding after 7–10 days upon arousal, it 
would require fuel for ATP production, not only for locomotor activity but also for 
tissue reconstruction/regeneration. Hence, during the first 3 days of arousal, the fuel 
is likely to be of endogenous origins as feeding has yet to occur (Chew et al., 2015). 
There might be an increase in the mobilization of proteins/amino acids from the 
skeletal muscle, which could lead to a high protein turnover and an increase in 
nitrogenous waste production. A significant increase in urea-N excretion in P. 
annectens upon arousal from aestivation is attributed mainly to the urea accumulated 
in P. annectens during the maintenance phase (Hung et al., 2009). However, the 
excretion of accumulated urea in P. dolloi is known to be regulated by the level of 
internal ammonia (Ip et al., 2005c). Therefore, as proposed by Chew et al. (2015), it 
is probable that an increase in amino acid catabolism leads to an increase in ammonia 
production, thereby acting as a signal to enhance urea excretion in P. annectens upon 
arousal. It is thus logical to predict that muscle formation may be reduced or remain 
unchanged. Indeed, results from this study revealed that the stable expression of ppargc-
1α/Ppargc-1α, myod1/Myod1, myog/Myog and Mapk1/3 in the muscle of P. 
annectens during the arousal phase is different from the response to fasting in 
mammalian models (Table 17). They suggest that protein synthesis remained 
unchanged in the skeletal muscle of P. annectens during this period. 
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5.5. Molecular changes in expression of hdac1/Hdac1, foxo/FoxO, tp53/TP53, 
mstn/Mstn and fbxo32/Fbxo32, which are involved in muscle degradation, 
occurring in the muscle of P. annectens during the three phases of aestivation 
Atrophy in the skeletal muscles of rodents is induced by fasting or disuse, and this is 
generally accompanied by increases in the expression of Hdac1/HDAC1 (Beharry et 
al., 2014), FoxO/FOXO (Calnan and Brunet, 2008; Senf et al., 2010), tp53/TP53 (Fox 
et al., 2014), Mstn/MSTN (Carlson et al., 1999; Shao et al., 2007; Allen et al., 2009, 
2010) and Fbxo32/FBXO32 (Bodine et al., 2001; Gomes et al., 2001; Jones et al., 
2004; Sandri et al., 2004; Abadi et al., 2009; Allen et al., 2009; Gustafsson et al., 
2010) (refer to section 1.4.6.). It is not clear if TP53 contributes to muscle atrophy 
induced by fasting, despite previous reports of increased TP53 activity in correlation 
with skeletal muscle atrophy in vivo under conditions of stress (Schwarzkopf et al., 
2006, 2008; Edwards et al., 2007; Rodier et al., 2007; Didier et al., 2012), though 
TP53 may contribute to apoptosis-mediated muscle wasting since its expression in 
the muscle is increased after 14 days of space-flight (Ohnishi et al., 1999), and after 7 
or 14 days of unloading (Siu and Alway, 2005a). It is apparent that these 
genes/proteins partake in muscle degradation, leading to muscle atrophy induced by 
fasting or disuse. However, in hibernators, it was reported that the protein expression 
of MSTN (Brooks et al., 2011) and the mRNA expression of Fbxo32 remained stable 
(Velickovska et al., 2005; Velickovska and van Breukelen, 2007; Lee et al., 2010; 
Andres-Mateos et al., 2013; Dang et al., 2016), implying that there was a protective 
effect conferred on the skeletal muscles during hibernation. Observations from these 
studies, together with results from this study, have been summarized in Table 18.   
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Table 18. Comparison of changes in expression of various genes/proteins involved in 
muscle degradation in response to fasting-induced muscle atrophy, disuse-induced 
muscle atrophy (includes denervation, hindlimb suspension and unloading), 
hibernation and the three phases of aestivation. Decreases in expression are denoted 
with ‘-‘, while increases in expression are denoted with ‘+’. No significant changes in 
expression are denoted with ‘0’. Unavailable information is indicated ‘N.A.’.  
Genes/Proteins Fasting Disuse Hibernation 
Aestivation 
Induction Maintenance Arousal 
hdac1/Hdac1 + + N.A. 0 0 + 
foxO1/FoxO1 + + N.A. 0 0 - 
foxO3/FoxO3 + + N.A. 0 0 0 
tp53/Tp53 N.A. + N.A. + 0 + 
mstn/Mstn + + 0 0 0 - 





5.5.1. Induction phase 
As mentioned in section 5.4.1., fasting is not severe and muscle disuse is incomplete. 
Moreover, the aestivating lungfish has to undergo tissue reconstruction (Chew et al., 
2015), leading to increased protein turnover in certain organs. Due to a lack of food 
supply, there could be an increased supply or mobilization of protein/amino acids 
from the skeletal muscle. Hence, it is logical to predict that muscle degradation may 
remain unchanged or enhanced, during the induction phase. Indeed, the expression of 
hdac1/Hdac1, FoxO, and Mstn in the skeletal muscle of P. annectens remained 
unchanged, and this could be explained by the short period of fasting and the 
incompleteness of muscle disuse. These results differed from those reported in 
mammals, where fasting and muscle disuse lead to increases in expression of almost 
all the genes/proteins of interest involved in muscle degradation (Table 18). These 
results also indicate that 6 days of fasting did not induce an increase in muscle 
degradation in P. annectens. However, unlike mammals, there was an increase and 
decrease in the expression of tp53 and Fbxo32, respectively, in the skeletal muscle of 
P. annectens during the induction phase of aestivation. 
A significant increase in the mRNA expression of tp53 in the muscle of P. 
annectens during the induction phase indicates that (1) there might be some form of 
muscle wasting, or (2) there could be cellular stress caused by aestivation. A recent 
study showed that TP53 directly represses MYOG/MYOG by binding to the MYOG 
promoter and suppresses muscle differentiation (Yang et al., 2015). It was thought 
that the repression of MYOG by TP53 allows for DNA damage repair and proper 
chromosome segregation when there is intersection of the muscle differentiation 
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program with the cell cycle checkpoint control (Yang et al., 2015). However, this was 
not the case in the muscle of P. annectens during the induction phase as the Myog 
protein abundance remained unchanged despite an increase in the mRNA expression 
of tp53. It is thus likely that the increase in tp53 expression could be purely due to 
cellular stress caused by aestivation. On the other hand, the decrease in the protein 
abundance of Fbxo32 in the muscle of P. annectens during the induction phase, 
indicates a decrease in the ubiquitination and proteolysis of muscle proteins and 
hence a suppression of muscle degradation. 
5.5.2. Maintenance phase 
During the maintenance phase, the aestivating lungfish must preserve muscle 
structure and strength to prepare for arousal (Chew et al., 2015) despite the extended 
period of severe fasting and muscle disuse (refer to section 5.4.2.). It is thus very 
likely that muscle degradation may be reduced or remain unchanged, during the 
maintenance phase to preserve muscle structure and strength.  
In mammalian disuse or fasting models, the expression of almost all the 
genes/proteins involved in muscle degradation increased (Table 18), but this was not 
observed in the skeletal muscle of P. annectens during the maintenance phase of 
aestivation. The lack of changes in the expression of these genes/proteins of interest 
in the skeletal muscle of P. annectens indicates that 6 months of fasting and lack of 
locomotor activity did not induce an increase in muscle degradation. These results 
corroborate previous studies in hibernators. It has been demonstrated that the protein 
expression of MSTN remains unchanged in the skeletal muscle of thirteen-lined 
ground squirrels during hibernation (Brooks et al., 2011). Furthermore, the stable 
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Fbxo32 mRNA expression and the suppression of proteolytic degradation by 
proteasome in the skeletal muscles are apparently associated with the protection of 
hibernators from disuse muscle atrophy (Velickovska et al., 2005; Velickovska and 
van Breukelen, 2007; Lee et al., 2010; Andres-Mateos et al., 2013; Dang et al., 2016).  
5.5.3. Arousal phase 
The lungfish resumes some locomotor activity during the early arousal phase of 
aestivation, and requires endogenous fuel for ATP production due to a lack of food 
supply (Chew et al., 2015) (refer to section 5.4.3.). This might result in increased 
mobilization of proteins/amino acids from the skeletal muscle, subsequently leading 
to increased protein turnover and nitrogenous waste production. It is thus logical to 
predict that muscle degradation may be enhanced during the arousal phase. 
However, contrary to our prediction, decreases in the expression of FoxO1, 
Mstn and Fbxo32 in the skeletal muscle of P. annectens occurred after 1 day of 
arousal from aestivation, suggesting that muscle degradation was still suppressed 
during the very early phase of arousal (Table 18). Although there was an increase in 
Hdac1 protein abundance in the skeletal muscle of P. annectens after 3 days of 
arousal, it was not accompanied by increases in the expression of other genes/proteins 
involved in muscle degradation or decrease in myod1/Myod1 expression. Class I 
HDACs are key regulators of FOXO and the muscle-atrophy program during both 
fasting and skeletal muscle disuse (Beharry et al., 2014). HDAC1 alone is adequate 
and required to activate FOXO and induce muscle fibre atrophy/degradation in vivo, 
and is pivotal to contractile dysfunction and muscle atrophy associated with muscle 
disuse (Beharry et al., 2014). The deacetylase activity of HDAC1 is necessary for 
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muscle atrophy to occur, and has been linked to the HDAC1-induction of several 
atrophy genes, including FBXO32, which requires the deacetylation of FOXO3a 
(Beharry et al., 2014). Since HDAC1 is also essential for the increased gene 
expression of other FOXO target genes involved in the inhibition of protein synthesis 
(Eif4ebp1) and in the ubiquitin proteasome pathway (FBXO32 and MuRF1), HDAC1 
could contribute to muscle atrophy/degradation by increasing FOXO-dependent 
transcription of target genes involved in various pathways which lead to increased 
protein turnover (Beharry et al., 2014), and repressing MYOD1 activity (Mal et al., 
2001). In the case of arousing P. annectens, it is likely that the increase in Hdac1 
could be for cell cycle progression and developmental events which might be crucial 
for the rebuild of muscle mass and strength upon subsequent feeding. Moreover, 
HDAC1 can deacetylate TP53, inhibiting TP53-dependent transcriptional activation, 
apoptosis and cell growth arrest (Luo et al., 2000). The increase in Hdac1 protein 
abundance could be a response to the increased mRNA expression of tp53 in the 
muscle of P. annectens during the arousal phase, to reduce or arrest cell death. 
However, this proposition can only be confirmed by further studies to investigate the 
protein abundance of Tp53 in the muscle of P. annectens during aestivation. 
5.6. Regulating muscle formation versus regulating muscle degradation 
Taken together, these results suggest that, contrary to the author’s prediction, muscle 
degradation was likely suppressed in the muscle of P. annectens during the induction 
phase (Table 18). Hence, it is unlikely that tissue reconstruction of certain organs 
involved the mobilization of amino acids from the skeletal muscle. Also, these results 
denote the importance of regulating muscle degradation over muscle formation 
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during the induction phase in the preservation of skeletal muscle structure in P. 
annectens.  
During the maintenance phase, these results suggest that, contrary to the 
author’s prediction, skeletal muscle formation was not suppressed in P. annectens 
during the maintenance phase (Table 17). Furthermore, FBXO32 promotes 
degradation of MYOD1 (Tintignac et al., 2005), and the rapid suppression of 
MYOD1 by FBXO32 leads to skeletal muscle wasting (Lagirand-Cantaloube et al., 
2009). It has been reported that inhibiting MYOD1 proteolysis by FBXO32 prevents 
skeletal muscle atrophy in vivo (Lagirand-Cantaloube et al., 2009). Since there was 
no corresponding increase in the protein abundance of Fbxo32 in the muscle of P. 
annectens during the maintenance phase, this supports the notion that decreased 
myogenesis did not occur in the muscle of aestivating P. annectens. On the other 
hand, the absence of increased expressions of genes/proteins involved in muscle 
degradation in P. annectens during the maintenance phase of aestivation is unique 
and different from the mammalian fasting and disuse models, and suggested that 
preservation of skeletal muscle structure involves a suppression of fasting- or disuse-
induced increase in muscle degradation. Overall, these results indicate that the 
regulation of both muscle formation and degradation is important in the preservation 
of skeletal muscle of P. annectens during the maintenance phase of aestivation. 
During the early arousal phase of aestivation, our results denote unchanged 
protein synthesis and suppressed protein degradation in the muscle of P. annectens 
during the first 3 days of arousal from aestivation. Hence, it is unlikely that tissue 
reconstruction/regeneration of certain organs involved the mobilization of amino 
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acids from the skeletal muscle during this initial arousal period. However, the 
possibility of skeletal muscles being mobilized for tissue reconstruction during the 
subsequent period of arousal before feeding cannot be eliminated.  
5.7. Molecular changes in expression of CuZnsod/CuZnSod, Mnsod/MnSod, 
cat/Cat, gpx1/Gpx1 and gpx4/Gpx4, and levels of several oxidative stress 
markers occurring in the muscle of P. annectens during the three phases of 
aestivation 
In general, there is a down-regulation in the expression of genes/proteins involved in 
oxidative defence in the skeletal muscle of animals experiencing fasting or disuse (Di 
Simplicio et al., 1997; Lawler et al., 2003; Rey et al., 2008) (refer to section 1.5.4.). 
This phenomenon could explain the increases in the levels of several oxidative stress 
markers in the skeletal muscle of animals experiencing fasting or disuse (Kondo et al., 
1991, 1993; Vogt and Richie, 1993; Di Simplicio et al., 1997; Lawler et al., 2003; 
Brocca et al., 2010; Desaphy et al., 2010), especially since prolonged skeletal muscle 
inactivity due to immobilization leads to chronic increases in production of ROS and 
oxidative damage in quiescent muscle fibres (Kondo et al., 1991). Although increases 
in the levels of oxidative stress markers were also reported in hibernating or 
aestivating animals, these increases were accompanied by increases in the expression 
of genes/proteins involved in oxidative defence (Grundy and Storey, 1998; Ramos-
Vasconcelos et al., 2003; Hudson et al., 2006; Nowakowska et al., 2010, 2014; 
Young et al., 2013a, b), indicating that increased oxidative defence conferred a 
protective effect on the skeletal muscle. These results, together with results obtained 
from this study, are summarised in Tables 19 and 20.   
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Table 19. Comparison of changes in expression of various genes/proteins involved in 
oxidative defense in response to fasting-induced muscle atrophy, disuse-induced 
muscle atrophy (includes denervation, hindlimb suspension and unloading), torpor 
(includes hibernation and aestivation) and the three phases of aestivation. Decreases 
in expression are denoted with ‘-’, while increases in expression are denoted with ‘+’. 
No significant changes in expression are denoted with ‘0’. ‘N.A.’ denotes no 
information is available. 
Genes/Proteins Fasting Disuse Torpor 
Aestivation 
Induction Maintenance Arousal 
CuZnsod/ 
CuZnSod 
- + + 0 + + 
Mnsod/MnSod - - + 0 0 0 
cat/Cat - - + + 0 + 
gpx1/Gpx1 0 - + 0 0 + 




Table 20. Comparison of changes in expression of oxidative stress markers in 
response to fasting-induced muscle atrophy, disuse-induced muscle atrophy (includes 
denervation, hindlimb suspension and unloading), torpor (includes hibernation and 
aestivation) and the three phases of aestivation. Decreases are denoted with ‘-’, while 
increases are denoted with ‘+’. No significant changes are denoted with ‘0’. ‘N.A.’ 
denotes no information is available.  
Oxidative 
stress markers 
Fasting Disuse Torpor 
Aestivation 
Induction Maintenance Arousal 
Total GSheq - - + 0 + + 
[GSSG]/[GSH] 
ratio 
+ + + + + 0 
Lipid 
hydroperoxides 
N.A. + + 0 0 0 
TBARS N.A. + + 0 0 - 
Carbonyl 
protein 




5.7.1. Induction phase 
During the induction phase, P. annectens experiences fasting (although not severe) 
and incomplete muscle disuse, especially for the first 3 days (refer to section 5.4.1.). 
Moreover, the lungfish hyperventilates during this period, and may experience 
increased oxidative stress. The stable expression of CuZnSod and MnSod in the 
muscle of P. annectens during the induction phase differs from the responses reported 
in fasting or disuse in mammalian models (Table 19). The stable expression of Gpx1 
and gpx4/Gpx4, although similar to responses reported in fasting, is different from the 
responses reported in disuse mammalian models (Table 19). These could be due to 
the short period of food deprivation and the incompleteness of muscle disuse, 
resulting in only mild oxidative stress which could be adequately handled by the 
other components of the oxidative defense mechanisms. Alternatively, oxidative 
stress during the induction phase could result from hyperventilation and a possibly 
increased metabolic rate (Chew et al., 2015). DeLaney et al. (1974) reported that 
hyperventilation occurred in P. aethiopicus and that the ventilation rate increased 
two- to five-fold during the first 30 days of aestivation before returning to the control 
range (2-10 hr) within 45 days. During the first 10 days of aestivation, there was an 
increase in the arterial PO2 from the control range of 25-40 to 50-58 mmHg, which 
then returned to the control range (DeLaney et al., 1974). The increase in metabolic 
rate could be a result from the structural and functional modifications of cells and 
tissues in preparation for the maintenance phase of aestivation (Chew et al., 2015).  
Indeed, increases in Cat protein abundance, Gr activity, [GSSG] and 
[GSSG]/[GSH] occurred in the muscle of P. annectens during the induction phase, 
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indicating increased physiological oxidative stress. Cat is thought to be crucial in 
maintaining the integrity of muscle (Stauber et al., 1977), and increase in its 
expression, as opposed to decreases reported in fasting and muscle disuse models, 
could be essential in preventing the onset of oxidative damages and avoiding 
subsequent muscle atrophy. Increases in [GSSG] and [GSSG]/[GSH] in the muscle of 
P. annectens during the induction phase indicate increases in peroxide and GSH 
consumption, respectively. Increased GSH consumption for peroxide detoxification 
occurs during dormancy, and is an indicator of physiological oxidative stress during 
the induction phase of aestivation. Furthermore, an increase in Gr activity could be a 
response to the increases in [GSSG] and [GSSG]/[GSH]. GR is responsible for 
replenishing the intracellular GSH pool by reducing GSSG to GSH and is believed to 
be the major regulator of the redox reaction involving GSSG and GSH (Yang et al., 
2006). Indeed, [GSH] remained unchanged in the muscle of P. annectens during the 
induction phase, despite an increase in GSH consumption, indicating that the 
intracellular GSH pool was probably maintained by Gr.  
Despite signs of increased oxidative stress in the muscle of P. annectens 
during the induction phase, there were no significant changes in the levels of 
oxidative damage products in the muscle of P. annectens as compared to the control. 
These results differ from the responses to disuse (Table 20) and demonstrate the 
robustness of the antioxidant defenses in the muscle of P. annectens, where 
antioxidant defenses are increased to deal with increased oxidative stress during the 
induction phase.  
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5.7.2. Maintenance phase  
During the maintenance phase, the aestivating lungfish faces severe fasting and 
muscle disuse (refer to section 5.4.2.), which might lead to increased ROS production 
in the skeletal muscle, and result in possible atrophy. A recent study demonstrated 
increases in the expression of MnSOD and CAT in the skeletal muscle of hibernating 
squirrels (Xu et al., 2013). These increases were associated with a corresponding 
increase in PPARGC-1a (Xu et al., 2013). An increase in MnSOD was also reported 
in the skeletal muscle of ground squirrels during early torpor (Allan and Storey, 
2012). In contrast, there was a stable expression of MnSod, cat/Cat and Ppargc-1a 
(section 5.4.2.) in the skeletal muscle of P. annectens during the maintenance phase, 
which differs from mammalian models of fasting or muscle disuse (Table 19). Only 
increases in the protein expression of CuZnSod and Gpx4, and glutathione 
biosynthesis, were observed in the skeletal muscle of P. annectens during the 
maintenance phase of aestivation. The stable expression of MnSod in the skeletal 
muscle of P. annectens during the maintenance phase indicated that (1) there was 
little superoxide generated in the muscle of P. annectens, or (2) another Sod could be 
taking over the role of MnSod in the muscle of P. annectens.  
As SODs are the first line of defense against oxidative stress, and since there 
could be intermittent bursts of ROS production during aestivation (Storey, 2002), it is 
highly unlikely that there was little superoxide generation in the muscle of P. 
annectens. Furthermore, the mitochondria appear to be the main site of inactivity-
induced ROS production in skeletal muscles (Muller et al., 2007; Kavazis et al., 2009; 
Min et al., 2011; Powers et al., 2011; Talbert et al., 2013). Although CuZnSOD is 
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classically reported to be a cytosolic enzyme (Halliwell and Gutteridge, 1989) and 
does not possess a mitochondrial targeting sequence, there is emerging evidence that 
CuZnSOD is also located in the mitochondrial inter-membrane space (Saito et al., 
1989; Kawamata and Manfredi, 2010), and is possibly present at high concentration 
in comparison with cytosolic CuZnSOD (Jackson, 2013). It is possible that CuZnSod 
plays a more important role in oxidative defense than MnSod in the muscle of P. 
annectens during the maintenance phase of aestivation. CuZnSOD is imported as a 
catalytically inactive enzyme into the intermembrane space during mitochondrial 
import, and is processed by the copper chaperone for CuZnSOD (CCS) into the active 
enzyme, thereby becoming trapped in the mitochondria (Leitch et al., 2009; 
Kawamata and Manfredi, 2010). The import of CuZnSOD and CCS occurs via a 
disulphide relay system involving the import receptor Mia40 (Reddehase et al., 2009; 
Kawamata and Manfredi, 2010).  
Thus, the CuZnSod of P. annectens could be imported into the mitochondria 
in a similar manner, and may be the main Sod scavenging superoxide generated in the 
mitochondria instead of MnSod. This could explain the significant increase in the 
protein abundance of CuZnSod, but not MnSod, in the muscle of P. annectens after 6 
months of aestivation. These results corroborate reports on increased CuZnSod 
activity in the muscle of aestivating snails (Hermes-Lima and Storey, 1995; Salway et 
al., 2010) and spadefoot toads (Grundy and Storey, 1998). Superficially, the increase 
in expression of CuZnSod in the muscle of P. annectens during the maintenance 
phase aestivation appears to bear similarity with the mammalian muscle disuse 
models (Table 19). However, in the case of mammalian muscle disuse, there are 
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significant decreases in the expression of multiple components of the oxidative 
defence system but those responses were absent from the skeletal muscle of 
aestivating P. annectens (Table 19).  
Increased superoxide scavenging capacity (possibly SOD activity) was also 
demonstrated in both iliofibularis and gastrocnemius muscles of aestivating 
Cyclorana alboguttata (Young et al., 2013b), although it is unclear which SOD is 
responsible for the increased superoxide scavenging capacity. A recent study reveals 
suppressed mitochondrial ROS production in the disused skeletal muscle of 
aestivating Cyclorana alboguttata, which might protect against potential oxidative 
injury, allowing the preservation of skeletal muscle structure during aestivation in 
preparation for arousal (Reilly et al., 2014). To confirm which Sod is responsible for 
scavenging mitochondrial ROS in the muscle of P. annectens during the maintenance 
phase, further studies need to be conducted to determine the localization of each of 
these two Sods. 
Among the selenoproteins of the GPX family, GPX4 protects membranes 
from oxidative insult as it has a unique ability to reduce not only H2O2 but also 
hydroperoxides in complex lipids including phospholipids, cholesterol and 
cholesterolester hydroperoxides, even when these lipids are found inserted into 
biomembranes or lipoproteins (Thomas et al., 1990). The increase in the expression 
of gpx4/Gpx4 in the muscle of aestivating P. annectens indicates increased protection 
of membranes against oxidative injury. Corresponding increases in SeGpx and total 
Gpx activities were also observed in the muscle of aestivating P. annectens, and 
could be attributed to the increase in the expression of gpx4/Gpx4, but not Gpx1. The 
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increased Gpx activities corroborated with increased SeGpx activity observed in the 
sea cucumber (Wang et al., 2011) and the muscle of aestivating land snails 
(Nowakowska et al., 2010, 2014), and total Gpx activity observed in spadefoot toads 
(Grundy and Storey, 1998).  
Decreases in GSH contents in sea cucumbers during the maintenance phase of 
aestivation were attributed to the adaptive strategy of sea cucumbers to reduce ROS 
production during aestivation at higher temperatures (Ji et al., 2008; Wang et al., 
2011). Similar decreases in GSH concentrations were also reported in several tissues 
of spadefoot toads under aestivation (Grundy and Storey, 1998). In contrast, 
increased GSH contents were observed in the muscle of aestivating P. annectens, 
accompanied with increases in GSSG and GSSG/GSH, indicative of physiological 
oxidative stress. This redox imbalance (increases in GSSG and GSSG/GSH) is also 
observed in land snails (Hermes-Lima and Storey, 1995) and spadefoot toads 
(Grundy and Storey, 1998; Hermes-Lima et al., 2001) during aestivation, and 
indicates oxidative stress.  
Increased oxidative stress is also observed in aestivating snails (Helix 
aspersa); they have increased carbonyl protein levels in foot muscle as compared to 
aroused active snails (Ramos-Vasconcelos et al., 2003). Furthermore, increases in 
lipid peroxidation are observed in the muscle of aestivating spadefoot toads (Grundy 
and Storey, 1998), and in the muscle of Helix pomatia during winter torpor, 
accompanied with increases in enzymatic antioxidant activities (Nowakowska et al., 
2009). Carbonyl protein levels also increase in the iliofibularis muscle, but not in the 
gastrocnemius muscle, in striped burrowing frogs after 6 months of aestivation 
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(Young et al., 2013b), indicating increased oxidative stress and is consistent with 
greater disuse muscle atrophy in iliofibularis than gastrocnemius (Young et al., 
2013a). In contrast, different from these observations (Table 20), there was a decrease 
in carbonyl protein levels in the muscle of P. annectens after 6 months of aestivation. 
This, together with results from the glutathione system, implies an increase in the 
antioxidant capacity in the skeletal muscle of P. annectens during the maintenance 
phase, thereby reducing oxidative insult and helping to prevent disuse muscle atrophy, 
as observed in the gastrocnemius muscle of aestivating striped burrowing frogs 
(Hudson et al., 2006; Young et al., 2013a, b).  
5.7.3. Arousal phase 
During the arousal phase of aestivation, there is resumption of locomotor but not 
feeding activity in P. annectens (refer to section 5.4.3.). Moreover, there are increases 
in metabolism and oxygen uptake, implying increased oxidative stress during the 
arousal phase. There could be increases in the expression of genes/proteins involved 
in oxidative defence and in the levels of oxidative stress markers in the muscle of P. 
annectens during the arousal phase.  
In mammals, fasting leads to decreases in expression of almost all the 
genes/proteins of interest involved in oxidative defense (Table 19), but a similar 
phenomenon did not occur in the skeletal muscle of P. annectens during the arousal 
phase of aestivation. The stable expression of MnSod and Gpx4 in the skeletal muscle 
of P. annectens was accompanied with increases in the protein expression levels of 
CuZnSod, Cat and Gpx1 during the arousal phase. There was also an increase in 
MnSod activity despite its stable expression. These results support the proposition 
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that an increase in the degradation of skeletal muscle might not have occurred in P. 
annectens during this early period of arousal.  
As the rate of superoxide and H2O2 production by the mitochondria is 
proportional to oxygen tension in many biological systems (Turrens et al., 1982; Cino 
and Del Maestro, 1989; Beckman and Ames, 1998), a rise in oxygen tension and 
consumption in aestivators/hibernators during arousal could result in increased 
production of ROS (Storey, 2002). It is expected that ROS production would increase 
in the muscle of P. annectens upon arousal due to the increase in oxygen 
consumption and metabolism, which must be dealt with rapidly by endogenous 
antioxidant defenses in order to avoid oxidative injury. Hermes-Lima and Storey 
(1995) measured intracellular antioxidant enzyme activities in aestivating snails and 
found that there was a broad-based up-regulation in various tissues. This was thought 
to provide protection against ischemia-reperfusion events associated with the 
transition from aestivation to arousal (Hermes-Lima and Zenteno-Savín, 2002). 
Similar results have been obtained for other terrestrial snail that undergo aestivation 
(Ramos-Vasconcelos and Hermes-Lima, 2003; Ramos-Vasconcelos et al., 2005; 
Nowakowska et al., 2009). Upregulation in antioxidant enzymes have also been 
reported in hibernators upon arousal. For example, there were increases in SOD and 
GPX activities in the interscapular brown adipose tissue of arousing hibernators 
(Buzadžić et al., 1990). Enhanced GPX activity occurred in the liver of arousing 13-
lined ground squirrels (Buzadžić et al., 1990; Page et al., 2009), while plasma SOD 
and CAT activities increased sharply in the plasma of Syrian hamsters upon arousal 
(Ohta et al., 2006; Okamoto et al., 2006).  
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The increases in MnSod activity and the expression of CuZnSod and Gpx1 in 
the skeletal muscle of P. annectens during the early arousal phase corroborates 
studies reporting an increase in SOD activity in the muscle of frogs aroused from 
winter hibernation (Bagnyukova et al., 2003) and enhanced Gpx activity in the foot 
muscle of arousing snails (Salway et al., 2010). The increase in Cat expression in the 
muscle of P. annectens corroborates with elevated CAT in the muscle of frogs 
(Bagnyukova et al., 2003) upon arousal from hibernation. Furthermore, increases in 
total Sod and Cat activities occurred in the foot muscle of snails upon arousal 
(Hermes-Lima et al., 1995). Overall, results from this study indicate increased 
antioxidant capacity in the muscle of P. annectens to counter increased oxidative 
stress upon arousal.  
The increase in anti-oxidative defense capacity in the skeletal muscle was 
apparently effective in preventing oxidative damages in the skeletal muscle of P. 
annectens during the early period of arousal. In fact, oxidative damage products 
decreased in the muscle of arousing P. annectens, which was similar to the decrease 
in TBARS in the foot muscle of apple snails upon arousal (Giraud-Billoud et al., 
2013). Levels of TBARS and carbonyl proteins remained unchanged in the foot 
muscle of snails upon arousal (Ramos-Vasconcelos et al., 2005; Nowakowska et al., 
2009). This contradicts reports of increased oxidative damages in some non-muscle 
organs of aestivators (Hermes-Lima and Storey, 1995; Ramos-Vasconcelos et al., 
2003) and hibernators (Orr et al., 2009) during arousal. Carbonyl proteins and lipid 
peroxide end products in brown adipose tissue of hibernating Arctic ground squirrels 
were greater in late arousal than during hibernation (Orr et al., 2009). Lipid 
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peroxidation also increased in the hepatopancreas of land snails during the first few 
minutes of arousal (Hermes-Lima and Storey, 1995; Ramos-Vasconcelos et al., 2003). 
Furthermore, [GSSG] returned to control values upon arousal. When taken together, 
these results indicate that the skeletal muscle of P. annectens was confronted with 
minimal or no oxidative stress during the arousal phase of aestivation. It could be that 
the skeletal muscle underwent a profound suppression of ROS formation during the 
maintenance phase (section 5.7.2.), and this was carried over into the early arousal 
phase and reduced the severity of the oxidative stress associated with the ischemic-
reperfusion event.  
5.8. Limitations of the study 
As this study only focuses on determining the transcript levels and protein 
abundances of various genes and proteins known to be involved in muscle atrophy, 
there is still a dearth of information, especially with regards to the structural and/or 
ultrastructural observations of the skeletal muscle of P. annectens during the three 
phases of aestivation. Furthermore, information on the presence of satellite cells is 
lacking, and it remains unclear if satellite cells partake in preventing muscle atrophy, 
especially during the maintenance phase of aestivation. However, this study provides 
novel insights into some of the molecular mechanisms and pathways, and provides 






Results from this study reveal that there are up- and down-regulation of various 
genes/proteins involved in muscle formation, muscle degradation and oxidative 
defense in the muscle of P. annectens during the three phases of aestivation. Hence, 
aestivation cannot be simply regarded as a general depression of metabolism (Ip and 
Chew, 2010). Aestivation instead involves a complex interplay between up- and 
down-regulation of diverse cellular activities and tightly-controlled subcellular 
organization of transcriptional and/or translational machineries to meet the challenges 
associated with aestivation.  
During the induction phase of aestivation, there were only minor changes in 
the expressions of various genes/proteins involved in both muscle formation and 
muscle degradation, involving only tp53 and Fbxo32 which increased and decreased, 
respectively, in the muscle of P. annectens. The lack of changes in the expressions of 
most genes/proteins involved in both muscle formation and muscle degradation could 
be due to the short period of fasting and the incompleteness of muscle disuse during 
this initial period of aestivation. The increase in tp53 could be due to the cellular 
stress brought on by aestivation, while the decreased Fbxo32 expression might 
indicate decreased ubiquitination and proteolysis of muscle proteins. These results 
indicate that muscle degradation was likely suppressed in the muscle of P. annectens 
during the induction phase, and is contrary to the proposition that tissue 
reconstruction involved mobilization of proteins/amino acids from the muscle of P. 
annectens during this initial period of aestivation (Chew et al., 2015). They also 
denote the importance of regulating muscle degradation over regulating muscle 
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formation. Although there were signs of increased oxidative stress in the muscle of P. 
annectens, as indicated by increased Cat protein abundance, Gr activity, [GSSG] and 
[GSSG]/[GSH], there were no significant changes in the levels of oxidative damage 
products in the muscle of P. annectens as compared to the control. This could be 
explained by the robustness of the antioxidant defense system in the muscle of P. 
annectens, whereby antioxidant defense mechanisms were up-regulated to deal with 
increased oxidative stress during the induction phase to prevent oxidative injury. 
During the maintenance phase of aestivation, there were only slight changes 
in the expression of genes/proteins involved in muscle formation, despite the 
aestivating lungfish undergoing severe fasting. The stable expression of Ppargc-1α, 
Myog and Mapk1/3 could have contributed to muscle mass preservation through 
maintaining a certain rate of protein synthesis. An upregulation in the protein 
abundance of Myod1 could also contribute to muscle mass preservation by increasing 
the conversion of non-muscle cells to muscle cells during the maintenance phase of 
aestivation. The absence of increased expressions of genes/proteins involved in 
muscle degradation in the muscle of P. annectens during the maintenance phase was 
unique and differed from the mammalian fasting and muscle disuse models. 
Preservation of skeletal muscle structure and strength in aestivating P. annectens 
probably involved a suppression of fasting- and/or disuse-induced increase in muscle 
degradation. Prolonged muscle disuse can lead to increased ROS production in the 
mitochondria and subsequent muscle atrophy. In the case of aestivating P. annectens, 
the expression of MnSod was stable, but the expression of CuZnSod increased in the 
skeletal muscle, suggesting that CuZnSod could be the main Sod scavenging 
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mitochondrial ROS and protecting the muscle from oxidative damages. The 
expression of gpx4/Gpx4 also increased in the skeletal muscle, indicating increased 
protection of membranes against oxidative injury. Although there were signs of 
increased oxidative stress in the muscle of P. annectens during the maintenance phase, 
as indicated by increased [GSSG] and [GSSG]/[GSH], there was a decrease in the 
levels of carbonyl proteins. Furthermore, there could be an increase in the production 
of glutathione. Overall, these results indicate an increase in the antioxidant capacity 
in the skeletal muscle of P. annectens during the maintenance phase of aestivation, 
thereby reducing oxidative insult and helping to prevent disuse muscle atrophy.  
During the arousal phase of aestivation, the expression of genes/proteins 
involved in muscle formation remained unchanged in the muscle of P. annectens. 
However, muscle degradation was apparently suppressed during the very early phase 
of arousal, as indicated by decreases in the protein abundances of FoxO1, Mstn and 
Fbxo32 after 1 day of arousal from aestivation. Although Hdac1 expression was 
upregulated after 3 days of arousal, it was not accompanied by increases in the 
expression of other genes/proteins involved in muscle degradation or a decrease in 
the expression of myod1/Myod1. Therefore, the increase in Hdac1 expression could 
be a response to the increased mRNA expression of tp53 in the muscle of P. 
annectens during this period, so as to reduce or arrest cell death. These results denote 
that tissue reconstruction/regeneration of certain organs during this initial arousal 
period was unlikely to involve the mobilization of amino acids from the skeletal 
muscle. However, the possibility of the skeletal muscles being mobilized for tissue 
reconstruction during the subsequent period of arousal before feeding cannot be 
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ignored and deserves further investigation in the future. Oxygen consumption is 
known to increase in the lungfish during the arousal phase of aestivation. Indeed, 
there were increases in MnSod activity and protein abundances of CuZnSod, Cat and 
Gpx1 in the muscle of P. annectens, indicating increased antioxidant defenses therein. 
These responses were apparently effective in protecting the skeletal muscle against 
oxidative insult, as the concentrations of oxidative damage products decreased in the 
muscle of the aroused fish. Taken together, these results indicate that the skeletal 
muscle of the aroused fish was confronted with minimal or no oxidative stress, and 
support the notion that an increase in the degradation of skeletal muscle might not 
have occurred in P. annectens during this early period of arousal.  
In the future, immunohistochemical studies should be conducted to determine 
the localization of CuZnSod and MnSod in the muscle of P. annectens during the 
three phases of aestivation. Immunohistochemical studies should also be performed 
on the skeletal muscle fibres of P. annectens during the three phases of aestivation to 
determine if there was a switch of muscle fibre types during aestivation, as certain 
muscle fibre types are reported to be more resistant to atrophy. As a pioneer study, 
information obtained from this study will guide the development of future research 
proposals on new interventions for the prevention of disuse muscle atrophy in many 
clinical situations and in our ageing society. Understanding the mechanism and 
pathways that contribute to amelioration or prevention of disuse muscular atrophy 
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Appendix 1a. List of selected species and their accession numbers used for 
dendrogram analyses of PPARGC-1α/Ppargc-1α. “*” indicates the outgroup. 
Species Accession number 
Callorhinchus milii Ppargc-1α isoform X1  XP_007887233.1 
Chelonia mydas PPARGC-1α  XP_007058167.1 
Ciona intestinalis Ppargc-1α XP_009858764.1 
Cynoglossus semilaevis Ppargc-1α XP_008324663.1 
Esox lucius Ppargc-1α  XP_012995919.1 
Fundulus heteroclitus Ppargc-1α  XP_012720393.1 
Harpegnathos saltator Ppargc-1α EFN77825.1 
Homo sapiens PPARGC-1α  NP_037393.1 
Ictalurus punctatus Ppargc-1α  AHH38878.1 
Larimichthys crocea Ppargc-1α  XP_010732114.1 
Latimeria chalumnae Ppargc-1α XP_005997925.1 
Mus musculus PPARGC-1α  NP_032930.1 
Oryzias latipes Ppargc-1α XP_011485675.1 
Pelodiscus sinensis PPARGC-1α isoform 1  XP_006138221.1 
Pelodiscus sinensis PPARGC-1α isoform 2  XP_006138222.1  
Rattus norvegicus PPARGC-1α  NP_112637.1 
Squalous acanthias Ppargc-1α ACY24363.1_1 
Takifugu rubripes Ppargc-1α  XP_011605089.1 
Xenopus (Silurana) tropicalis Ppargc-1α isoform 1  XP_002936759.2 
Xenopus (Silurana) tropicalis Ppargc-1α isoform 2  XP_004911281.1 





Appendix 1b. List of selected species and their accession numbers used for 
dendrogram analyses of MYOD1/Myod1 and MYOG/Myog. “*” indicates the 
outgroup. MDF: Myogenic determination factor; MRF: Myogenic regulatory factor. 
Species Accession number 
Ameiurus catus Myog AAS67040.1 
Callorhinchus milii Myod1 XP_007885677.1 
Cyprinus carpio Myod1 BAA33565.1 
Cyprinus carpio Myog BAA33564.1 
Danio rerio Myod1 AAI14262.1 
Danio rerio Myog NP_571081.1 
Devario aequipinnatus Myog ABB00908.1 
Epinephelus coioides Myog ADJ95349.1 
Himantura signifier Myog KX494984 
Hippoglossus hippoglossus Myod1 CAF34063.1 
Hippoglossus hippoglossus Myog CAD32316.1 
Homo sapiens MYOD1 AAH64493.1 
Homo sapiens MYOG NP_002470.2 
Latimeria chalumnae Myod1 XP_005990556.1 
Latimeria chalumnae Myog XP_005987662.1 
Megalobrama amblycephala Myod1 AHW49178.1 
Mus musculus MYOD1 AAI03620.1 
Mus musculus MYOG AAB59676.1 
Oncorhynchus mykiss Myod1 Q91205.1 
Oreochromis aureus Myog ADA84044.1 
Oreochromis niloticus Myog NP_001266455.1 
Paralichthys olivaceus Myog ABO43958.1 
Rattus norvegicus MYOD1 AAI27481.1 
Rattus norvegicus MYOG NP_058811.2 
Salmo salar Myod1 CAD89607.1 
Salmo salar Myod2 NP_001117026.1 
Salmo salar Myog NP_001117072.1 
Sparus aurata Myog ABR22022.1 
Xenopus laevis Myod1A NP_001079366.1 
Xenopus laevis Myod1B NP_001081292.1 
Xenopus laevis Myog NP_001079326.1 
Xenopus (Silurana) tropicalis Myod1 NP_988972.1 
Xenopus (Silurana) tropicalis Myog NP_001016725.1 
Branchiostoma belcheri MDF AAL47678.1 




Appendix 1c. List of selected species and their accession numbers used for 
dendrogram analyses of MAPK/Mapk. “*” indicates the outgroup. 
Species Accession number 
Astyanax mexicanus Mapk1 XP_007229493.1 
Astyanax mexicanus Mapk3 XP_007234538.1 
Bos taurus MAPK1 NP_786987.1 
Bos taurus MAPK3 NP_001103488.1 
Callorhinchus milii Mapk1 AFP02819.1 
Chrysemys picta bellii Mapk3 XP_005290239.1 
Clarias batrachus Mapk3 AKC01948.1 
Clupea harengus Mapk1 XP_012671405.1 
Danio rerio Mapk1 NP_878308.2 
Danio rerio Mapk3 NP_958915.1 
Harpegnathos saltator Mapk1 XP_011148219.1 
Homo sapiens MAPK1 NP_620407.1 
Homo sapiens MAPK3 isoform 1 NP_002737.2 
Homo sapiens MAPK3 isoform 2 NP_001035145.1 
Hydra vulgaris Mapk1 CDG71148.1 
Larimichthys crocea Mapk1 KKF25704.1 
Larimichthys crocea Mapk3 KKF25582.1 
Latimeria chalumnae Mapk1 XP_005990239.1 
Maylandia zebra Mapk1 XP_004555701.1 
Mus musculus MAPK1 NP_036079.1 
Mus musculus MAPK3 NP_036082.1 
Oreochromis niloticus Mapk1 XP_003444522.1 
Poecilia formosa Mapk1 XP_007547416.1 
Poecilia reticulata Mapk1 XP_008417574.1 
Rattus norvegicus MAPK1 NP_446294.1 
Rattus norvegicus MAPK3 NP_059043.1 
Scleropages formosus Mapk3 KKX11163.1 
Squalus acanthias Mapk1 KT324594.1 
Stegastes partitus Mapk1 XP_008298479.1 
Stegastes partitus Mapk3 XP_008303580.1 
Xenopus (Silurana) tropicalis Mapk1 NP_001017127.1 
Xenopus laevis Mapk1 NP_001083548.1 




Appendix 1d. List of selected species and their accession numbers used for 
dendrogram analyses of HDAC1/Hdac1. “*” indicates the outgroup. 
Species Accession number 
Callorhinchus milii Hdac1  AFO97213.1 
Cynoglossus semilaevis Hdac1  XP_008314048.1 
Danio rerio Hdac1  NP_775343.1 
Esox lucius Hdac1  XP_010877522.1 
Homo sapiens HDAC1  NP_004955.2 
Mus musculus HDAC1  NP_032254.1 
Notothenia coriiceps Hdac1  XP_010770908.1 
Rattus norvegicus HDAC1  NP_001020580.1 
Stegastes partitus Hdac1  XP_008282430.1 
Takifugu rubripes Hdac1  AAL89665.1 
Xenopus (Silurana) tropicalis Hdac1  AAH90604.1 
Xenopus laevis Hdac1  NP_001079396.1 





Appendix 1e. List of selected species and their accession numbers used for 
dendrogram analyses of FOXO/FoxO. “*” indicates the outgroup. 
Species Accession number 
Danio rerio FoxO1b AAI63020.1 
Danio rerio FoxO3 NP_571160.1 
Homo sapiens FOXO1 AAH21981.1 
Homo sapiens FOXO3 AAH68552.1 
Homo sapiens FOXO4 isoform 1  NP_005929.2 
Homo sapiens FOXO4 isoform 2  NP_001164402.1 
Mus musculus FOXO1 NP_062713.2 
Mus musculus FOXO3 NP_062714.1 
Mus musculus FOXO4 NP_061259.1 
Rattus norvegicus FOXO4 NP_001100413.1 
Xenopus laevis FoxO1 NP_001086417.1 
Xenopus laevis FoxO3 NP_001086418.1 
Xenopus laevis FoxO4 ACO24746.1 





Appendix 1f. List of selected species and their accession numbers used for 
dendrogram analyses of MSTN/Mstn. “*” indicates the outgroup. 
Species Accession number 
Catla catla Mstn AEN75196.1 
Cyprinus carpio Mstn1a ACY01745.1 
Cyprinus carpio Mstn1b ACY01746.1 
Danio rerio Mstn AAB86693.1 
Homo sapiens MSTN ABI48513.1 
Labeo fimbriatus Mstn AEN75197.1 
Latimeria chalumnae Mstn XM_005996542.1 
Mus musculus MSTN AAI05675.1 
Oncorhynchus mykiss Mstn1a AAZ85121.1 
Oncorhynchus mykiss Mstn1b ABA42586.1 
Rattus norvegicus MSTN AAB86691.1 
Salmo salar Mstn1b CAC59700.1 
Salmo salar Mstn1a ABN72586.1 
Xenopus (Silurana) tropicalis Mstn XP_002931542.1 





Appendix 1g. List of selected species and their accession numbers used for 
dendrogram analyses of FBXO32/Fbxo32. “*” indicates the outgroup. 
Species Accession number 
Astyanax mexicanus Fbxo32  XP_007250892.1 
Callorhinchus milii Fbxo32  XP_007898752.1 
Chelonia mydas Fbxo32  XP_007070931.1 
Chrysemys picta bellii Fbxo32  XP_005288831.1 
Danio rerio Fbxo32  NP_957211.1 
Esox lucius Fbxo32  XP_010891067.1 
Homo sapiens FBXO32 isoform 1  NP_478136.1 
Larimichthys crocea Fbxo32  XP_010738325.1 
Latimeria chalumnae Fbxo32 XP_006000858.1 
Mus musculus FBXO32  NP_080622.1 
Notothenia coriiceps Fbxo32  XP_010780879.1 
Oncorhynchus mykiss Fbxo32  NP_001180255.1 
Pelodiscus sinensis Fbxo32 isoform X1  XP_006137545.1 
Pelodiscus sinensis Fbxo32 isoform X2  XP_006137546.1 
Poecilia reticulata Fbxo32  XP_008430324.1 
Rattus norvegicus FBXO32  NP_598205.1 
Salmo salar Fbxo32  NP_001171956.1 
Stegastes partitus Fbxo32  XP_008275201.1 





Appendix 2a. The nucleotide sequence and the translated amino acid sequence of 
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha (ppargc-
1α)/Ppargc-1a from the muscle of Protopterus annectens. The stop codon is indicated 












Appendix 2b. The nucleotide sequence and the translated amino acid sequence of 
myogenic differentiation 1 (myod1)/Myod1 from the muscle of Protopterus annectens. 





Appendix 2c. The nucleotide sequence and the translated amino acid sequence of 
myogenin (myog)/Myog from the muscle of Protopterus annectens. The stop codon is 





Appendix 2d. The nucleotide sequence and the translated amino acid sequence of 
mitogen-activated protein kinase 1 (mapk1)/Mapk1 from the muscle of Protopterus 









Appendix 2e. The nucleotide sequence and the translated amino acid sequence of 
mitogen-activated protein kinase 3 (mapk3)/Mapk3 from the muscle of Protopterus 









Appendix 2f. The nucleotide sequence and the translated amino acid sequence of 
histone deacetylase 1 (hdac1)/Hdac1 from the muscle of Protopterus annectens. The 









Appendix 2g. The nucleotide sequence and the translated amino acid sequence of 
forkhead box O1 (foxO1)/FoxO1 from the muscle of Protopterus annectens. The stop 











Appendix 2h. The nucleotide sequence and the translated amino acid sequence of 
forkhead box O3 (foxO3)/FoxO3 from the muscle of Protopterus annectens. The stop 












Appendix 2i. The nucleotide sequence and the translated amino acid sequence of 
myostatin (mstn)/Mstn from the muscle of Protopterus annectens. The stop codon is 








Appendix 2j. The nucleotide sequence and the translated amino acid sequence of F-
box protein 32 (fbxo32)/Fbxo32 from the muscle of Protopterus annectens. The stop 
codon is indicated by an asterisk. 
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